Unnamed: 0,patient_filename,t,text,type,n,cmem_n_reasoning,cmem_n_ans_str,cmem_n_num_update
664,TCGA-A8-A095.41A41A7F-E4DD-4D3A-B97D-B4657CA211E1,0,"2. Invasive ductal breast carcinoma (maximum diameter 1.8 cm, malignancy grade II) with. angioinvasion and infiltration of the neural sheath in the tumor periphery. Likewise in the. tumor periphery a concomitant DCIS (malignancy grade II, procomponent of tumor < 10%). Distant fibrocystic parenchyma of the breast with fibroadenoma buds free of tumor and/or. DCIS. Tumor classification: G2 (L1, V0), pTlc, pNO (sn), MX, R0 (minimum width of dorsocranial. safety margin 1 cm!). 1711E1.",BRCA,0,"The report states 'pNO (sn)', which indicates that there is no evidence of cancer in the regional lymph nodes (N0) based on sentinel lymph node sampling. The N stage is determined by the presence and extent of cancer in the regional lymph nodes.",N0,0.0
618,TCGA-A8-A06Z.956F45E5-A8C6-4A4A-9D1F-D31912180584,2,"Diagnosis: 1. Moderately differentiated invasive ductal carcinoma (tumor diameter: 8 cm). Distance to dorsal resection margin less than 0.1 cm. Concluding tumor classification for the right breast: NOS, G II, pT3LOVORX.",BRCA,0,"The pathology report does not mention any involvement of regional lymph nodes (axillary, internal mammary, or supraclavicular) in the context of breast cancer. Therefore, based on Rule 2, the N stage is N0, indicating no evidence of cancer in the regional lymph nodes.",N0,1.0
621,TCGA-A8-A079.81ADDBAB-C02F-4DA8-9429-76293FB42E42,3,"Diagnosis: Ablated breast sample with a multifocal poorly differentiated invasive ductal. carcinoma (tumor diameter: 7 cm, 2.2 cm and 1.7 cm), the largest tumor focus with. focal ulceration of the skin and circumscribed intraductal spread. Focal. angioinvasion. Tumor-free dorsal resection margin. Together with the preliminary finding, this gives rise to the following tumor. classification: NOS, G III, pT4b(mult)N3aL1V0R0.",BRCA,3,"The report mentions 'pT4b(mult)N3aL1V0R0', indicating that the patient has regional lymph node involvement (N3a) with metastasis in at least 10 axillary lymph nodes (L1). This suggests that the N stage is N3.",N3,2.0
549,TCGA-A2-A3KC.593AF241-8F84-4BA0-8878-7C1CE72A460B,1,"Chief of Pathology. Specimen: !tatus: SOUT. Spec Type: SURGICAL P. GROSS DESCRIPTION. C RECEIVED LABELED. RIGHT NONSENTINEL NODE #1 IS A 3.4. x 2 x 1.5 CM PORTION OF YELLOW FATTY TISSUE WHICH IS A GROSSLY FAT. REPLACED LYMPH NODE SUBMITTED ENTIRELY LABELED C1 THROUGH C3. D RECEIVED LABELED. RIGHT BREAST SIMPLE MASTECTOMY. STITCH AT 12 O' CLOCK IS A 1,250 GRAM SIMPLE MASTECTOMY WHICH INCLUDES. 4. IRREGULAR ADDITIONAL FRAGMENTS OF YELLOW-RED FATTY TISSUE IN AGGREGATE. MEASURING 9 x 7 x 1 CM. THIS TISSUE IS NOT ORIENTED. THE MASTECTOMY. ITSELF MEASURES 28.5 x 21 x 5 CM. THE NIPPLE IS FLATTENED AND SITS. WITHIN A 26 x 13 CM SKIN ELLIPSE. THERE IS PALPABLE FIRMNESS IN THE. LOWER OUTER QUADRANT. THE SUPERFICIAL ASPECT OF THE MASTECTOMY IS. MARKED WITH BLUE INK, THE DEEP WITH BLACK. SECTIONING REVEALS 2. DISTINCT FIRM MASSES, ONE IN THE 12 O'CLOCK AREA AND THE 2ND. CORRESPONDING TO THE PALPABLE FIRMNESS IN THE LOWER OUTER QUADRANT. THIS HAS A RIBBON CLIP AND THE 12 O' CLOCK LESION HAS A WING CLIP. THE. DEEP MARGIN ASSOCIATED WITH THE LOWER OUTER QUADRANT LESION IS FIRM AND. PINK-TAN FIBROUS TISSUE DOES EXTEND TOWARDS THE MARGIN BUT THE ACTUAL. FIRM MASS IS GROSSLY WITHIN THE CONFINES. THE LOWER OUTER MASS MEASURES. 2.5 x 2.5 x 2.5 CM. THE 12 O'CLOCK MASS IS SEPARATED BY 3 CM OF TISSUE. AND MEASURES 3.5 X 2.5 x 2.5 CM IN GREATEST DIMENSION. ADDITIONAL. PINK-TAN FIBROUS TISSUE IS FOUND IN THE MIDPORTION OF THE SPECIMEN WHICH. IS THEN SURROUNDED BY YELLOW FATTY TISSUE. SECTIONS ARE SUBMITTED AS. FOLLOWS: D1--NIPPLE, D2 AND --DEEP MARGIN OVER LOWER OUTER QUADRANT. LESION, D4--DEEP MARGIN TO 12 O' CLOCK LESION, D5 AND 6--12 O' CLOCK. LESION, D7 THROUGH --LONGITUDINAL SECTION OF 12 0'CLOCK LESION,. D10--TISSUE BETWEEN THE 2 LESIONS, D11 AND 12 -LOWER OUTER QUADRANT. LESION LONGITUDINAL SECTION, D13--TUMOR LOWER OUTER QUADRANT. THE. TISSUE TO THE 6 O'CLOCK MARGIN OF THE LOWER OUTER QUADRANT LESION IS. NODULAR AND FOCALLY THERE IS BROWN DISCOLORATION. A SECTION IS. SUBMITTED IN D14. THIS IS 1 CM FROM THE LOWER OUTER QUADRANT LESION AND. 5 CM FROM THE 12 0'CLOCK LESION. OTHER NODULES DEMONSTRATE CYSTS AS A. SECTION IN D15 DEMONSTRATES. D16--UPPER INNER QUADRANT (3 CM FROM 12. O' CLOCK LESION), 17--UPPER OUTER QUADRANT (5 CM FROM 12 O' CLOCK. LESION), D18--LOWER OUTER QUADRANT (3 CM FROM LOWER OUTER QUADRANT. LESION) , 019--LOWER INNER QUADRANT (3 CM FROM LOWER OUTER QUADRANT. LESION) THE SEPARATELY SUBMITTED PORTIONS OF FATTY TISSUE ARE GROSSLY. UNREMARKABLE AND REPRESENTATIVE TISSUE IS SUBMITTED IN D20 AND 21. E RECEIVED LABELED. RIGHT AXILLARY NODE CONTENTS IS. YELLOW-RED FATTY TISSUE MEASURING 12 x 9.5 x 2.5 CM. THE TISSUE IS. EXAMINED FOR LYMPH NODES. LYMPH NODES ARE IDENTIFIED AND SUBMITTED AS. FOLLOWS: E1--ONE-HALF OF A FIRM NODE WITH MIRROR IMAGE SUBMITTED PER. PROTOCOL, E2--1 NODE BISECTED, E3--1 NODE BISECTED (MAY ACTUALLY. REPRESENT 2 IMMEDIATELY ADJACENT NODES), E4--1 NODE TRISECTED, E5--1. NODE BISECTED, E6--1 NODE BISECTED, E7--1 NODE TRISECTED, E8--3 NODES (1. BISECTED), E9--6 NODES, E10-- NODE BISECTED. /F. Specimen. Spec Type: SURGICAL P. PREOPERATIVE DIAGNOSIS. RIGHT BREAST CANCER INVASIVE. OPERATION PERFORMED. DOCTOR (s) : PROCEDURE: SENTINEL NODE Bx/LYMPHADENECTOMY/STMPLE MASTECTOMXY/AXILLARY. PROCEDURE (CONT) : NODE DISSECTION. TISSUE REMOVED. A. RT SENTINEL NODE #1 - FS. B. RT SENTINEL NODE #2 - FS. C. RT AXILLARY NON SENTINEL NODE. D. RT BREAST SIMPLE MASTECTOMY. E. RT AXILLARY NODE CONTENTS. FROZEN SECTION DIAGNOSIS. A. NEGATIVE FOR TUMOR. B. METASTATIC CARCINOMA. GROSS DESCRIPTION. THE SPECIMEN IS RECEIVED IN 5 PARTS. PART A IS RECEIVED DESIGNATED. RIGHT AXILLARY SENTINEL. NODE 1 GAMMA. HOT AT. IT IS RECEIVED IN THE FRESH STATE FOR. FROZEN SECTION AND CONSISTS OF A 3.5 X 2.3 x 0.5 CM FRAGMENT OF. YELLOWISH-PINK FIBROADIPOSE TISSUE WITH 2 PALPABLE NODULES MEASURING 2 x. 1.2 x 0.6 CM AND 0.8 x 0.8 x 0.5 CM. EACH NODULE IS PINKISH-RED AND. SECTIONING SHOWS REDDISH-PINE CROSS SECTION. ONE-HALF OF EACH IS. SUBMITTED FOR FROZEN SECTION LABELED FSA. SUBSEQUENT TO THE FROZEN. SECTION, THE FROZEN TISSUE IS SUBMITTED FOR PERMANENTS LABELED FSA. THE. REMAINING UNFROZEN NODULES ARE SUBMITTED FOR PERMANENTS LABELED A. PART B IS RECEIVED DESIGNATED. RIGHT AXILLARY SENTINEL. NODE 2 GAMMA. HOT/BLUE AT. IT IS RECEIVED IN THE FRESH STATE. FOR FROZEN SECTION AND CONSISTS OF A 2.7 x 2.1 x 0.5 CM FRAGMENT OF. YELLOWISH-PINK FIBROADIPOSE TISSUE WITH PALPABLE NODULE. THE NODULE IS. ISOLATED AND FOUND TO MEASURE 1.7 x 1.4 X 0.5 CM. THE NODULE IS. BISECTED SHOWING A REDDISH-PINK RIM SURROUNDING YELLOW ADIPOSE TISSUE. WITH A GLISTENING WHITISH-TAN NODULE AT ONE MARGIN MEASURING 0.4 CM IN. DIAMETER. SUBSEQUENT TO THE FROZEN SECTION, THE FROZEN TISSUE IS. SUBMITTED FOR PERMANENTS LABELED FSB. THE REMAINDER OF THE NODULE IS. SUBMITTED FOR PERMANENTS LABELED B. Specimen: Req# : spec Type: SURGICAL P. GROSS DESCRIPTION. PATH PROCEDURES. PROCEDURES: 88305, 88307/2, 88309, PATH FS /2, A BLK, B BLK, C BLK, D BLK/21, E BLK/10,. FS-A, FROZ.SEC.-B. FINAL DIAGNOSIS. PART A RIGHT AXILLARY NO EVIDENCE OF %/ISN. SENTINEL LYMPH NODE #1, BIOPSY: MALIGNANCY. PART B RIGHT AXILLARY SENTINEL LYMPH NODE #2, BIOPSY: METASTATIC. BREAST CARCINOMA HAVING A MAXIMUM MICROSCOPIC DIMENSION OF 0.6 CM IS. IDENTIFIED IN 1 LYMPH NODE EXAMINED. THERE IS NO EVIDENCE OF EXTRANODAL. EXTENSION OF TUMOR. PART C RIGHT AXILLARY NONSENTINEL LYMPH NODE, BIOPSY: NO EVIDENCE OF. MALIGNANCY IN 1 LYMPH NODE EXAMINED. PART D RIGHT BREAST, SIMPLE MASTECTOMY: MULTICENTRIC INTRALOBULAR, AND INFILTRATING LOBULAR CARCINOMA OF THE. 1. PLEOMORPHIC TYPE. THE INVASIVE COMPONENT SHOWS NUCLEAR GRADE 2/3,. LOW MITOTIC INDEX, AND TUBULE FORMATION 3 WITH TOTAL NOTTINGHAM SCORE. OF 6. LCIS OF THE PLEOMORPHIC TYPE, NUCLEAR GRADE 2/3, AND LOW 50% LCIS 8 2. MITOTIC INDEX COMPRISES APPROXIMATELY 50% OF THE TUMOR. 2. THE LARGEST FOCUS OF INVASIVE TUMOR MEASURES 3.5 CM IN GREATEST. DIMENSION AND IS LOCATED IN THE 12 O'CLOCK PORTION OF THE BREAST. THE SECOND LARGEST MEASURES 2.5 CM AND IS SEEN IN THE LOWER OUTER. QUADRANT. ADDITIONAL SMALLER FOCI OF INVASION MEASURING FROM 1 MM TO. 5 MM IN GREATEST DIMENSION ARE PRESENT. LCIS IS SEEN ON 14 OF 21. BLOCKS EXAMINED HAVING A MAXIMUM CALCULATED DIMENSION OF 5.6 CM. 3. THE MARGINS OF RESECTION AND NIPPLE SKIN ARE FREE OF TUMOR. 4. LYMPHOVASCULAR INVASION IS NOT IDENTIFIED. 5. PROLIFERATVE FIBROCYSTIC CHANGES INCLUDING INTRADUCTAL PAPILLOMAS,. INTRADUCTAL PAPILLOMATOSIS, MICROSCOPIC COMPLEX SCLEROSING LESIONS,. ADENOSIS, APOCRINE METAPLASIA, MICROCYST FORMATION, PATCHY DENSE. STROMA AND RARE LUMINAL CALCIFICATIONS. Specimen: Received: (. spec Type: SURGICAL P. FINAL DIAGNOSIS. 6. THE BIOPSY SITES (. ARE PRESENT. PART E RIGHT AXILLA, LYMPH NODE DISSECTION: METASTATIC BREAST. CARCINOMA IS IDENTIFIED IN 1 OF 16 LYMPH NODES EXAMINED. NO EVIDENCE OF. EXTRANODAL EXTENSION BY TUMOR. CODE. 1. (prelim.).",BRCA,1,"Based on the pathology report, sentinel lymph node sampling was performed and metastatic breast carcinoma was identified in 1 out of 16 lymph nodes examined in the right axilla (part E). This indicates that the patient has cancer involvement in regional lymph nodes, which corresponds to N1 stage according to the AJCC staging system for breast cancer.",N1,3.0
516,TCGA-A2-A0T1.7546B7FB-1976-4994-AFB7-6270382D44D7,2,"SURGICAL REPORT. Sex: F. Date Collected: Date Received: M.R. Number. Doctor: Account Number. PRE-OPERATIVE DIAGNOSIS. RIGHT BREAST CANCER. POST-OPERATIVE DIAGNOSIS. RIGHT BREAST CANCER. PROCEDURE. RIGHT BREAST LUMPECTOMY WITH FULL AXILLARY NODE DISSECTION. TISSUES. A. BREAST EXCISION, NEEDLE LOC,SIMPLE,MARGINS,ETC.- - RIGHT BREAST. LUMPECTOMY. B. AXILLARY - CONTENTS. C. MARGINS - RIGHT BREAST. FS DIAGNOSIS. A. RIGHT BREAST LUMP (GROSS MARGINS) -. TUMOR EXTENDS TO SUPERIOR MARGIN, NEAR SKIN. (Reported to surgeon: Diagnosed by: FINAL DIAGNOSIS. A. RIGHT BREAST LUMP NEEDLE LOC -. POORLY DIFFERENTIATED INVASIVE DUCTAL CARCINOMA, 7.5 CM. IN GREATEST. DIMENSION, EXTENDING TO SUPERIOR INKED SURGICAL MARGIN. SCARFF-BLOOM-RICHARDSON BREAST CANCER HISTOLOGIC SCORE, 9. (3+3+3). HIGH NUCLEAR GRADE DUCTAL CARCINOMA IN-SITU (DCIS) COMPONENT WITH. CENTRAL NECROSIS AND CALCIFICATION EXTENDS WITHIN LESS THAN 0.1 CM. OF THE SUPERIOR SURGICAL MARGIN. REMAINING DESIGNATED SURGICAL MARGINS ARE FREE OF TUMOR. PATHOLOGIC TNM STAGE: T3 N3 MX, STAGE IIIC, G3, INVASIVE DUCTAL CARCINOMA. PQRI CATEGORY II: 3260F. B. AXILLARY CONTENTS -. TEN (10) REGIONAL LYMPH NODES POSITIVE FOR METASTATIC INVASIVE. SURGICAL REPORT. DUCTAL CARCINOMA. C. RIGHT BREAST MARGINS -. SKIN AND ATTACHED FIBROFATTY BREAST TISSUE, NEGATIVE FOR. MALIGNANCY. Diagnosed by: (. Revlawed and alecimnicallu signed out by: GROSS DESCRIPTION. The specimen is received in three separate containers labele. unated A, B,. C. A. The container is received fresh unfixed labeled ""right breast lump"" and consists of a 67 gm. ovoid. mass of apparent fatty and fibrous-encased tissue which is 7.5 : 7.5 x 3 cm. in greatest overall. dimension. The attached skin ellipse is 4 x 1 cm. There is a single short suture indicating. superior margin inked with black dye, inferior is inked orange. There is a single long suture. indicating lateral margin inked with blue dye, medial is inked green. The skin represents the. anterior margin, posterior is inked with red dye. Sectioning reveals an irregular bordered tan-gray. firm slightly whorled nodule with scattered hemorrhagic areas varying up to 3.5 cm. in greatest. overall dimension and grossly appears to be less than 0.1 cm. from the superior margin and. directly beneath the ellipse of skin. Gross margins are observed by Dr. The tumor. mass grossly appears to be approximately 1.5 cm. from the inferior, 1 cm, from the lateral, 1 cm. from the medial directly beneath the anterior, and 1 cm. from the posterior. The specimen is. submitted in tweive blocks. Key Note Block Summary: 1-superior, 2-inferior, 3-lateral, 4-medial, 5-anterior, 6-. posterior, 7 through 12-random. B. The container is received fresh unfixed labeled ""axillary contents"" and consists of an irregular. mass of apparent fat which is 13 x 12 x 4 cm. in greatest overall dimension. Sectioning reveals. firm tan-gray nodules varying up to 7 cm. in greatest dimension. The largest has scattered green-. black areas and scattered yellow-tan chalky material. The specimen is submitted in seven. blocks. C. The container is received fresh unfixed labeled ""additional right breast margin -skin represents. the anterior margin, suture on new superior margin"" and consists of an ellipse of skin with. attached underlying soft tissue which is 7 x 2.5 x 0.4 cm. in greatest overall dimension. There is. an attached suture indicating new superior margin inked with black dye. The entire specimen is. submitted in five blocks. MICROSCOPIC EXAM. MICROSCOPIC EXAMINATION CONDUCTED BY PATHOLOGIST CONFIRMS FINAL DIAGNOSIS. SURGICAL REPORT.",BRCA,3,"The report mentions 'ten (10) regional lymph nodes positive for metastatic invasive ductal carcinoma' under the 'Axillary Contents' section. According to Rule 3, N1, N2, and N3 indicate increasing involvement of regional lymph nodes. Based on Rule 9, N1 stage indicates metastasis in 1 to 3 axillary lymph nodes. Since there are 10 positive lymph nodes, the N stage is at least N3.",N3,4.0
503,TCGA-A2-A0ET.E9D3FFF1-5FB2-4F17-9C1D-D9775E3CC5AC,1,"Specimen #: Race: WHITE. Physician (s) : SPECIMEN: A: RIGHT BREAST LUMPECTOMY. B: RIGHT AXILLARY NODE DISSECTION. FINAL DIAGNOSIS: A. BREAST, RIGHT, LUMPECTOMY: TUMOR TYPE: INVASIVE DUCTAL CARCINOMA. NOTTINGHAM GRADE: MODERATELY DIFFERENTIATED (G2). NOTTINGHAM SCORE: 6/9. (Tubules= 2, Nuclei=2, Mitoses= 2; mitotic count 10 per 10 HPF at. 20x power-0.5 field diameter). TUMOR SIZE (GREATEST DIMENSION) : 1.9 CM (measured microscopically) . TUMOR NECROSIS: ABSENT. MICROCALCIFICATIONS: ABSENT. VENOUS / LYMPHATIC INVASION: ABSENT. MARGINS : - INVASIVE CARCINOMA PRESENT 1.2 CM FROM ANTERIOR MARGIN. DUCTAL CARCINOMA IN SITU PRESENT 0.5 CM FROM INFERIOR MARGIN. INTRADUCTAL COMPONENT: DUCTAL CARCINOMA IN SITU, CRIBIFORM TYPE, LOW. NUCLEAR GRADE. LYMPH NODES: FIVE OF SIXTEEN POSTIVE FOR TUMOR. (see specimen B). SKIN INVOLVEMENT: ABSENT. MULTICENTRICITY: ABSENT. ESTROGEN RECEPTORS: POSITIVE. (see. PROGESTERONE RECEPTORS NEGATIVE. (see. HER 2 NEU by IHC: NEGATIVE. (see. PATHOLOGIC STAGE: pT1c N2a Mx. ADDITIONAL PATHOLOGIC CHANGES: BENIGN FIBROCYSTIC CHANGES. B. SOFT TISSUE, RIGHT AXILLA, LYMPH NODE DISSECTION: - FIVE OF SIXTEEN LYMPH NODES POSITIVE FOR METASTATIC CARCINOMA. Specimen #: CLINICAL DIAGNOSIS AND HISTORY: -year-old female with 2.0 cm right breast mass found on routine. mammagram. Patient was also found to have two lymph nodes seen. largest 1.5 cm, BIRIDS-5 Ultrasound guided biopsy of breast mass showed. Grade I Invasive Ductal Carcinoma with DCIS and FNA of axillary lymph node. showing metastatic carcinoma from primary breast on. PRE-OPERATIVE DIAGNOSIS: Right breast cancer. GROSS DESCRIPTION: A. Received fresh, labeled with the patient's name,. designated ""RIGHT BREAST LUMPECTOMY"" is an irregular, oblong portion of. soft tissue oriented with a short stitch superior and a long stitch. medial. The specimen measures 14.0 cm in medial to lateral, 7.0 cm. superior to inferior, and 2.5 cm anterior to posterior. The lightly. pigmented superficial skin ellipse measures 8.5 x 2.2 cm and is otherwise. unremarkable. The specimen is inked as follows superior = blue, inferior. = green, medial = red, lateral = yellow, anterior = orange, and posterior. = black. Serial sections reveal a firm, pink-white, gray mass measuring. 3.3. x 2.2 x 1.5 cm. The mass is well circumscribed, and approaches the. margins as follows: 0.2 cm from the deep margin, 0.5 cm from the anterior. margin, 1.5 cm from the inferior margin, and 1.8 cm from the superior. margin. The remainder of the specimen is predominantly composed of. lobulated, yellow-tan, adipose tissue. The fibrous tissue comprises. 5%. of. the cut surface, and is tan-white, markedly dense, and otherwise. unremarkable. Representative sections are submitted as follows: Cassette Summary : A1: Mass. A2: Adjacent normal. A3: Skin. A4-A5: Additional sections adjacent to mass. A6-A9: Additional sections of mass. A10-12 Additional sections adjacent to A1 and A9. Matched sections of A1-A2 are submitted in. or CBCP protocol. The specimen was placed in formalin at. pm for a total time in. formalin for approximately 28 hours. B. Received fresh, labeled with the patient's name,. designated ""RIGHT AXILLARY NODE DISSECTION"" is an 11.0 x 8.0 x 2.5 cm. irregular, unoriented portion of soft tissue. Serial sectioning reveals. Y. Specimen # : GROSS DESCRIPTION (continued). 16 lymph nodes ranging in size from 0.7 x 0.7 x 0.5 cm to 4.0 x 2.0 x 1. . 0. cm. On sectioning, four of the lymph nodes show a firm, pink-tan, cut. surface consistent with metastatic involvement. The remaining lymph nodes. are pink-yellow and otherwise unremarkable. Representative sections are. submitted as follows: Cassette Summary : B1-B4: Largest lymph node. B5: Lymph node #1. B6: Lymph node #2. B7: Lymph node #3. B8: Lymph node #4. B9: One lymph node. B10: One lymph node. B11: One lymph node bisected. B12: One lymph node bisected. B13: One lymph node bisected. B14: Two lymph nodes, each bisected. B15: Four lymph nodes. Matched sections of B1, B5-B10 - are submitted in. or CBCP protocol.",BRCA,2,"Based on the pathology report, the patient has 5 out of 16 positive lymph nodes in the right axillary node dissection. This corresponds to N2a stage in the AJCC staging system for breast cancer.",N2,5.0
509,TCGA-A2-A0ST.1E8B978E-3D1B-46E8-80EE-3A11EE571CEC,0,"Patient: : Specimen # : Race: WHITE. AMENDED. SPECIMEN: A: RIGHT BREAST BIOPSY B: SENTINEL LYMPH NODE#1. C: SENTINEL LYMPH NODE#2. FINAL DIAGNOSIS: A. BREAST, RIGHT; EXCISION: - INFILTRATING DUCTAL CARCINOMA, POORLY DIFFERENTIATED (MODIFIED. BLOOM-RICHARDSON GRADE 9: MITOSES=3, NUCLEAR PLEOMORPHISM=3, TUBULE. FORMATION=3). -TUMOR SIZE 2.0 CM. - -TUMOR IS LESS THAN 0.1 CM FROM ANTERIOR AND MEDIAL SURGICAL MARGINS. - -ASSOCIATED FINDINGS: FIBROCYSTIC CHANGES INCLUDING STROMAL SCLEROSIS. AND MICROCYSTS. -MICROCALCIFICATIONS IDENTIFIED, ASSOCIATED WITH BENIGN BREAST TISSUE. - IMMUNOHISTOCHEMICAL STAINS FOR ESTROGEN AND PROGESTERONE AS FOLLOWS. ESTROGEN RECEPTOR: NEGATIVE. PROGESTERONE RECEPTOR: POSITIVE. -HER2/NEU (FISH METHODOLOGY) : NOT AMPLIFIED (1.3). B. LYMPH NODE, SENTINEL LYMPH NODE#1, BIOPSY: -ONE (1) LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA ON H AND E AND. IMMUNOHISTOLOGIC SECTIONS. -TUMOR SEEN IS APPROXIMATELY 0.5 CM IN SIZE. C. LYMPH NODE, SENTINEL LYMPH NODE#2, BIOPSY: -ONE (1) LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA ON H AND E AND. IMMUNOHISTOLOGIC SECTIONS. -TUMOR SEEN LESS THAN 0.1 CM IN SIZE. COMMENT: This case is amended to reflect the review of. immunohistochemical stains for estrogen and progesterone receptors and. FISH for Her2/neu amplification. There is no change in diagnosis. COMMENT. ge 1. specimen #: FINAL DIAGNOSIS (continued) : Case amended. to report results of HER2 analysis by. immunohistochemistry (DAKO Hercep Test) : HER2/NEU PROTEIN OVEREXPRESSION: NEGATIVE (SCORE: 1+) . CLINICAL DIAGNOSIS AND HISTORY: -year-old female with palpable mass on right breast with no ultrasound. or mammographic correlation. GROSS DESCRIPTION: A. RIGHT BREAST BIOPSY received in formalin, labeled with the patient's. name, designated ""RIGHT BREAST EXCISIONAL BIOPSY"" is a lumpectomy specimen. measuring 10.2 x 7.0 x 3.0 cm in dimension. The specimen is composed. largely of yellow, lobulated, glistening adipose tissue admixed with white. fibrous areas. The specimen will be inked and oriented as follows: Black=deep, yellow=anterior, blue=medial, green=lateral, and red denotes. superficial and inferior. The specimen is serially sectioned from superior. to inferior revealing a fiarly well-defined, grey/tan nodule, 1.5 cm in. greatest dimension, abutting the anterior margin in the mid portion of the. specimen. Immediately adjacent to this nodule is a 1.5 cm patch of. indurated fibrous tissue involving the anterior and medial margins. The. remaining tissue consists of an admixture of fibrous tissue (approximately. 40%) and fat (approximately 60%) . The fibrous tissue is variably. indurated, particularly in the inferior half of the specimen. Sections of. nodule and fibrous tissue are harvested for the CBCP protocol. Matching. paraffin sections are as follows: A1: Nodule. A2: Indurated fibrous tissue adjacent to A1. A3: Fibrous tissue 3.0 cm inferior to nodule. A4: Fibrous tissue 6.0 cm inferior to nodule at the inferior margin. The remainder of the specimen is serially sectioned and submitted from. superior to inferior as follows: A5-A12: Representative section from each level from superior to inferior. Specimen #: GROSS DESCRIPTION (continued) : A13-A14: Next lower level. A15-A16: Next lower level. A17-A18 Inferior most section. B. SENTINEL LYMPH NODE#1 received in formalin, labeled with the patient'. name, designated ""SUPERIOR LYMPH NODE NUMBER ONE"" is a 1.7 x 1.3 x 0.8 cm. lymph node. A small portion of the node is harvested for the CBCP. protocol. The remaining tissue is entirely submitted in cassette B1. C. SENTINEL LYMPH NODE#2 received in formalin, labeled with the patient' S. name, designated ""SENTINEL LYMPH NODE NUMBER TWO"" is a 1.2 x 0.8 x 0.5 cm. tan/brown lymph node. The tissue is entirely submitted in cassette C1.",BRCA,1,"Based on the pathology report, there are positive metastatic carcinomas found in 2 out of 2 sentinel lymph nodes (SLN) examined. The size of the metastasis in SLN#1 is approximately 0.5 cm and in SLN#2 is less than 0.1 cm. According to the rules provided, specifically New Rule 9, N1 stage indicates metastasis in 1 to 3 axillary lymph nodes. Therefore, the N stage for this patient is N1.",N1,6.0
610,TCGA-A8-A06O.EB9B8904-F6CC-451F-8628-50CC71F1F7C3,0,"Diagnosis: Poorly differentiated invasive ductal carcinoma with focal intraductal spread. (maximum microscopic tumor diameter: 1.5 cm; distance from nearest resection. margin less than 0.1 cm) with multiple ulcerations of the skin. Diagnosis: 1. Ablated breast sample with a further focus of poorly differentiated invasive ductal. carcinoma (tumor diameter: 1.5 cm; distance from dorsal margin 0.8 cm and from. nearest lateral resection margin 1 cm, other margins remain free). Concluding tumor classification: NOS, G III, pT1c(m)pNO(0/13)LOVORO.",BRCA,0,"The report mentions pNO(0/13), which indicates that out of 13 examined lymph nodes, there is no evidence of cancer involvement in any of them. According to the provided rules, N0 indicates no evidence of cancer in the regional lymph nodes (Rule 2).",N0,7.0
585,TCGA-A7-A26I.CCE33A95-774E-4242-B2A1-05FF002ED1D9,1,"Date Coll: SPECIMEN. A. Left axillary sentinel node. B. Left breast mass. Long stitch anterior, short stitch superior. CLINICAL NOTES. PRE-OP DIAGNOSIS: Left breast cancer. CLINICAL HISTORY: year-old white female with breast cancer. POST-OP DIAGNOSIS: Left breast cancer. GROSS DESCRIPTION. A. Received fresh labeled ""left axillary sentinel nodes"". are two slightly rubbery tan-white-pink tissues in keeping. with lymph nodes measuring 0. and 1.0 cm. in greatest dimension. The specimens are bisected and entirely submitted independently in. two blocks (one bisected tissue per cassette). B. Received fresh within a TranSpec container labeled. 'left breast mass"" is a 7.3 cm. (medial to lateral) x 6.5. cm. (superior to inferior) x 3.7 cm. (anterior to posterior), soft,. lobulated tan gold-white portion of fibroadipose tissue with two. sutures as stated previously. The margins are inked as follows: Anterior - blue, posterior - black, superior - green, and inferior. orange. The specimen is sectioned from medial to lateral. There is. a central, moderately well-circumscribed, 3.2 cm. (medial to. lateral) x 2.5 cm. (superior to inferior) x 2.4 cm. (anterior to. posterior), firm tan white tumor mass with several central. associated cylindrical tan white structures in keeping with cyte of. prior needle core biopsy. A portion of tumor and a portion of. normal parenchyma are submitted for tissue procurement as requested. The tumor appears to focally extend to within 0.3 cm. of both the. anterior and posterior inked margins. The cut surfaces throughout. the remainder of the specimen consist predominantly of glistening. lobulated golden yellow adipose tissue with a minimal amount of. interspersed dense tan-white fibrous tissue. No additional. abnormality is noted. Representative sections are submitted in. a. sequential manner from medial to lateral in 10 blocks as labeled. BLOCK SUMMARY: 1 - Representative perpendicular sections medial. margin cap; 2-9 sequential sections; 10 - representative. perpendicular sections lateral margin cap. MICROSCOPIC DESCRIPTION. A. Microscopic examination involved the evaluation of the. four H&E stained sections of each of the tissue blocks. Also pan cytokeratin AE1/AE3 immunohistochemical stains were. evaluated of each tissue block and no metastatic tumor was. identified in any of the examined sections (0/2) (snpNO). B. Microscopic examination of the left breast lumpectomy. specimen reveals: Invasive Carcinoma: Present. Histologic type: Infiltrating ductal. Histologic grade: Elston's SBR grade 2. Overall grade: 2. Architectural score: 2. Nuclear score: 2. Mitotic score: 2. Greatest dimension (pT) : 3.2 cm. in greatest dimension (pT2). Specimen margins: The resection margins are negative for. carcinoma with the closest resection margins being superior and. anterior where invasive tumor is 2 mm. from the resection. margin. Tumor is 3 mm from the posterior resection margin. Vessel invasion: Not identified. Calcification: Present. Ductal carcinoma in situ: Present. Histologic pattern: Solid with cancerization of lobules. Nuclear grade: High grade. Central necrosis: Absent. % DCIS of total tumor (if mixed) : Less than 10%. Extensive intraductal component (present/absent) : Absent. Specimen margins: DCIS is 2 mm from the anterior and superior. margins and 3 mm from the posterior margin. Calcification: not identified. Description of non-tumorous breast: Fibrosis, apocrine metaplasia. and microcysts with sclerosing adenosis. Prognostic markers, Umpon been reported previously on the core. biopsy see. 4x2, 20x1. DIAGNOSIS. A. Left axillary sentinel lymph nodes, biopsy: Two lymph nodes negative for metastatic tumor (0/2). B. Left) breast, lumpectomy: Invasive ductal carcinoma, Elston's SBR grade 2, tumor size. 3.2 cm. Associated high grade solid ductal carcinoma in-situ. Invasive and in-situ carcinoma are 2 mm from the resection. margins designated superior and anterior and 3 mm from the. resection margin designated posterior. No lymphovascular space invasion identified. See microscopic description. (Electronic Signature). End Of Report ---.",BRCA,0,"The report states that the sentinel lymph nodes were negative for metastatic tumor (0/2). This indicates no evidence of cancer in the regional lymph nodes, which corresponds to N0 stage according to Rule 2 and Modified Rule 8.",N0,7.0
622,TCGA-A8-A07B.F24A752C-1AAE-4C70-B6D4-DD0E8C89D9AA,1,"Diagnosis: Poorly differentiated invasive ductal carcinoma (tumor diameter: 3.0 cm). Concluding tumor classification: NOS, G III, pT2LOVORO.",BRCA,0,"The pathology report does not mention any involvement of regional lymph nodes. According to Modified Rule 8, if the pathology report does not mention any involvement of regional lymph nodes, the N stage is N0.",N0,7.0
661,TCGA-A8-A092.93D66EAD-B7D3-4688-8EC9-75C4380619D9,1,Diagnosis: 5. Moderately differentiated invasive ductal carcinoma (tumor diameter: 3.8 cm) with. focal intraductal components and focal angioinvasion. NS.,BRCA,2,"The pathology report does not mention any involvement of regional lymph nodes. Therefore, based on Modified Rule 8, the N stage is N0.",N0,7.0
586,TCGA-A7-A26J.5CC0C09F-70F6-458A-B8E6-18BDC074BE74,1,"Date Coll: SPECIMEN. A. Left axillary sentinel node. B. Left breast silk on superior breast. CLINICAL NOTES. PRE-OP DIAGNOSIS: Left breast cancer. CLINICAL HISTORY: year-old white female with cancer. POST-OP DIAGNOSIS: Same. GROSS DESCRIPTION. A. Received fresh labeled ""left axillary node"" is a 3.8. x. 2.4 x 0.6 cm. portion of soft, lobulated golden-yellow. adipose tissue. Two (2) slightly rubbery tan-pink tissues in. keeping with lymph node measuring 0.8 and 1.8 cm. in greatest. dimension are recovered. The specimen is entirely submitted in. three blocks as labeled: BLOCK SUMMARY: #A1,A2 - One (1) bisected lymph node per cassette;. -1 adipose tissue. B. Received fresh labeled ""left breast"" is a 21.5 cm. (superior to inferior) x 20.5 cm (medial to lateral) x 3.8. cm (anterior to posterior) diffusely cauterized soft, lobulated. tan-gold-white portion of fibroadipose tissue in keeping with breast. designated as left per requisition slip and container and oriented. by a single suture as stated previously. A 7.2 cm (medial to. lateral) x 4.7 cm (superior to inferior) tan-white skin ellipse is. present along the anterior aspect. The intact deep margin is inked. black and the specimen is sectioned. There is a central, stellate,. 3.0 cm (medial to lateral) x 2.2 cm (superior to inferior) x 2.0. cm. (anterior to posterior) rubbery tan-white lesion at the junction of. the four quadrants with several cylindrical tan-white structures in. keeping with site of prior needle core biopsy. A portion of the. lesion and a portion of normal are submitted for tissue procurement. as. requested. The lesion is present within 0.8 cm of the skin. surface in the vicinity of the nipple and is within 0.5 cm of the. inked deep margin. The parenchyma throughout the remainder of the. specimen consists predominantly of glistening lobulated golden. yellow adipose tissue with a moderate amount of interspersed dense. tan-white fibrous tissue. No additional mass lesion or abnormality. is identified. Three rubbery white-pink tissues in keeping with. lymph nodes measuring up to 0.8 cm in greatest dimension are. recovered from the lateral aspect of the specimen. Representative. sections are submitted in 12 blocks as labeled. BLOCK SUMMARY: 1-2 - Tumor to inked deep margin; 3-4 - tumor to. skin (4 includes nipple); 5-6 - tumor to adjacent parenchyma; 7 -. random upper outer quadrant; 8 - upper inner quadrant; 9 - lower. inner quadrant; 10 - lower outer quadrant; 11 - two whole lymph. nodes; 12 - one bisected lymph node. MICROSCOPIC DESCRIPTION. Invasive carcinoma: Histologic type: Ductal (with lobular features). Histologic grade : III. Overall grade: 8/9. Architectural score: 3. Nuclear score: 3. Mitotic score: 2. Greatest dimension (pT) : 3.0 cm. Specimen margins: Negative. Vessel invasion: Present. Calcification: Negative. Nipple (Paget's) : Carcinoma involves the deep nipple tissue, and. is present in the deep dermis within the skin adjacent to the. nipple (areolar area) . Invasion of skin or chest wall: As above. Ductal carcinoma in situ: Histologic pattern: Cribriform. Nuclear grade: 3. Central necrosis: Present. 8 DCIS of total tumor (if mixed) : < 10%. Extensive intraductal component (present/absent) : Absent. Specimen margins: Negative. Calcification: Negative. Description of non-tumorous breast: Fibrocystic changes,. fibroadenomata. Comments: Prior biopsy site identified within the main tumor mass. There is an additional satellite nodule of invasive tumor, 2 mm in. greatest dimension, in the lower outer quadrant, away from the main. tumor mass, and associated with ductal carcinoma in-situ. This. focus of invasive tumor is 2 mm from the deep margin. Lymph nodes: Two negative sentinel lymph nodes, and two negative. additional lymph nodes (0/4). Prognostic markers: See previous report,. 4x2. DIAGNOSIS. A. Sentinel lymph node, left axilla, biopsy: Two negative lymph nodes (0/2). B. Breast, deft mastectomy: Invasive ductal carcinoma, grade III, 3.0 cm in greatest. dimension. Negative margins of excision. Lymphovascular invasion identified. Two negative lymph nodes (0/2). ectronic Signature). End Of Report ---.",BRCA,0,"The report states that there are two negative sentinel lymph nodes and two negative additional lymph nodes (0/4). This indicates no evidence of cancer in the regional lymph nodes, which corresponds to N0 stage according to Rule 2 and Modified Rule 8.",N0,7.0
604,TCGA-A7-A5ZX.A8834D03-81F5-43BC-A4AB-F215C89CB095,1,"Final Surgical Pathology Report. Procedure: Diagnosis. A. Lymph nodes, left axillary sentinel, excision -. Metastatic carcinoma in two of two (2/2) lymph nodes in this part. B. Breast, right, excision -. Invasive lobular carcinoma, 0.5 cm in greatest dimension (see. microscopic description, including for prognostic marker results) . Lobular carcinoma-in-situ. Fibrocystic changes, with microcalcifications present. Skin, nipple, and deep margin negative for tumor. C. Breast, left, excision -. Invasive lobular carcinoma, forming a 3.2 cm in greatest dimension. mass, with additional scattered foci of invasive lobular carcinoma. present. Invasive lobular carcinoma present at least very near (<1 mm from), and. possibly at, the deep margin in the separate foci. Skin and nipple negative for malignancy. Lobular carcinoma-in-situ. Biopsy site changes. Fibrocystic changes, with microcalcifications present. D. Lymph nodes, left axillary, excision. Metastatic carcinoma in nineteen of twenty-two (19/22) lymph nodes in. this part, including with metastatic carcinoma in the superior-most. lymph node. Microscopic Description: A,D. There is metastatic carcinoma in two of two (2/2) sentinel lymph. nodes in part A, and in nineteen of twenty-two (19/22) lymph nodes in. part D. Thus overall in this case, there is metastatic carcinoma in. twenty-one of twenty-four (21/24) lymph nodes (pN3a) There is. extracapsular extension. The largest involved lymph node is one of the. sentinel lymph nodes, 2.5 cm in greatest dimension. The largest lymph. node in part D is negative for tumor. There is metastatic carcinoma in. the superior-most lymph node in part D. Please note that in addition. to examining H&E stained sections, immunostains with antibodies to. keratin (AE1-AE3) were examined on representative blocks in both parts. to aid in assessment. B. The following template summarizes the findings in this part: Invasive carcinoma: Present. Histologic type: Invasive lobular carcinoma, identified. incidentally in block B4. Histologic grade : Overall grade: 2. Architectural score: 3. Nuclear score: 2. Mitotic score: 1. Greatest dimension (pT) : slightly >0.5 cm (pT1b). Specimen margins: Negative. Vessel invasion: Not identified. Nipple: Negative for tumor. Invasion of skin or chest wall: Not identified. Ductal carcinoma in situ: Not identified. Description of non-tumorous 'breast: Fibrocystic changes, with. microcalcifications present. Comments: There is also lobular carcinoma-in-situ present. Please note. that immunostains with antibodies to p63, keratin (AE1-AE3), and. e-cadherin were examined on representative blocks to aid in assessment. Distant metastasis (pM) : Not applicable. Breast prognostic marker results. Estrogen receptor: 80% / moderate intensity. Progesterone receptor: 5% / weak intensity. Her2 by IHC: 1+. Interpretation. Estrogen receptor: Positive. Progesterone receptor: Weakly positive. Her2 by IHC: Negative for Her2 expression. Comments. Fixation time : 30:00. Cold ischemia time: 0:30. The analyzed tissue met quality requirements of the ASCO/CAP guidelines. for Her2 testing. Control materials stained appropriately. Based on data collected in our laboratory and reported in the. literature we recommend FISH analysis for Her2 in cases that stain with. intermediate intensity by immunohistochemistry. Prognostic markers were done by immunohistochemical stain on paraffin. sections from 10% neutral buffered formalin fixed tissue using. antibodies on a Benchmark automated stainer. The Her2 antibody is clone 4B5 and has been approved by the FDA as an. aid in the assessment of breast cancer patients for whom Herceptin. treatment is considered. This laboratory meets the test validation and quality assurance. requirements of the ASCO/CAP guidelines for Her2, ER and PR testing for. carcinoma of the breast. C. The following template summarizes the findings in this part: Invasive carcinoma: Present. Histologic type: Invasive lobular carcinoma. Invasive lobular. carcinoma is identified comprising the main mass lesion, as well as in. multiple additional foci in random sections of this breast (blocks C7,. C8, C10, C11). Histologic grade: Overall grade: 2. Architectural score: 3. Nuclear score: 2. Mitotic score: 1. Greatest dimension (pT) : The main mass lesion is 3.2 cm in. greatest dimension (pT2). Specimen margins: Although the margins surrounding the main mass. lesion are negative, tumor in the additional foci of invasive lobular. carcinoma is present at least very near (<1 mm from). and possibly at,. the deep margin, with fragmentation hindering assessment. Vessel invasion: Not identified. Nipple: Negative for tumor. Invasion of skin or chest wall: Not identified. Ductal carcinoma in situ: Not identified. Description of non-tumorous breast: Fibrocystic changes, with. microcalcifications present. Biopsy site changes. Comments: There is also lobular carcinoma-in-situ present. Please note. that immunostains with antibodies to keratin (AE1-AE3), and e-cadherin. were examined on representative blocks to aid in assessment. Distant metastasis (pM) : Not applicable. Prognostic markers: Previously performed. Note: have reviewed this case. [A few of the antibodies used in our laboratory may be classified as. analyte specific reagents. These antibodies are monitored and. controlled in our laboratory and their performance for in vitro. diagnosis is well described in the medical literature. They have not. been cleared or approved by the FDA.]. Specimen. A. Left axillary sentinel node. B. Right breast. C. Left breast. D. Left axillary contents. Clinical Information. CLINICAL HISTORY: yo white female with invasive lobular cancer left. breast. Intraoperative Consultation. A. Metastatic carcinoma present. Gross Description. A. Received fresh in a container labeled ""left axillary sentinel node"". is a portion of tissue which is tan-yellow and fatty externally. On. palpation, it appears to consist of two adherent lymph nodes, spanning. an area 2.5 x 1 X 0.5 cm and 1.8 x 1 X 0.4 cm. On cut surface, both. vary from soft and tan to yellow, to firmer and tan-white. The. specimen is entirely submitted for frozen section in two blocks, with. one lymph node per block. B. Received fresh (excised at. placed in. formalin at. in a container labeled ""right breast"" is a 21 cm from. superior to inferior x 18 cm from medial to lateral x 3.2 cm from. anterior to posterior soft tan-yellow mastectomy specimen, with an. orienting suture present. On the anterior surface there is a 7. X 4.4. cm. tan-white skin ellipse, with a centrally located 1.3 X 1.3 x 1 cm. nipple. The intact deep margin is inked, and the specimen is serially. sectioned. On cut surface, the specimen consists of interspersed. yellow adipose tissue and tan tissue, without focal lesion. RS-10,. following fixation. BLOCK SUMMARY: B1,B2 - upper outer quadrant; B3,B - upper inner. quadrant; 85,B6 - lower inner quadrant; B7,B8 - lower outer quadrant;. B9 - central breast; B10 - nipple. C. Received fresh (excised at. placed in. formalin at. in a container labeled ""left breast"" is a 20.5 cm. from superior to inferior x 18.8 cm from medial to lateral x 3.2 cm. from anterior to posterior soft tan-yellow mastectomy specimen, with an. orienting suture present. On the anterior surface there is a 7 X 5 cm. tan-white skin ellipse, with a centrally located 1.2 x 1.2 x 0.5 cm. nipple. The intact deep margin is inked, and the specimen is serially. sectioned. There is a circumscribed 3.2 x 2.9 X 1.8 cm rubbery. tan-white mass within the upper outer quadrant. The lesion is 1.1 cm. from the deep margin, and 1.3 cm from the anterior surface, which is. subsequently inked blue. The specimen away from the nodule consists of. interspersed yellow adipose tissue and tan tissue, without additional. focal lesion. RS-12, following fixation. BLOCK SUMMARY: C1-C3 - tumor to anterior surface; C4,C5 - tumor to deep. margin; C6 - central tumor; C7 - upper outer quadrant; C8 - upper. inner quadrant; C9 - lower inner quadrant; C10 - lower outer quadrant;. C11 - central breast; C12 - nipple. D. Received fresh in a container labeled ""left axillary contents"" is a. 6.5 x 6.3 x 2.4 cm aggregate of yellow lobular fatty tissue which has a. suture designating superior axilla. Dissection of the specimen reveals. multiple lymph nodes, up to 3.5 cm in greatest dimension. RS-9,. following fixation, with all lymph nodes submitted, from superior to. inferior, with the superior-most lymph node in block D1, four lymph. nodes in block D2, five lymph nodes in block D3, three lymph nodes in. block D4, one sectioned lymph node in blocks D5 & D6, four lymph nodes. in block D7, one lymph node in block D8, and three lymph nodes in block. D9.",BRCA,3,"Based on the pathology report, there are metastatic carcinomas found in 21 out of 24 examined lymph nodes (pN3a) in the left axillary region. This indicates that the cancer has significantly spread to the regional lymph nodes, which corresponds to N3 stage according to the AJCC staging system for breast cancer.",N3,7.0
534,TCGA-A2-A0YT.1C420F6B-8720-4CB0-9FB3-86A0EC05FBBD,3,"SURGICAL REPORT. Sex: F. Date Collected: Date Received: M.R. Number: Doctor: Account Number: PRE-OPERATIVE DIAGNOSIS. LEFT BREAST CANCER. POST-OPERATIVE DIAGNOSIS. LEFT BREAST CANCER. PROCEDURE. LEFT MODIFIED RADICAL MASTECTOMY. TISSUES. A. BREAST MASTECTOMY (WANO) NODES - LEFT BREAST & AXILLARY CONTENTS. B. MARGINS - ADDITIONAL INFERIOR SKIN LEFT BREAST. WRI TISSUE. FINAL DIAGNOSIS. A. LEFT BREAST AND AXILLARY CONTENTS, 1619 GMS. -. INFILTRATIVE DUCT CARCINOMA (CONFLUENT REGION MEASURES 13.6 CM.). SCARFF-BLOOM-RICHARDSON GRADING: GRADE 3 OF 3 (ABSENT TUBULAR FORMATIONS, HIGH NUCLEAR GRADE. AND MODERATE MITOTIC INDEX). DCIS: NONE IDENTIFIED. ANGIOLYMPHATIC INVASION: PRESENT, MULTIFOCAL. TUMORAL CALCIFICATION/NECROSIS: PRESENT. SURGICAL MARGINS: UNINVOLVED. NON-NEOPLASTIC BREAST -. FIBROADENOMA 0.3 CM. FIVE POSITIVE LYMPH NODES WITH EXTRACAPSULAR EXTENSION (6/5). THE LARGEST NODE MEASURES 1.6 CM. AND THE TUMOR INVOLVES THREE-FOURTHS. OF THE NODE. OVERLYING NIPPLE, AREOLA AND SKIN: FOCAL EXTENSION OF THE TUMOR INTO EPIDERMIS WITHOUT ULCERATION. B. ADDITIONAL INFERIOR SKIN LEFT BREAST -. POSITIVE FOR INFILTRATIVE DUCT CARCINOMA, THE TUMOR INVOLVES THE DERMIS. WITHOUT EXTENSION TO EPIDERMIS. (SATELLITE SKIN NODULE). THE INKED MARGINS ARE FREE. PTNM CLASSIFICATION: SURGICAL REPORT. T4B, N2a, MX, STAGE GROUPING IIIB. Diagnosed by: and. COMMENT. The multiple sections from the tumor reveal a poorly differentiated infiltrative duct carcinoma with. widespread angiolymphatic invasion. The satellite nodule grossly observed appears to be a direct. extension from the primary tumor with peripheral tumefaction. The overlying epidermis is involved by the. tumor but does not exhibit ulceration. The Bloom-Richardson grading was upgraded to 3 based on. complete evaluation of the entire tumor mass. The ER, PR, and Her-2/neu have been performed on the previous surgical. This case Is discussed with. on. GROSS DESCRIPTION. The specimen is received in two separate containers labelec. esignated A and B. A. The container is received fresh unfixed labeled ""left breast and axillary contents - suture on. upper outer quadrant"". The specimen consists of a 1,519 gm. apparent left breast which is 30 x. 20 x 7.5 cm. in greatest overall dimension. There is an attached suture indicating upper outer. quadrant inked with orange dye, lower outer quadrant is inked yellow, upper inner quadrant is. inked with green dye, lower inner quadrant is inked with red dye. The deep margin is inked black. Sectioning reveals a tumor mass directly beneath the nipple which is 13.5x 7 x 4 cm. in greatest. overall dimension and is 1.5 cm. from the deep margin, 2 cm. from the upper outer margin, 2.5. cm. from the lower outer margin, 2 cm. from the upper inner margin, and 4 cm. from the lower. inner margin. There is a satellite nodule which is 0.6 cm. in greatest dimension and is 1.5 cm. from the main tumor mass and has a distance of 0.6 cm. from the upper inner margin. Sectioning. through the remaining breast stroma reveals fatty and fibrous-encased tissue. Sectioning through. the attached axillary fat reveals rare tan-gray nodules varying up to 1 cm. in greatest dimension. The specimen is submitted in twelve blocks. Key Note Block Summary: 1-nipple with underlying tumor, 2 through 4-tumor mass, 5-. satellite nodule and upper inner quadrant, 6-lower inner quadrant, 7-lower outer quadrant, 8-. upper outer quadrant, 9-deep, 10 through 12-rare nodules. B. The container is received fixed labeled ""additional inferior skin left breast"". The specimen. consists of a skin ellipse which is 7 x 1x 1 cm. in greatest overall dimension. The skin. has been previously marked with purple-blue dye. The specimen is serially sectioned. revealing no apparent gross abnormalities. The entire specimen is submitted in two. blocks. MICROSCOPIC EXAM. MICROSCOPIC EXAMINATION CONDUCTED BY PATHOLOGIST CONFIRMS FINAL DIAGNOSIS. SURGICAL REPORT.",BRCA,2,"The report mentions 'FIVE POSITIVE LYMPH NODES WITH EXTRACAPSULAR EXTENSION (6/5)', which indicates that there are 5 positive lymph nodes with extracapsular extension. According to the new rule 11, N2 stage for breast cancer indicates metastasis in 4 to 9 axillary lymph nodes or positive in internal mammary nodes in the absence of axillary lymph node metastasis. However, the report does not mention any involvement of internal mammary nodes, so we can assume that the patient has 5 positive axillary lymph nodes, which falls under N2a.",N2a,8.0
561,TCGA-A2-A4RX.CA88491F-5572-4B0D-8E3D-D536E3CE5069,1,"Specimen #: SPECIMEN: A: right axillary sent. node #1 and #2. B: right axillary sent. node #3 C: rt breast. FINAL DIAGNOSIS: A. LYMPH NODES, RIGHT AXILLARY SENTINEL NODES #1 AND #2, EXCISION : - TWO LYMPH NODES, NEGATIVE FOR MALIGNANCY ON ROUTINE AND. IMMUNOHISTOCHEMICAL STAINS. B. LYMPH NODE, RIGHT AXILLARY SENTINEL NODE #3, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR MALIGNANCY ON ROUTINE AND. IMMUNOHISTOCHEMICAL STAINS. C. BREAST, RIGHT, SIMPLE MASTECTOMY: predominant, per T35. - MIXED EPITHELIAL/MESENCHYMAL METAPLASTIC CARCINOMA (CARCINOSARCOMA). - HISTOLOGIC GRADE: 3, POORLY DIFFERENTIATED. - TUMOR SIZE: 2.5 CM. - MARGINS: NEGATIVE. - LYMPH NODES: SEE PARTS ""A"" AND ""B"". - PATHOLOGIC STAGE: pT2 (m) NO (sn). - HORMONE STATUS: (Performed on specimen. - ESTROGEN RECEPTOR: POSITIVE. - PROGESTERONE RECEPTOR: POSITIVE. - HER 2 NEU: NEGATIVE. Comment: Three distinct masses were identified in the mastectomy. specimen, all located in the lower outer quadrant. The two larger masses. (#1 and #2) are histologically similar, showing a poorly differentiated. epithelial component as well as a mesenchymal component displaying marked. pleomorphism and fascicles of spindled cells. Staining of these biphasic. areas show strong pancytokeratin positivity in the epithelial component. while the spindled areas are negative. The histologic and. immunohistochemical pattern is consistent with metaplastic carcinoma. with a malignant sarcomatous component (carcinosarcoma) . While. mass. #1. and #2 are morphologically similar, they are not grossly or histologically. contiguous. The third mass (#3) is a different histologic type (adenoid. cystic carcinoma) It is also grossly separate from masses #1 and #2. As. per the AJCC Cancer Staging Manual, the grade and stage of multiple tumors. of different histologic grade and/or type is based on the largest tumor. Specimen #: FINAL DIAGNOSIS (continued) : (mass #1) , as reflected above. Mass #3 is weakly ER positive (<5% of tumor. nuclei staining), PR negative, and Her- neu negative (1+ staining) . This case received intradepartmental peer review. References: Edge SB., Byrd DR, Carducci MA, Compton CC, eds. AJCC Cancer Staging. Manual. 7th ed. New York, NY: Springer; 2009. Start synoptic report format. - Specimen: Total breast. - Procedure: Simple mastectomy. - Specimen laterality: Right. - Tumor Site: Lower outer quadrant. - Histologic type: Mass #1: Mixed epithelial/mesenchymal metaplastic carcinoma. (carcinosarcoma). Mass #2: Mixed epithelial/mesenchymal metaplastic carcinoma. (carcinosarcoma). Mass #3 : Adenoid cystic carcinoma. - Tumor size (dominant mass) : 2.5 cm (measured grossly) . - Histologic grade (dominant mass) : - Glandular differentiation : 3. - Nuclear pleomorphism: 3. - Mitotic count: 2. - Overall grade: grade 3 score 8 of 9. - Tumor focality: Multifocal. Number of foci: 3. Sizes of individual foci: - Tumor #1: 2.5 x 2.0 x 1.8 cm (measured grossly). - Tumor #2: 2.0 x 2.0 x 1.8 cm (measured grossly). - Tumor #3: 1.1 x 0.8 cm (measured microscopically). Ductal carcinoma in situ (DCIS) : DCIS is present; high nuclear grade. with central necrosis. - Lobular carcinoma in situ: Not identified. - Specimen integrity: Single intact specimen. - Specimen size (greatest dimension) : 21.0 cm. - Margins : Margins uninvolved by invasive carcinoma. - Distance from closest (deep) margin: 1.2 cm (Slide C3, Mass #1). Margins uninvolved by DCIS. - Distance from closest (deep) margin: 1.2 cm (Slide C5). - Macroscopic and microscopic extent of tumor: Page 2 4. Specimen #: CLINICAL DIAGNOSIS AND HISTORY: F diagnosed with right breast IDC, stage 2 ER/PR weakly positive Her2. 1+, that presents for preoperative evaluation prior to planned right. mastectomy with SLNB. PRE-OPERATIVE DIAGNOSIS: POST-OPERATIVE DIAGNOSIS: Operative Findings: Post-operative Diagnosis: GROSS DESCRIPTION: A: The specimen is received in formalin, labeled with the patient's name. designated ""Right Axillary Sentinel Node 1 and #2 Right. Axillary Sentinel Node"" and consists of a 2.5 x 2.0 x 0.8 cm irregular. portion of yellow-tar soft tissue. Sectioning reveals two pink-tan lymph. nodes measuring 1.5 x 1.5 x 0.8 cm and 2.0 x 1.0 x 0.4 cm. Each lymph. node is trisected to reveal a pink-tan cut surface that is otherwise. unremarkable. The lymph nodes are entirely submitted as follows. A1: first described lymph node. A2: second described lymph node. B. The specimen is received in formalin, labeled with the patient's. designated ""Right Axillary Sentinel Node #3"" and. consists of a pink-gray lymph node measuring 2.0 x 1.5 x 0.6 cm. The. lymph node is trisected to reveal an unremarkable cut surface. The. specimen is entirely submitted in two cassettes. The specimen is received in formalin, labeled with the patient's.  designated ""Right Breast"" and consists of a right. mastectomy oriented with a short stitch superior and long stitch lateral. The specimen measures 21.0 cm from medial to lateral, 21.0 cm from. superior to inferior and 4.0 cm anterior to posterior. The darkly. pigmented superficial skin ellipse measures 6.2 x 4.5 cm and displays a. centrally located everted nipple measuring 1.0 cm in diameter. No. discharge is noted. No scars are noted. The specimen is inked as. follows: deep margin = black. superior surface of the lower outer quadrant = blue. Upon sectioning the cut surface is composed predominantly of yellow-tan. lobulated adipose tissue admixed with approximately 20% dense pink-white. fibrous tissue which is predominantly located in the central breast. Two. discrete masses are identified in the lower outer quadrant. Mass #1. Specimen #: FINAL DIAGNOSIS (continued) : - Skin involvement : Not involved by carcinoma. - Nipple involvement : Not involved by carcinoma. - Skeletal muscle involvement: Muscle is not present. - Treatment effect: - In the breast: No known presurgical therapy. - In the lymph nodes : No known presurgical therapy. - Lymphvascular invasion: Not identified. - Necrosis : Present within DCIS. - Microcalcifications: Identified within invasive and in situ carcinoma. - Lymph Nodes: - Lymph nodes sampling: Sentinel lymph nodes. - Number of sentinel nodes: 3. - Total number of lymph nodes: 3. - Lymph nodes with macrometastasis (>0.2cm) : 0. - Lymph nodes with micrometastasis (>0.2mm to 0.2cm) : 0. - Lymph nodes with isolated tumor cells (<=0.2 mm) : 0. - Size of largest deposit: Not applicable. - Extranodal extension: Not applicable. - Additional findings. - Intraductal papilloma. - Biopsy site changes. Ancillary studies: Performed on. - Estrogen receptor: Positive (1-5% tumor nuclei staining). - Staining intensity: Weak. Progesterone receptor: Positive (5% tumor nuclei staining) . - Staining intensity: Intermediate. Her-2 Neu by IHC: Negative (score 1+) . - Her- 2 Neu by FISH: Not performed. - Pathologic staging: - Primary tumor: pT2 (m). - Regional lymph nodes : pNO (sn). - Distant metastasis: Not applicable. Specimen #: GROSS DESCRIPTION (continued) : measures 2.5 x 2.0 x 1.8 cm. The cut surface is pink-ta and gritty. The. mass is located 1.4 cm from the deep margin and 1.0 cm from the. superficial margin. Mass #2, also located within the lower outer. quadrant, measures 2.0 x 2.0 x 1.8 cm. The mass is also well defined,. pink-tan and gritty. Mass #2 is located 3.0 cm from the deep margin and. approximately 1.0 cm from the superficial surface. Mass #2 is located. anterior and medial to mass #1. The two masses are adjacent and yet. appear discrete. The remainder of the lower outer and mid outer breast. shows a 5.0 x 3.0 x 2.5 cm area of dense pink-white fibrous tissue which. is focally indurated (mass #3) On sectioning, the cut surface is. pink-white and otherwise unremarkable with no discrete lesions identified. No additional lesions are identified. No lymph nodes are identified. Representative sections are submitted in twenty-two cassettes as follows: C1: skin and nipple. C2-C4: mass #1 with deep margin. C5: mass #1 with superficial margin. C6,C7&C8: additional mass #1. C9&C10: intervening tissue between mass #1 and mass #2. C11: mass #2 with superficial margin. C12: mass #2. C13: mass #2 with superficial margin. C14: mass #2. C15, C16&C17: indurated fibrous tissue mid outer breast (mass #3). C18: upper outer quadrant. C19: lower outer quadrant. C20: lower inner quadrant. C21: upper inner quadrant. C22: central breast. (some saved, three images taken labeled with mass #1 and mass #2). Mirrored images of mass #1 and mass #2 are submitted in paraffin and OCT. per. protocol. Time/Date of Specimen removal unknown. Time/Date in Pathology: Time/Date in formalin: Total time prior to fixation: unknown. Time/Date out of formalin: Total fixation time: 28 hr 45 min. Discrep ancy. Date Re ieweit.",BRCA,0,The report states that there is no evidence of cancer in the regional lymph nodes (N0) as the sentinel lymph nodes (3 examined) were negative for malignancy on both routine and immunohistochemical stains.,N0,8.0
650,TCGA-A8-A08J.C1D59BA7-FC3E-46EA-B095-3B6DF42892B0,3,"Diagnosis: Ablated (right) breast sample with moderately differentiated invasive and focal ductal. 1. discrete intraductal components, angioinvasion resection ulceration of. the carcinoma skin. Tumor with size at least 7 cm. Paget's disease of the nipple. Dorsal. margin tumor-free. Tumor classification: NOS, G II, pT4bN1aL1 1VORO.",BRCA,3,"Based on the report, the patient has been diagnosed with moderately differentiated invasive ductal carcinoma of the right breast, with a tumor size of at least 7 cm and metastasis in 1 axillary lymph node (N1a). The 'N1' stage is supported by 'New Rule 9: For breast cancer, N1 stage indicates metastasis in 1 to 3 axillary lymph nodes.'",N1,9.0
565,TCGA-A2-A4S2.4A5630FF-0ADC-4E69-B22A-02F1F34F61F9,2,"/F. Acct# : M.D. Specimen: Sp type: SURGICAL P. A.D. PREOPERATIVE DIAGNOSIS. CANCER OF THE RIGHT BREAST AND AXILLARY NODES. A. OPERATION PERFORMED. DOCTOR (S) : PROCEDURE: MASTECTOMY MODIFIED RADICAL. TISSUE REMOVED. A. RIGHT BREAST. B. RIGHT AXILLARY CONTENTS. GROSS DESCRIPTION. RECEIVED IN 2 PARTS. PART A RECEIVED LABELED. RIGHT BREAST DOUBLE BLACK. STITCH 12 O'CLOCK AT NIPPLE IS A 1, 416 GRAM MASTECTOMY MEASURING 28.5 CM. FROM MEDIAL TO LATERAL, 26.5 CM FROM SUPERIOR TO INFERIOR, AND UP TO 6. CM FROM ANTERIOR TO POSTERIOR. A SUTURE DENOTES 12 O'CLOCK. THE NIPPLE. IS FLAT WITH THE SURROUNDING AREOLA MEASURING 6 CM IN DIAMETER. IN THE. UPPER OUTER QUADRANT 6 CM FROM THE NIPPLE THERE IS A 0.3 CM ULCERATION. AT THE MOST LATERAL ELLIPTICAL TIP OF THE SKIN IS A 2ND SMALL ULCERATION. 0.5 CM IN GREATEST DIMENSION. THIS IS 16 CM FROM THE NIPPLE. THE SKIN. ELLIPSE MEASURES 25.6 x 11.5 CM. THERE IS A PALPABLE MASS AT 12. O'CLOCK. ""MRM"" IS WRITTEN ON THE SPECIMEN AT 12 O'CLOCK. THE ANTERIOR. MARGIN IS MARKED BLUE AND THE DEEP IS MARKED BLACK. SECTIONING REVEALS. THE MAJORITY OF THE BREAST TO CONSIST OF BLAND YELLOW FATTY TISSUE WITH. FINE FIBROUS BANDS. THERE ARE BROADER AREAS OF FIBROSIS IN THE MORE. CENTRAL ASPECT OF THE SPECIMEN. IN THE 12-1 O'CLOCK AREA THERE IS A. FIRM GRAY-TAN MASS WHICH IS GREATER THAN 1 CM FROM THE DEEP MARGIN. MEASURING 5.8 CM FROM SUPERIOR TO INFERIOR, 2.5 CM FROM ANTERIOR TO. POSTERIOR, AND 4 CM FROM MEDIAL TO LATERAL. CENTRALLY THERE IS AN. IRREGULAR AREA OF RED-BROWN DISCOLORATION. THIS IS ALSO GREATER THAN. 1. CM FROM THE OVERLYING SKIN. A COIL CLIP IS IDENTIFIED WITHIN THE. LESION. SECTIONS ARE SUBMITTED AS FOLLOWS: A1--NIPPLE, A2--KKIN. ULCERATIONS AND 12 O'CLOCK SKIN MARGIN, A3--DEEP MARGIN TO CENTRAL. LESION, A4--ANTERIOR MARGIN TO CENTRAL LESION, A5 THROUGH A7--A SUPERIOR. TO INFERIOR CROSS SECTION THROUGH THE LESION AT LEVEL OF CLIP, A8--THE. MOST MEDIAL ASPECT OF LESION, A9--MOST LATERAL ASPECT OF LESION, A10 AND. Specimen: Raceived: sp type: SURGICAL P. M.D. GROSS DESCRIPTION. 11--ADDITIONAL SECTIONS OF MASS, A12--UPPER INNER QUADRANT 4 CM FROM. LESION, A13--UPPER OUTER QUADRANT 5 CM FROM LESION, A14--LOWER OUTER. QUADRANT 5 CM FROM LESION, A15--LOWER INNER QUADRANT 4 CM FROM LESION,. A16--TISSUE DEEP TO NIPPLE AT MEDIAL EDGE OF LESION. NOTE:TISSUEIS-SUBMITTED--PER-CLINICAL-BREAST-CARE-PROJECT-RESEARCH-. PROTOCOL OF THE TUMOR LABELED P1-p10 AND MIRROR IMAGE SECTIONS OF THE. NIPPLE (A1) AND THE RANDOM QUADRANT SECTIONS (A12-A15) ARE SUBMITTED. FROZEN IN CCI. PART B RECEIVED LABELED. AXILLARY CONTENTS ARE 4. FRAGMENTS OF YELLOW-PINK FATTY TISSUE TOGETHER MEASURING 10 X 7.5 x 1.5. CM. THE SPECIMEN IS THEN EXAMINED FOR LYMPH NODES. ALONG ONE EDGE. OF. THIS SPECIMEN THERE ARE STRANDS OF RED MUSCLE FIBERS. EXAMINATION. REVEALS 8 NODAL STRUCTURES. THESE ARE SUBMITTED AS FOLLOWS. FOUR (4). OF THESE MEASURE LESS THAN 0.5 CM AND ARE SUBMITTED AS B1. ONE OF THE. LARGER NODES IS GROSSLY POSITIVE, ONE-HALF IS SUBMITTED IN B2, THE. MIRROR IMAGE AS Pll PER THE CLINICAL BREAST CARE PROJECT RESEARCH. PROTOCOL. THE REMAINING 3 LARGE NODES ARE EACH SUBMITTED BISECTED AND. SEPARATELY LABELED B3 THROUGH B5. B6 IS REPRESENTATIVE MUSCLE. A. BIOPSY CLIP IS NOT GROSSLY IDENTIFIED. COMMENT: THIS CASE IS IN COMPLIANCE WITH CAP/ASCO GUIDELINES OF 6-48. HOURS FORMALIN FIXATION TIME. PATH PROCEDURES. PROCEDURES: 88309, A BLK/16, B BLK/6. FINAL DIAGNOSIS. PART A RIGHT BREAST, SIMPLE MASTECTOMY: INTRALOBULAR AND INFILTRATING LOBULAR CARCINOMA WITH SIGNET-RING. CELL DIFFERENTIATION, GRADE II SHOWING NUCLEAR GRADE 2/3 AND LOW. MITOTIC INDEX. LCIS OF THE CLASSIC TYPE SHOWS NUCLEAR GRADE 1. COMPRISING APPROXIMATELY 5% OF THE TUMOR. 2. THE INVASIVE COMPONENT HAS A MAXIMUM GROSS DIMENSION OF 5.8 CM. WITHIN THE CENTRAL PORTION OF THE BREAST WHICH EXTENDS INTO THE. Specimen: Req# : Sp type: SURGICAL P. 1.D. ADDENDUM. METASTATIC CARCINOMA IS IDENTIFIED IN ONE OF FOUR ADDITIONAL AXILLARY. LYMPH NODES INCLUDING EXTENSION OF TUMOR INTO THE EXTRANODAL SOFT. TISSUE (1/4). A SEPARATE AREA HAVING BIOPSY CHANGES IS ALSO PRESENT. Addendum Signed. (signature on file). M.D. M.D. Speciment. tus: Req# : Sp type: SURGICAL P. .D. FINAL DIAGNOSIS. RETICULAR DERMIS UNDERLYING THE NIPPLE SKIN. 3. THE NIPPLE SKIN, SKIN AND BREAST MARGINS OF RESECTION, AND. RANDOM SECTIONS FROM THE REMAINING QUADRANTS ARE FREE OF TUMOR WITH. THE CLOSEST LOCATED 4 MM FROM THE NEAREST INKED DEEP MARGIN (A3) -. 4. LYMPHOVASCULAR INVASION IS IDENTIFIED. 5. FIBROCYSTIC CHANGES INCLUDING SCLEROSING ADENOSIS, MICROCYST. FORMATION AND PATCHY DENSE STROMA. 6. CALCIFICATIONS ARE SEEN WITHIN THE TUMOR AS WELL AS BENIGN PORTIONS. OF THE BREAST. 7. SCLEROTIC INTRADUCTAL PAPILLOMA. 8. BIOPSY CHANGES. ARE IDENTIFIED. 9. SMALL SKIN ULCERATIONS (2) -. PART B RIGHT AXILLA, LYMPH NODE DISSECTION: METASTATIC BREAST. CARCINOMA IS IDENTIFIED IN 4 OF 6 AXILLARY LYMPH NODES EXAMINED (4/6). EXTENSION OF TUMOR INTO THE PERINODAL SOFT TISSUE INVOLVES THE. LARGEST AREA OF METASTATIC TUMOR WHICH MEASURES 1.1 CM IN GREATEST. MICROSCOPIC DIMENSION. A REPRESEN'TATIVE SECTION OF SKELETAL MUSCLE IS. NEGATIVE FOR TUMOR. BIOPSY CHANGES ARE NOT IDENTIFIED GROSSLY OR. MICROSCOPICALLY IN THE NODAL DISSECTION. ADDENDUM. Addendum #1. Entered: THE LATERAL UPPER OUTER QUADRANT IS RE-EXAMINED AND A WING CLIP IS. IDENTIFIED IN AN AREA OF FATTY TISSUE, WITH THE TISSUE ANTERIOR HAVING A. YELLOW-WHITE INDURATION CONSISTENT WITH A PREVIOUS BIOPSY AREA. THE AREA. OF THE CLIP PROPER IS SUBMITTED IN A17 AND 18. THE TISSUE ANTERIOR TO. THIS AREA IS SUBMITTED IN A19 AND 20. LATERAL TO THIS, THERE IS A. GROSSLY POSITIVE NODAL STRUCTURE 0.6 CM IN DIAMETER. THIS IS SECTIONED. AND SUBMITTED IN A21. AN ADDITIONAL POSSIBLE NODE IS SUBMITTED IN A22. AND 23. AN ADDITIONAL POSSIBLE 0.4 CM NODE IS SUBMITTED IN A24.",BRCA,2,"Based on the report, metastatic breast carcinoma is identified in 4 out of 6 axillary lymph nodes examined (4/6). This indicates that the patient has cancer in at least one to three axillary lymph nodes and possibly in internal mammary nodes in the absence of axillary lymph node metastasis, which corresponds to N2 stage according to the new rules 9, 11, and 14.",N2,10.0
584,TCGA-A7-A26H.1159E2EF-6407-4D90-8ED6-7AB04CF4FB32,0,"DEPARTMENT OF PATHOLOGY AND LABORATORY MEDICINE. Date Coll: SPECIMEN. A. Left axillary sentinel node. B. Left breast (arrow points up). C. Right axillary sentinel node. D. Right axillary sentinel node #2 active in blue. E. Right breast (arrow points up). F. Left axillary contents. CLINICAL NOTES. PRE-OP DIAGNOSIS: Bilateral breast. FROZEN SECTION DIAGNOSIS. A) Sentinel lymph node, left axilla, biopsy: One lymph node,. positive for carcinoma. C. Sentinel lymph node, opsy: One lymph node,. negative for carcinoma. D. Sentinel lymph node, right axilia #2, biopsy: One lymph node,. negative for carcinoma. GROSS DESCRIPTION. A. The specimen is received unfixed labeled ""left axillary sentinel. noand consists of a yellow and red piece of soft tissue measuring. 2.5 x 2 x 0.8 cm. On cut section there is a contained lymph node. measuring 1.2 cm. in greatest dimension. The node is bis -and. submitted all for frozen section diagnosis as requested. B. The specimen is received unfixed labeled ""left breast. arrow points up"" and consists of a breast resection. specimen measuring 19.5 x 18.5 x 3.0 cm. There is an overlying. white ellipse of skin measuring 16 x 9.3 cm. There is a central. areola measuring 3 x 4 cm. and a central nipple measuring 1.2 x 1. x. 0.4 cm. There is an arrow incised in the skin and there is an area. of induration at the superior edge of the areola that might be. a. biopsy scar. It measures 1.5 x 0.7 cm. The deep surface of the. specimen is inked. The breast is sectioned at 1 cm. intervals in. the deep surface towards the skin. Some blue-domed cysts are. present. There is a relatively central red area compatible with a. biopsy site defect and there is some firmness around this area. The. firm area measures 1.5 x 1.5 x approximately 1.5 cm. This area. is. central and inferior and there is another area that is central below. the indurated part of the skin that looks like carcinoma grossly and. measures 1.2 x 1.5 x approximately 1.5 cm. A portion of the larger. area is taken for research purposes. Sections after fixation. Block summary: 1,2 nipple and skin with tumor; 3 deep margin; 4-6. biopsy site; 7-10 quadrants (UO, UI, LO, LI). C. Received unfixed labeled ""right axillary sentinel node"". and consist of two pieces of yellow and red soft tissue. measuring 2 x 1.8 x 0.7 cm. and 2.5 x 2.5 x 0.7 cm. There is a. contained lymph node measuring 1 cm. in greatest dimension and the. entire node is submitted for frozen section diagnosis as requested. D. Received unfixed labeled ""right axillary sentinel node. #2 active in blue"" and consist of a yellow, red and blue. piece of soft tissue measuring 5.5 x 3 x 0.6 cm. There is. a. partially blue contained lymph node measuring 2.3 cm. in greatest. dimension. The specimen is submitted all for frozen section. diagnosis as requested. E. [The original gross dictation on specimen E. is lost.] The. specimen was received unfixed labeled right breast and consisted of. a 27 x 19 x 4.5 cm breast resection specimen with overlying ellipse. of skin measuring 16.5 x 9 cm. There was a central areola and. nipple. An area of arrow was incised to the skin. Some blue dye. and. injected. The deep surface the specimen was inked and the breast. resection at 1 cm intervals from the deep surface towards the skin. There was a central biopsy site and additional relatively central. firm area compatible with carcinoma. Block summary: 1, nipple; 3 skin; 4 - deep margin; 5-7 biopsy. site; 8,9 area resembling tumor; 10-13 quadrants (UO.UI.LO.LI). F. The specimen was received unfixed, labeled ""left. axillary contents"" and consists of a yellow and pink of. soft tissue measuring 12 x 8 x 2 cm. RS-2. MICROSCOPIC DESCRIPTION. A. Metastatic carcinoma is present in one lymph node. The tumor is. 0.7 cm in diameter. No extranodal tumor is seen. B. Invasive carcinoma. Tumor type: Infiltrating ductal carcinoma. Tumor grade: 1 (Elston SBR grade; A/N/M = 2/2/1). Mitotic index: 3 mitoses/10 HPFs (1 HPF = 0.196 sq mm). Tumor size: 1.5 cm. Vessel invasion: Absent. Calcification: Absent. pTNM stage: T1 pN1a. Prognostic markers: Requested. Nipple: Carcinoma is present in skin adjacent to the nipple. Deep margin: Negative for malignancy. Nontumorous breast: Sections from the biopsy site away from. the tumor show scar, cyst formation, columnar metaplasia,. benign calcification, usual ductal hyperplasia and focal atypical. ductal hyperplasia. C. A Single lymph node is negative for malignancy. D. A single lymph node is negative for malignancy. E. Invasive carcinoma. Tumor type: Infiltrating ductal carcinoma. Tumor grade: 2 (Elston SBR grade; A/N/M = 3/2/1). Mitotic index: 3 mitoses/10 HPFs (1 HPF = 0.196 sq mm). Tumor size: 1.2 cm on the glass slide. Vessel invasion: Absent. Calcification: Absent. pTNM stage: T1. Prognostic markers: See previous biopsy. The tumor is specimen E from the right breast has a central fibrotic. focus. Sections near the biopsy site away from the gross carcinoma. described above show columnar metaplasia, usual ductal hyperplasia,. cyst formation apocrine metaplasia. An atypical area is p63. positive. F. There is no evidence of malignancy in any of 4 lymph nodes. 4x6,25x3,20,14x3. DIAGNOSIS. A. Sentinel lymph node, left axilla, biopsy: Metastatic carcinoma in. a single lymph node. B. Breast, left, resection: Infiltrating ductal carcinoma, Elston. SBR grade 1. C. Sentinel lymph node, right axilla, biopsy: A single lymph node is. negative for malignancy. D. Sentinel lymph node #2, right axilla, biopsy: A single lymph node. is negative for malignancy. E. Breast, right, resection: Infiltrating ductal carcinoma, Elston. SBR grade 2 F. Lymph nodes, left axilla, blopsy: There is no. evidence of malignancy in any of 4 lymph nodes. ictronic Signature).",BRCA,1,"Based on the information provided in the pathology report, there is metastatic carcinoma present in one lymph node in the left axilla, as stated in section A of the report. This indicates that the patient has some level of regional lymph node involvement. According to the rules provided, N1 stage indicates metastasis in 1 to 3 axillary lymph nodes (New Rule 15: N1a). Therefore, the N stage for this patient is N1.",N1,11.0
674,TCGA-A8-A09I.AF12859A-D67A-488D-8BC2-ED28698F2ACA,1,"Diagnosis. 1. and 2. Poorly differentiated invasive ductal right breast carcinoma measuring up to 4.4 cm. with a minimum dorsal margin of 2.9 cm in the ablated breast tissue. Circumscribed ductal. carcinoma in situ (high-grade DCIS with comedo necrosis) in the tumor center, about 0.2 cm. in diameter. Lipomatous atrophy of the remaining breast tissue. Regular nipple. Regular skin. Sixteen right axillary lymph nodes free of metastases (0/16). Tumor classification: M-8500/3, G 3, pT2, pNO (0/16), pMX, stage II A.",BRCA,0,"The report mentions that sixteen right axillary lymph nodes are free of metastases (0/16). According to Rule 2 and Modified Rule 8, if there is no evidence of cancer in the regional lymph nodes, the N stage is N0.",N0,11.0
560,TCGA-A2-A4RW.C1D4D6BB-AF86-4208-A729-C61365941217,1,"34. Unit#: : Specimen: Spec Type: SURGICAL P. PREOPERATIVE DIAGNOSIS. RIGHT BREAST CANCER INVASIVE. OPERATION PERFORMED. DOCTOR. PROCEDURE: MASTECTOMY MODIFIED RADICAL. TISSUE REMOVED. A. RT BREAST MASTECTOMY. B. RT AXILLARY NODE DISSECTION. GROSS DESCRIPTION. RECEIVED IN 2 PARTS. A RECEIVED LABELED. RIGHT BREAST STITCH 12 O'CLOCK IS A. 650 GRAM SIMPLE MASTECTOMY SPECIMEN MEASURING 23.5 X 21.5 x 3.7 CM. THE. NIPPLE IS UNREMARKABLE WITHIN A SKIN ELLIPSE MEASURING 23.5 x 12.5 CM. A SUTURE DENOTES 12 O'CLOCK. THE SUPERFICIAL ASPECT IS MARKED WITH BLUE. INK, THE DEEP WITH BLACK. SECTIONING REVEALS A CENTRAL PORTION OF THE. BREAST TO BE A MIXTURE OF TAN FIBROUS TISSUE AND YELLOW FAT. THE. PERIMETER CONSISTS OF BLAND YELLOW FATTY TISSUE. IN THE 10 O'CLOCK AREA. OF THE BREAST IS A FIRM MASS MEASURING 4 CM FROM MEDIAL TO LATERAL BY. 3.5 CM FROM SUPERIOR TO INFERIOR AND 2.1 CM FROM ANTERIOR TO POSTERIOR. THERE IS A SMALL RIM OF FATTY TISSUE DEEP TO THE LESION. GROSSLY THERE. IS AT LEAST 0.5 CM OF TISSUE. THIS DOES NOT INVOLVE THE SKIN GROSSLY. SECTIONS ARE SUBMITTED AS FOLLOWS: A1--NIPPLE, A2 AND 3--LESION IN DEEP. MARGIN, A4--FAR LATERAL ASPECT OF LESION WITH SKIN, A5--GROSS MEDIAL. ASPECT OF LESION 4 CM FROM A4, AND A10 IS THE TISSUE SUPERFICIAL TO A8. SUPERFICIAL TO DEEP MEASUREMENT. SECTIONS OF THE LESION ARE ALSO. SUBMITTED PER PROTOCOL. A BOWTIE-SHAPED CLIP IS IDENTIFIED WITHIN THE. LESION, A11--TUMOR, A12--UPPER INNER QUADRANT, A13--UPPER OUTER QUADRANT. LATERAL TO LESION, A14--LOWER OUTER QUADRANT, A15--LOWER INNER QUADRANT. B RECEIVED LABELED. RIGHT AXILLARY NODE DISSECTION ARE 2. IRREGULAR PORTIONS OF YELLOW-RED FATTY TISSUE TOGETHER MEASURING 9 X 7 x. 2.5 CM. THIS TISSUE IS EXAMINED FOR LYMPH NODES. THE LARGEST NODE. WHICH IS 2.5 CM IN DIAMETER DEMONSTRATES A ROD-SHAPED METAL CLIP. IT. HAS ILL-DEFINED BORDERS. ONE-HALF IS SUBMITTED IN B1. THE REMAINDER IS. Specimen: q#. Spec Type: GROSS DESCRIPTION. TAKEN PER PROTOCOL. ADDITIONAL NODES ARE ALSO IDENTIFIED AND SUBMITTED. AS. FOLLOWS. THERE IS A 2ND 2.5 CM LYMPH NODE WHICH IS GROSSLY. UNREMARKABLE. ONE-HALF IS SUBMITTED AS B2. THE REMAINDER IS TAKEN PER. PROTOCOL. A 1.7 CM LYMPH NODE IS BISECTED, ONE-HALF SUBMITTED IN B3,. THE REMAINDER SUBMITTED PER PROTOCOL. ADDITIONAL NODES ARE THEN. SUBMITTED AS FOLLOWS: B4--2 NODES EACH BISECTED, B5--3 NODES EACH. BISECTED, B6--3 NODES EACH BISECTED, B7--1 NODE TOTAL, B8--5 NODES,. B9~-4 NODES, B10-4 NODES. FORMALIN FIXATION TIME IS 6 HOURS AND 10 MINUTES. PATH PROCEDURES. PROCEDURES: 88309, A BLK/15, B BLK/10. FINAL DIAGNOSIS. PART A RIGHT BREAST, SIMPLE MASTECTOMY: 1. INTRALOBULAR AND INFILTRATING LOBULAR CARCINOMA OF THE PLEOMORPHIC. TYPE. THE INVASIVE COMPONENT SHOWS NUCLEAR GRADE 2/3, LOW MITOTIC. INDEX AND TUBULE FORMATION 3 FOR A TOTAL NOTTINGHAM SCORE OF. LCIS. WITH RARE FOCI OF LUMINAL NECROSIS COMPRISES APPROXIMATELY 30% OF THE. TUMOR. 2. THE TUMOR HAS A MAXIMUM GROSS DIMENSION OF 4 CM ALTHOUGH RARE IN. SITU AND INVASIVE FOCI ARE IDENTIFIED IN A RANDOM SECTION FROM THE. LOWER OUTER QUADRANT. 3. INVASIVE TUMOR IS FOCALLY IDENTIFIED 4 MM FROM THE NEAREST INKED. SUPERFICIAL MARGIN (A2) AND 4 MM FROM THE SKIN SURFACE (A4) . 4. THE BIOPSY SITE. ) AND A BOWTIE-SHAPED CLIP ARE IDENTIFIED. 5. ALTHOUGH LYMPHOVASCULAR INVASION IS NOT IDENTIFIED, PERINEURAL. INVASION IS PRESENT. PART B RIGHT AXILLA,. IS IDENTIFIED IN ALL. OF LYMPH THE NODE 27 LYMPH DISSECTION: NODES EXAMINED. METASTATIC FOCAL BREAST EXTRANODAL CARCINOMA 27/27/20. EXTENSION INTO THE PERINODAL FAT IS PRESENT. A BIOPSY SITE INCLUDING A. Specimen: Spec Type: 1, D.O. FINAL DIAGNOSIS. ROD-SHAPED METAL CLIP IS ALSO PRESENT. :, M.D.",BRCA,3,"Based on the pathology report, there is evidence of metastasis in 20 out of 27 examined lymph nodes in the right axillary node dissection (part B). This indicates a N2 stage for breast cancer, as per New Rule 11.",N2,12.0
487,TCGA-A2-A0CW.7D1C2CD8-9842-48AC-BB16-897E2A45B88D,1,"Specimen #: F Race: WHITE. Physician( (s) : 3. SPECIMEN: A: SENTINEL LYMPH NODE #1 B: NON-SENTINEL - LYMPH NODE. C: RIGHT BREAST LUMPECTOMY. FINAL DIAGNOSIS: A. LYMPH NODE, SENTINEL, EXCISION: ONE (1) SENTINEL LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA WITH. THE LARGEST FOCUS MEASURING 0.4 CM. - TUMOR IDENTIFIED IN THE PERINODAL SOFT TISSUE. B. LYMPH NODE, NON-SENTINEL, EXCISION: ONE (1) LYMPH NODE COMPLETELY REPLACED BY METASTATIC CARCINOMA. MEASURING 1.5 CM. EXTRANODAL EXTENSION CANNOT BE ASSESSED DUE TO LACK OF PERINODAL. SOFT TISSUE. C. BREAST. RIGHT, LUMPECTOMY: - INFILTRATING DUCTAL CARCINOMA, POORLY DIFFERENTIATED. - -NOTTINGHAM SCORE: 9/9 (TUBULES=3, NUCLEI=3, MITOSES=3). - TUMOR SIZE: 2.7 CM (MEASURED GROSSLY). - TUMOR NECROSIS: ABSENT. - MICROCALIFICATIONS: ABSENT. - VENOUS / LYMPHATIC INVASION: PRESENT. - INVASIVE TUMOR INVOLVES THE SMOOTH MUSCLE OF THE NIPPLE. - MARGINS: NEGATIVE. - DISTANCE OF TUMOR FROM NEAREST MARGIN IS 0.6 CM,. FROM NEAREST (SUPERIOR) MARGIN. - INTRADUCTAL COMPONENT DUCTAL CARCINOMA IN SITU, SOLID TYPE,. NUCLEAR GRADE II, WITH NECROSIS (<5% OF TUMOR). - ESTROGEN RECEPTORS, PROGESTERONE RECEPTORS, AND HER 2 NEU. PERFORMED ON PREVIOUS SPECIMEN (SEE COMMENT). - PATHOLOGIC STAGE: pT2 N1a MX. - ADDITIONAL PATHOLOGIC CHANGES: PRIOR BIOPSY SITE CHANGES. COMMENT: E. Hormone receptors performed on previous biopsy. and are as. follows: - Estrogen Receptor: Positive (approximately 100% nuclear staining). - Progesterone Receptor: Positive (25% nuclear staining). - ER-2-NEU - Postive (3+, strongly positive). Specimen #: FINAL DIAGNOSIS (continued) : CLINICAL DIAGNOSIS AND HISTORY: year old female with right breast invasive cancer. PRE-OPERATIVE DIAGNOSIS: Right breast invasive cancer. POST-OPERATIVE DIAGNOSIS: Right breast invasive cancer. GROSS DESCRIPTION. A. Received fresh labeled with patient's name. designated ""SENTINEL LYMPH NODE"" is a 1.5 x 0.5 x 0.3 cm lymph node with. attached fibrous fatty tissue. Specimen is bisected and entirely submitted. in cassette one. B. Received fresh labeled with patient's name. designated 'NON-SENTINEL LYMPH NODE"" are two irregular portions of. presumed previously intact lymph node each measuring 1.5 x 1.5 x 0. 1 cm. Sectioning reveals uniform tan and whtie cut surface. Specimen entirely. submitted in three cassettes as follows. B1-B2: first portion of node (match of B1 submitted in OCT for CBCP. protocol). B3: remaining portion of lymph node. C. Received fresh labeled with patient's name. designated ""RIGHT BREAST LUMPECTOMY"" consists of an irregular portion of. fibrofatty tissue oriented with single stitch medial and two stitches. superior. The specimen measures 10 cm medial to lateral, 7 cm anterior to. posterior and 3 cm superior to inferior. Superficial surface displays an 8. x 4 cm lightly pigmented skin ellipse with centrally located fimr inverted. nipple. No discharge or scar is identified. Specimen is inked as follows : superior blue, inferior green, medial red, lateral yellow, posterior. black. Serial sections reveal well defined 2.7 x 2.7 x 2.2 cm firm pink. white gritty mass subadjacent to and involving the nipple. Surrounding. breast tissue is fibrofatty and otherwise unremarkable. Cassette key. Specimen # : GROSS DESCRIPTION (continued). C1: mass. C2: normal fibrous 1 cm away. C3: normal skin. C4: : nipple with mass. C5-C10: representative sections of presumed mass with close proximity to. margin. C11: medial margin. C12: lateral margin. 12CM.",BRCA,1,"Based on the pathology report, there is metastasis in one sentinel lymph node (1.5 cm) and one non-sentinel lymph node (completely replaced by metastatic carcinoma). This information aligns with New Rule 15 and New Rule 9, which indicate N1 stage for breast cancer with metastasis in 1 axillary lymph node.",N1,13.0
666,TCGA-A8-A097.5B867CB6-F94D-435D-83E3-0ADB814B8077,1,"Diagnosis: 1. Poorly differentiated invasive ductal carcinoma with a discrete. intraductal component (tumor diameter 2.8 cm). Provisional tumor classification: NOS, G III, pT2 N1mi(sn)LOVORO.",BRCA,1,"The report mentions 'pT2 N1mi(sn)LOVORO', which indicates that the patient has T2 (tumor size > 2 cm and < 5 cm) and N1mi (micrometastasis in 1 to 3 sentinel lymph nodes) disease. The micrometastasis is indicated by 'mi' in N1mi.",N1,14.0
456,TCGA-A1-A0SG.89A67051-898A-4E2A-A874-E0165F274E63,1,"Final Pathologic Diagnosis: A. Right axillary sentinel lymph node #1, count = 3500, dissection: Metastatic. adenocarcinoma in one of two lymph nodes (1/2). B. Right axillary sentinel lymph node #2, count = 500, dissection: No tumor in two. lymph nodes (0/2). C. Right breast, partial mastectomy: 1. Invasive micropapillary carcinoma, 2.1 cm, associated with microcalcifications; see. comment. 2. Atypical lobular hyperplasia. 3. Fibroadenoma. 4. Microcalcifications in benign ducts. D. Sentinel lymph node #3, count = 350, dissection: No tumor in two lymph nodes. (0/2). Note: Breast Tumor Synoptic Comment. - Laterality: Right. - Invasive tumor type: Invasive micropapillary carcinoma. - Invasive tumor size: 2.1 cm maximum diameter. The tumor is present in slices 4, 5, 9, and 10; however. the tumor has been banked from slices 6, 7, and 8. Therefore, the tumor extends through seven. consecutive slices, each with a width of approximately 0.3 cm, for a total maximum diameter of 2.1 cm. - Invasive tumor grade (modified Bloom-Richardson): 2. Nuclear grade: 3, 3 points. Mitotic count: < 10 mitotic figures/1 HPF, 1 point. Tubule/papilla formation: Definite tubule formation in <10%, 3 points. Working Draft. Total points and SBR grade - 7 points, grade 2. - Lymphatic-vascular invasion: None identified. - Perineural invasion: None identified. - Resection margins for invasive tumor: - Deep margin: Negative (1 cm). - Medial margin: Negative (0.9 cm). - Lateral margin: Negative (0.6 cm). - Anterior/superio: margin: Negative (0.5 cm). - Anterior/inferior margin: Negative (greater than 1 cm). - Ductal carcnoma in situ (DCIS) type: None identified. Microcalcifications: Present involving both benign ducts and invasive carcinoma. - Lobular carcinoma in situ (LCIS): None identified. - Lymph node status: - Number of positive lymph nodes: 1. - Total number sampled: 6. - Diameter of largest metastasis: 2.1 mm. - Extranodal extension: Absent. - AJCC/UICC stage: pT2N1aMX. - Nontumorous breast tissue: Atypical lobular hyperplasia, fibroadenoma, and sclerosing adenosis. - Additional comments: We reviewed the original frozen section slides and concur with the frozen section. diagnosis rendered. The metastatic tumor in Part A was only present in the additionally submitted. sections of the lymph node (slide A2). Level sections on A2-A4 confirms the diagnosis. Select slides from. part C were shown at the. the faculty in attendance concurred. with the above diagnosis of micropapillary type of invasive carcinoma. Dr. has reviewed A2. and concurs with the diagnosis. An immunohistochemical test for estrogen and progesterone receptors was performed on block C9. The test for estrogen receptors is positive. There is 3+ nuclear staining in >95% of tumor cells. The test for progesterone receptors is positive. There is 3+ nuclear staining in >95% of tumor cells. Result of HER2/neu test: This carcinoma is negative for HER2/neu oncoprotein over-expression. An immunohistochemical assay was performed on block C9 using the CB11 monoclonal antibody to. HER2/neu oncoprotein. The staining intensity of this carcinoma was 1 on a scale of 0-3. Carcinomas with staining intensity scores of 0 or 1 are considered negative for over-expression of HER2/neu oncoprotein. Those with a staining intensity score of 2 are considered indeterminate. We and others have observed that many carcinomas with. staining intensity scores of 2 do not show gene amplification. All carcinomas with staining intensity scores of 2 are therefore. submitted for FISH testing. The results of the FISH test are issued directly from the molecular cytogenetics laboratory. Carcinomas with staining intensity scores of 3 are considered positive for over-expression of HER2/neu oncoprotein. Tumors in this. category show an excellent correlation between the results of immunohistochemical and FISH testing, and almost always show gene. amplification. Slide A2 was shown at the departmental Consensus Conference, and the faculty in attendance concurred. with the above diagnosis. Intraoperative Consult Diagnosis. FS1 (A) Right axillary SLN #1, biopsy: Negative for carcinoma. (Dr. Clinical History. The patient is a. year-old woman with right breast carcinoma. Working Draft. Gross Description. The specimen is received in four parts, each labeled with the patient's name and medical record number. Part A is received fresh and labeled. It consists of one pink-yellow,. soft, fatty tissue that measures 3.1 x 2.5 x 0.8 cm. The specimen is strained and two candidate lymph. nodes are found, the smallest is inked blue and submitted with a representative section of the largest. submitted for frozen diagnosis #1, thereafter submitted in cassette A1. The remnant of the largest lymph. node is transected and entirely submitted in cassettes A2-A3, and the remnant of the yellow fatty tissue is. submitted in cassette A4. Part B, additionally labeled. consists of a single fragment of yellow,. fibrofatty tissue measuring 2 x 1.8 x 0.4 cm. The specimen is entirely submitted in cassette B1. Part C, additionally labeled. consists of a right breast specimen oriented. with a short superior and a long stitch lateral. The specimen measures 3.2 cm from anterior to posterior,. 5 cm from medial to lateral and 6.5 cm from superior to inferior. The resection margins are inked as. follows for microscopic evaluation: anterior superior in blue, anterior inferior in green and posterior in. black. The specimen is serially sectioned from medial to lateral into twelve slices. There is gray-white,. fibrous tissue in the superior half of the specimen in slices 3-11, measuring 2.4 x 2 x 1.5 cm. White. fibrous tissue extends from this area to the anterior inferior aspect in slices 5-8. The gray-white fibrous. tissue appears extend to the inked margin in the posterior superior aspect of slices 3 and 4, and appears. to be 0.5 cm from the anterior superior inked margins in slices 5 and 9. Representative sections are. submitted as follows: Cassette C1: Representative medial margin, slice 1, bread-loafed. Cassette C2: Representative section of slice 3. Cassettes C3-C5: Slice 4. Cassette C6: Representative section of slice 5. Cassette C7: Representative section of slice 6. Cassette C8: Representative section of slice 8. Cassette C9: Representative section of slice 9. Cassettes C10-C11: Representative sections of slice 10. Cassette C12: Representative section of slice 11. Cassette C13: Representative lateral margin, slice 12, bread-loafed. Part D, additionally labeled. consists of a single, yellow, fibrofatty tissue fragment. measuring 2.5 x 1.5 x 0.4 cm. The specimen is entirely submitted in cassette D1. The immunoperoxidase stain(s) reported above were developed and their performance characteristics determined by the. They have not been cleared or approved by the U. S. Food and Drug Administration The FDA has. determined that such clearance or approval is not necessary. These tests are used for clinical purposes. They should not be regarded. as. investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (""CLIA""). as qualified to perform high-complexity clinical testing. Fee Codes: Other Specimens. pecimen Class: Accessioned: Specimen(s) Received: Right axillary contents. Final Diagnosis. Axilla, right, ""contents,"" excision: 1. Scar tissue, fat necrosis and suture with giant cell reaction. No malignancy is. identified. Working Draft. 2. No metastatic tumor identified in five lymph nodes. (0/5). Specimen Class: Accessioned: Specimen(s) Received: Final Diagnosis. Review of. from : Breast, right, 10 o'clock, core biopsies: Infiltrating ductal carcinoma, SBR Grade 2; see. comment. FND OF REPORT.",BRCA,1,"Based on the pathology report, there is metastasis in 1 out of 6 examined lymph nodes (1/6). This corresponds to the N1 stage according to the AJCC staging system for breast cancer.",N1,15.0
587,TCGA-A7-A2KD.3C301346-4594-4071-A754-04F8B3BE894C,1,"Date Coll: SPECIMEN. A. Right breast tissue long stitch 12 o'clock, short stitch apical. node and axillary contents. B. Left breast tissue stitch marks 12 o'clock. CLINICAL NOTES. PRE-OP DIAGNOSIS: Right multifocal invasive breast tumor 9 o'clock. and 1 o'clock status post core biopsy. Left breast DCIS 2. o'clock and LCIS at 9 o'clock. POST-OP DIAGNOSIS: Right MRM, left simple mastectomy. GROSS DESCRIPTION. A. Received fresh labeled ""right breast tissue and. axillary contents"" is a 19.0 cm. (medial to lateral) x 16.0. cm. (superior to inferior) x 5.2 cm. (anterior to posterior) soft,. lobulated tan gold-white portion of fibroadipose tissue in keeping. with breast designated as right per requisition slip and container. and oriented by a single suture as stated previously. An 11.5 x 8.0. x 3.0 cm. portion of axillary fat extends from the lateral aspect of. the specimen. There is a 12.5 x 6.9 cm. brown portion of skin with. an eccentric, everted, 1.5 x 1.5 x 0.5 cm. nipple along the anterior. aspect. On section, the nipple appears unremarkable. The intact. deep margin is inked black and the specimen is sectioned. There is. a moderately well circumscribed, 3.8 cm. (superior to inferior) x. 3.5 cm. (medial to lateral) x 3.2 cm. (anterior to posterior). rubbery tan white tumor mass at the junction of the upper and lower. inner quadrants. A portion of tumor and a portion of normal. parenchyma are submitted for tissue procurement as requested. The. tumor is present to within 1.5 cm. of the inked deep margin and 1.0. cm. of the anterior surface of the specimen (subsequently inked. blue) Approximately 6.5 cm. lateral to the primary lesion is a. second, palpable firm tan white tumor mass measuring 2.0 cm. (medial. to lateral) x 1.8 cm. (anterior to posterior) x 1.3 cm. (superior to. inferior) The second lesion is located within the lower outer. quadrant. The second tumor extends to within 1.4 cm. of the inked. deep margin. The parenchyma between the two lesions is dense tan. white. An apparent core biopsy site is noted at the junction of the. four quadrants (see blocks 10 and 11) No additional mass lesion. or. abnormality is identified. The remaining cut surfaces consist. predominantly of glistening lobulated golden yellow adipose tissue. with a moderate amount of interspersed tan white fibrous tissue. Located at the apex of the attached axillary dissection is a rubbery. 1. cm. tan white lymph node (see block 16) Multiple additional. rubbery tan white to tan pink tissues in keeping with lymph nodes. measuring up to 5 cm. in greatest dimension are recovered from the. remainder of the axillary fat. The largest node appears in keeping. with a matted lymphoid aggregate with tan white cut surfaces. suggestive of metastasis (see representative sections blocks 19 and. 20) Received separately within the specimen container is an. additional, ovoid, 2.5 cm. rubbery tan tissue in keeping with lymph. node. Representative sections are submitted in 24 cassettes as. labeled. BLOCK SUMMARY: 1 and 2 - large tumor to inked deep margin; 3 and 4 -. large tumor to anterior surface (inked blue) i 5 and 6 - large tumor. to adjacent parenchyma. 7 - smaller tumor lower outer quadrant to inked deep margin; 8 and 9. - remainder of smaller tumor. 10 and 11 - parenchyma between the two lesions including presumptive. prior core biopsy site; 12 - random upper outer quadrant; 13 - upper. inner quadrant; 14 - lower inner quadrant; 15 - lower outer. quadrant; 16 - bisected apical node; 17 - three whole lymph nodes;. 18 - one bisected lymph node; 19 and 20 - representative from. largest (?matted) node, three sections total; 21 and 22 - bisected. separately received lymph node (one half per cassette) ; RR1 nipple;. RR2 skin over main tumor. B. Received fresh labeled ""left breast tissue"" is a 17.5. cm. (medial to lateral) x 14.8 cm. (superior to inferior). x. 4.8 cm. (anterior to posterior) soft, lobulated tan gold-white. portion of fibroadipose tissue in keeping with breast designated as. left per requisition slip and container and oriented by suture as. stated previously. There is a 9.5 cm. (medial to lateral) x 4.4 cm. (superior to inferior) wrinkled brown skin ellipse with an. eccentric, everted, 1.5 x 1.5 x 0.8 cm. nipple along the anterior. aspect. Within 1 cm. of the superior skin margin, corresponding to. the junction of the upper inner and outer quadrants, is a 7.4 x 4.5. cm. defect which communicates with a subjacent 9.5 cm. (medial to. lateral) x 5.0 cm. (anterior to posterior) x 4.0 cm. (superior to. inferior) vacant biopsy cavity (?biopsy cavities) . The cavity is. oblique traversing the lower inner quadrant, extending to the upper. outer. The cavity focally extends to within 0.8 cm. of the inked. deep margin at its medial aspect (see blocks 1 and 2). A stellate. firm focus measuring 1.0 x 1.0 x 1.0 cm. is identified along the. deep margin 3.5 cm. inferior to the medial portion of the cavity. (see blocks 3 and 4) Residual discrete lesion is not identified. grossly along the periphery of the cavity. Margins are inked as. follows: anterior surface defect orange; inferior black and. posterior blue. The remaining cut surfaces consist predominantly of. glistening lobulated golden yellow adipose tissue with a scant. amount of interspersed delicate tan white fibrous tissue. Representative sections are submitted in 17 cassettes as labeled. BLOCK SUMMARY: 1 and 2 - biopsy cavity to closest inked deep margin;. 3. and 4 - bisected nodule subjacent to biopsy cavity extending to. inked deep margin (one half per cassette) 5 through 12 -. representative biopsy cavity to anterior defect and adjacent. parenchyma sequentially from medial to lateral; 13 - random upper. outer quadrant; 14 - upper inner quadrant; 15 - lower inner. quadrant; 16 - lower outer quadrant; 17 - nipple. MICROSCOPIC DESCRIPTION. A. This modified radial mastectomy specimen contains two. foci of invasive ductal carcinoma. The larger is in the. mid-medial portion measuring 3.8 cm. The smaller one is in the. lower outer quadrant, 6.5 cm lateral to the larger tumor. Morphologically, they are quite similar and both of high grade. Between the tumors, lymphovascular space invasion is present without. parenchymal invasion. The smaller tumor is also associated with. high-grade ductal carcinoma in situ. It is likely, therefore, that. these two foci represent separate primaries, even though there. remains a possibility that the smaller tumor is metastatic. Please. see the template below. The template incorporates the findings on. both of the tumors. Invasive carcinoma: Histologic type Infiltrating ductal carcinoma. Histologic grade: Both tumors are poorly differentiated. Overall grade: Elston SBR grade 3. Architectural score: 3. Nuclear score: 3. Mitotic score: 3. Greatest dimension (pT) : The larger tumor measures 3.8 cm and. the smaller. measures 2 cm, pT2. Specimen margins: : Negative. Vessel invasion: Extensive lymphatic invasion present. Calcification: Negative. Nipple (Paget's) : Negative for Pagets's. Dermal lymphatic. invasion present. Invasion of skin or chest wall: Negative. Ductal carcinoma in situ: Both tumors are associated with similar. high-grade. ductal carcinoma in situ. Histologic pattern: Cribriform and solid. Nuclear grade: 3. Central necrosis: Positive. 8 DCIS of total tumor (if mixed) : DCIS is a minor component. Extensive intraductal component (present/absent) : Absent. Specimen margins: Negative. Calcification: Positive. Description of non-tumorous breast: Fibrocystic changes present. including. cysts and apocrine metaplasia. Random sections of the lower. inner. quadrant and lower outer quadrant disclose lymphatic. invasion. Comments: In the mid-breast, a biopsy site is noted consistent with. prior core biopsy. This site discloses lymphovascular space. invasion. Lymph nodes: Number of positive nodes of total: Eight out of 10 lymph contain. metastatic carcinoma, including the apical node, 8/10. Size of largest metastasis: 1.0 cm. Extracapsular extension (present/absent) : Absent. pN: pN2a. Distant metastasis (pM) : Cannot be assessed. Prognostic markers: Previously performed. B. This simple mastectomy specimen contains a large biopsy. cavity. In the vicinity there is lobular carcinoma in. situ. No invasive tumor and no ductal carcinoma in situ present. An E-cadherin stain was performed on block #1. Fibrocystic changes. are noted, including cysts, apocrine metaplasia, florid ductal. hyperplasia and calcifications. The nipple is negative for tumor,. as is the overlying skin. [A few of the antibodies used in our laboratory may be classified as. analyte. specific reagents. These antibodies are monitored and controlled in. our. laboratory and their performance for in vitro diagnosis is well. described in. the medical literature. They have not been cleared or approved by. the FDA.]. DIAGNOSIS. A. Right breast, modified radical mastectomy -. Two foci (multifocal) of invasive ductal carcinoma, Elston SBR. grade 3. Extensive lympovascular space invasion is present. Skin, all margins negative for tumor. Metastatic disease present in 8/10 axillary lymph nodes. Dermal lymphatics of nipple positive for tumor. B. Left breast, simple mastectomy -. Breast with large prior biopsy cavity and lobular carcinoma in. situ. Fibrocystic changes present. No invasive carcinoma or ductal carcinoma present. M.D. (Electronic Signature). End Of Report ---.",BRCA,2,"Based on the report, there are 8 positive lymph nodes out of 10 examined, which indicates N2 stage. More specifically, N2a indicates metastasis in 1 to 3 axillary lymph nodes with extracapsular extension or metastasis in 4 to 9 axillary lymph nodes without extracapsular extension. In this case, the report mentions extracapsular extension, but it does not specify the exact number of involved lymph nodes. However, since there are 8 positive nodes out of 10, it can be inferred that the number of involved lymph nodes is within the range for N2a.",N2a,15.0
495,TCGA-A2-A0D4.990F5885-8EDD-42A2-AEFE-9DEE3E95A0B1,1,"Specimen #: Race: BLACK. Physician (s) : SPECIMEN: A: LEFT BREAST QUADRANTECTOMY. B: LEVEL #1 & #2 AXILLARY LYMPH NODES. FINAL DIAGNOSIS: A. BREAST, LEFT, QUADRANTECTOMY: - MODERATELY DIFFERENTIATED (GRADE II) INFILTRATING DUCTAL CARCINOMA. NOTTINGHAM SCORE: 7 OUT OF 9 (TUBULES=3, NUCLEI=2, MITOSES=2) . MAXIMUM TUMOR SIZE: 3.0 CM (MEASURED GROSSLY). VENOUS/LYMPHATIC INVASION: PRESENT (E.G., SLIDES A3 AND A4). MARGINS NEGATIVE. TUMOR PRESENT 0.27 CM FROM THE ANTERIOR (BLUE. INKED) TISSUE EDGE (SLIDE A1). INTRADUCTAL COMPONENT: PRESENT. DUCTAL CARCINOMA IN SITU,. INTERMEDIATE NUCLEAR GRADE (DCIS, GRADE II) i SOLID TYPE WITH. FOCAL INTRALUMINAL NECROSIS AND MICROCALCIFICATIONS. LYMPH NODES: 1 OF 23 LYMPH NODES POSITIVE FOR METASTATIC CARCINOMA. (1/23; PLEASE SEE PART ""B""). ESTROGEN RECEPTORS: POSITIVE (>95% NUCLEAR STAINING; PLEASE SEE. PROGESTERONE RECEPTORS: POSITIVE (60-70% NUCLEAR STAINING; PLEASE. SEE. HER 2 NEU BY IHC: 2+ (PLEASE SEE. HER 2 NEU BY FISH: PENDING (PLEASE SEE. PATHOLOGIC STAGE: pT2N1MX. - ADDITIONAL FINDINGS: PRIOR BIOPSY SITE CHANGES. B. LYMPH NODES, LEFT AXILLA LEVELS 1 AND 2, AXILLARY DISSECTION: - ONE OF TWENTY-THREE - LYMPH NODES POSITIVE FOR METASTATIC CARCINOMA. (1/23) . LARGEST METASTATIC FOCUS: 1.4 CM WITH FOCAL EXTRANODAL. EXTENSION (LESS THAN 0.1 CM) . Specimen #: FINAL DIAGNOSIS (continued) : CLINICAL DIAGNOSIS AND HISTORY: yo black female with breast cancer, left inner mid breast g2 (7/9). +lvi, er/pr+, her2/neu 2+, fna+ of left axillary lymph node. Time in. formalin: 84 hours. PRE-OPERATIVE DIAGNOSIS: breast cancer. POST-OPERATIVE DIAGNOSIS: none provided. GROSS DESCRIPTION: A: Received fresh, labeled with the patient's name,. : and. designated ""Left Breast Quadrantectomy"" is a 408 gm lumpectomy specimen. oriented with a single short black stitch superior, long black lateral,. double blue deep, triple blue medial, and anterior margin is inked blue. The specimen measures 19.0 cm superior to inferior, 14.0 cm medial to. lateral, and 4.0 cm anterior to posterior. The specimen is inked as. follows: anterior-blue, superior-orange, lateral-yellow, medial-red,. inferior-green, and deep-black. Serial sections reveal a 3.0 x 2.0 x 1.7. cm well-defined, tan-pink, gritty mass with focal congestion. The mass. comes to within 0.5 cm of the closest margin (anterior). On sectioning. through the mass a 0.4 cm red-brown biopsy cavity is identified, with an. embedded metallic clip. The remainder of the specimen is predominantly. composed of lobulated, yellow-tan adipose tissue admixed with. approximately 20% fibrous tissue. No additional lesions are identified. Representative sections are submitted. Cassette. Summary: A1-A2- anterior margin; A3-A4- mass; A5-A6- mass with. cavity; A7- mass; A8- adjacent normal; A9- section with medial (red inked). tissue edge adjacent to sections from A1-A6; A10- - adjacent section of. medial-posterior (red and black inked) tissue edges; A11-A12- sections of. white fibrous area with lateral (yellow inked) tissue edge in plane. immediately next to plane of sections A1-A10; A13 - sections of anterior. (blue inked) tissue edge adjacent to tumor area taken from A7; A14-. medial-anterior (red and blue inked) tissue edges taken from area adjacent. to A7. Matched sections of A3, A5-A8 are submitted in OCT for CBCP Protocol. Specimen #: GROSS DESCRIPTION (continued). B: Received fresh, labeled with the patient's name,. and. designated ""Level 1 and 2 Axillary Lymph Node"" is a 10.0. x. 7.5. x. 2.0. cm. irregular portion of soft tissue. Sectioning reveals multiple pink-red to. pink-tan - lymph nodes ranging in size from 0.7 cm in greatest dimension to. 3.0 x 1.0 x 0.7 cm. Sectioning through the larger lymph nodes reveals a. markedly congested cut surface. The lymph nodes are submitted entirely as. follows: Cassette Summary: B1-B2- one lymph node; B3-B4- - one lymph node; B5- one. lymph node, bisected; B6 - one lymph node; B7 - four lymph nodes; B8- one. lymph node; B9- one lymph node, bisected; B10- one lymph node, bisected;. B11- - one lymph node; B12 - one lymph node, bisected; B13- - two lymph nodes. bisected (one inked green) ; B14-21: additional lymph node candidates. Matched sections of B1, B3,B6,B8 are submitted in OCT for CBCP Protocol.",BRCA,1,"Based on the pathology report, 1 out of 23 lymph nodes was found to be positive for metastatic carcinoma. This corresponds to the N1 stage, as defined in the rules provided.",N1,16.0
600,TCGA-A7-A4SF.C1B1FAA6-EB15-43BB-B3A3-D11511C76060,1,"Final Surgical Pathology Report. Procedure. Diagnosis. A. Sentinel lymph node, right axilla, biopsy: Two negative lymph. nodes (0/2). B. Breast, right, excisional biopsy: Invasive ductal carcinoma, grade 2, size not less than 2.5 cm,. present at the medial and posterior margins; see microscopic. description. Ductal carcinoma in-situ, grade 2, present at the inferior. margin. Microscopic Description: Invasive Carcinoma: Histologic type: Ductal. Histologic grade: 2. Overall grade: 7/9. Architectural score: 3. Nuclear score: 2. Mitotic score: 1. Greatest dimension (pT2) : Not less than 2.5 cm, and possibly as. much as 4.0 cm (invasive carcinoma extends away from the main. tumor mass into the surrounding fat throughout much of the. specimen). Specimen margins: Invasive carcinoma is broadly present at. the medial and posterior margins. Vessel invasion: Not identified. Calcification: Not identified. Ductal carcinoma in situ: Histologic pattern: Solid, cribriform. Nuclear grade: 2. Central Necrosis: Focal. % DCIS of total tumor (if mixed) : 28. Extensive intraductal component (present/absent) : Absent. Specimen margins: DCIS is at the inferior margin of the. specimen. Calcification: Negative. Comments: Two prior biopsy sites are identified in the mid-portion of. the specimen. There is a confluence of tumor present microscopically. between the two apparent masses formed by the tumor, supporting the. conclusion of a single tumor mass lesion. Additionally, there is. tumor infiltrating around and beyond the tumor mass areas, into the. surrounding fat, and to the specimen margins as stated above. p63. immunostaining performed to confirm the presence of invasive carcinoma. at the margin. E-cadherin performed to exclude LCIS and confirm DCIS. at the inferior margin. Cytokeratin immunostaining performed on two lymph node blocks to. exclude metastatic carcinoma; stains are negative. Prognostic markers: See previous biopsy report. [A few of the antibodies used in our laboratory may be classified as. analyte specific reagents. These antibodies are monitored and. controlled in our laboratory and their performance for in vitro. diagnosis is well described in the medical literature. They have not. been cleared or approved by the FDA. Specimen. A. Right axillary sentinel lymph node. B. Right breast mass, long anterior, short superior - tissue. Clinical Information. Right breast cancer;. year old black female with two side by side. cancers. Gross Description. A. Received unfixed, labeled right axillary sentinel node, are. 2. lymph nodes, 0.7 and 0.8 cm in greatest dimension each, entirely. submitted with each lymph node and a separate block (bisected). B. Received unfixed, and a transparent container, labeled right. breast mass, is a 5.5 x 4.3 x 3.0 cm portion of fibroadipose tissue. with orienting sutures. Margins are inked: Anterior black,. posterior blue, lateral green, and medial yellow. The specimen is. serially sectioned from superior to inferior. There is a 2.5 x 2.5. x 1.5 cm tumor mass, which is somewhat dumbbell-shaped, but appears. to consist of one tumor mass. Sections submitted as follows: 1. superior margin, 2 through 6 superior-most portion of tumor, 7. through 9 transition area of probable second lobe of tumor mass. (contiguous sections), 10 breast tissue intervening between tumor. mass and margin, 11 - inferior margin. Portion of tumor and normal. submitted for tissue procurement, as requested. Additional. sections submitted: RR1 intervening tissue between superior margin. and tumor; 2-4 additional superior tissue, 5-7 representative. remaining first half of specimen; 8-14 inferior half of specimen;. 15 additional inferior margin.",BRCA,0,"The report mentions that two sentinel lymph nodes were negative for cancer involvement (0/2). This indicates that there is no evidence of cancer in the regional lymph nodes, which corresponds to N0 stage.",N0,16.0
602,TCGA-A7-A5ZV.FA5CF5A2-F44A-4303-9200-32250FAEF374,1,"Final Surgical Pathology Report. Procedure: Diagnosis. A, B. Lymph nodes, left axillary sentinel #1 & #2, excisions -. Negative for malignancy. C. Breast, left, segmental mastectomy -. Invasive mammary carcinoma, no special type, high combined histologic. grade, high proliferative rate. D. Breast, left, posterior to segmental mastectomy, excision. Negative for malignancy. Note: The above diagnoses are rendered per expert consultation from. of. Please see the. consultation report from Dr. In a comment,. states: ""This invasive carcinoma is curcumscribed and has an expansile. rather then infiltrative growth pattern, which may explain the lack of. nodal involvement. The margins are adequate.' In an addendum comment,. :ates: ""The closest margin from the left segmental. mastectomy (specimen C) is posterior (1.5 mm), however the separately. submitted new posterior margin (specimen D) is negative. The other. margins are negative by least 4 mm. Microscopic Description: A,B,D. Microscopic examination performed. C. The following template summarizes the findings in part C: Invasive Carcinoma: Present. Histologic type: Invasive mammary carcinoma, no special type. Histologic grade: High combined histologic grade, high. proliferative rate. Greatest dimension (pT) : 4.2 cm (pT2). Specimen margins : The margins are adequate (see comment in. diagnosis). Vessel invasion: Not identified. Calcification: Not identified. Ductal carcinoma in situ: Not identified. Comment: Please note that in addition to examining H&E stained. sections, representative blocks in part C were immunostained with. antibodies to p63 to aid in assessment. Prognostic markers: Previously performed (see. [A few of the antibodies used in our laboratory may be classified as. analyte specific reagents. These antibodies are monitored and. controlled in our laboratory and their performance for in vitro. diagnosis is well described in the medical literature. They have not. been cleared or approved by the FDA.]. Specimen. A. Left axillary sentinel node #1, hot, not blue, 1018. B. Left axillary sentinel node #2, hot, blue, 237. C. Left breast segmental mastectomy. D. Tissue posterior. to segmental mastectomy. Clinical Information. PRE-OP DIAGNOSIS: Left breast CA. Gross Description. A. Received fresh in a container labeled ""left axillary sentinel node. #1, hot, not blue, 1018"" is a 2.2 x 1.7 x 1 cm soft tan-pink lymph node. with some surrounding yellow adipose tissue. AS-4, following fixation. B. Received fresh in a container labeled ""left axillary sentinel node. #2, hot, blue, 237"" is a 2.5 x 2.2 x 1.2 cm portion of tissue. containing two soft tan-pink lymph nodes with surrounding yellow. adipose tissue, with the lymph nodes 1 and 1.5 cm in greatest. dimension. RS-4, following fixation, with the lymph nodes entirely. submitted, with the larger lymph node in blocks B2-B4. C. Received fresh in a. container labeled ""left breast. segmental mastectomy"" is a 7.3 x 5.7 x 4.3 cm portion of soft. tan-yellow breast tissue, with orienting sutures present. The margins. are inked as follows based upon the sutures: anterior - green;. posterior - black; lateral - orange; medial - red; inferior - blue;. superior - violet. The specimen is serially sectioned revealing a 4.2 x. 4.2 x 3.5 cm red-brown to white-tan nodular mass, which grossly comes. near to the medial, posterior, and anterior margins. RS-10, following. fixation, with tumor to closest medial margin in block C1, tumor to. closest lateral margin in block C2, tumor to closest anterior margin in. block C3, tumor to closest posterior margin in block C4, tumor to. closest superior margin in block C5, tumor to closest inferior margin. in block C6, and with additional sections of tumor in blocks C7-C10. D. Received fresh in a container labeled ""tissue posterior to segmental. mastectomy"" is a 1.7 x 1.2 x 1.2 cm portion of soft red-brown skeletal. muscle, with a suture indicating the new posterior border. The new. margin is inked. The specimen is sectioned and is without focal. lesion. AS-3, following fixation.",BRCA,0,"The report states that both left axillary sentinel nodes (specimens A and B) were negative for malignancy. Additionally, there is no mention of any other involved regional lymph nodes in the report. Based on the provided rules, the N stage for this patient is N0, as there is no evidence of cancer in the regional lymph nodes.",N0,16.0
476,TCGA-A2-A0CK.B065FC65-CD33-4878-AE2C-7E8C04F5ECAB,2,"I. Specimen #: (Age : ) F Race : WHITE. Physician (s) : AMENDED / ADDENDUM: SPECIMEN: RIGHT BREAST TISSUE. FINAL DIAGNOSIS: BREAST, RIGHT INFERIOR LATERAL RETRO-AREOLA, EXCISION : INFILTRATING LOBULAR CARCINOMA. SURGICAL MARGINS POSITIVE FOR TUMOR. TUMOR SIZE: 0.5 CM BY MICROSCOPY. LOBULAR CARCINOMA IN SITU. PERINEURAL INVOLVEMENT BY CARCINOMA. MICROCALFICIATIONS IDENTIFIED. AJCC STAGING: STAGE I (T1, NX, MX), SEE COMMENT. COMMENT: (visiting pathology resident from. discussed the. above diagnosis with Dr. on. at. AMENDMENT. At the request of the clinician, tumor was evaluated for HER2-neu -. overexpression by immunohistochemical methods (DAKO HercepTest) with. the. following results: HER2/neu overexpression: NEGATIVE (1+). COMMENT: Membranous staining is interpreted on a scale of 0 to 3+ with. positivity defined as 2+ or qreater. Test performed at. Interpretation rendered by. -5. Specimen #: ADDENDUM: HER2/NEU BY FISH = 1.1 NOT AMPLIFIED. TEST: FISH for detection of HER2-neu gene amplification (Path Vision Her2. DNA probe by Vysis) Ratio of Her2-neu over chromosome 17 signals. RANGE FOR INTERPRETATION. Ratio less than 2.0 HER2-neu gene amplification not observed. Ratio equal to or greater than 2.0: HER2-neu gene amplification. observed. ER/PR IMMUNOSTAINS ARE NEGATIVE. C. INICAL DIAGNOSIS AND HISTORY: YO FEMALE WITH SMALL 1X.6CM COMPLEX MASS BY U/S AT INFERIOR/LATERAL. RETROAREOLAR. PRE-OPERATIVE DIAGNOSIS: FIBROUS TISSUE VS MALIGNANCY. POST-OPERATIVE DIAGNOSIS: Post-operative Diagnosis: SAA. GROSS DESCRIPTION: RIGHT BREAST TISSUE ""inferior lateral retro-areola"" consists of a single. irregularly shaped fragment of fibro fatty tissue, which previously has. been inked and sectioned. When reapproximated, the specimen measures 2 x. 1 x 1 cm. The previous sectioning reveals that the specimen is mostly fat. with admixed fibrous tissue. The specimen is placed in its entirety. in the 5 gray cassettes marked. A1-A5. The specimen was previously. inked blue before being received by this observer.",BRCA,2,"The N stage is not specified in this report. The report mentions 'Surgical margins positive for tumor' and 'TUMOR SIZE: 0.5 CM BY MICROSCOPY', which are T stage related information. The report also mentions 'PERINEURAL INVOLVEMENT BY CARCINOMA' but this is not sufficient to determine the N stage. The N stage is determined by the presence and extent of cancer in the regional lymph nodes. In this report, there is no information about the regional lymph nodes.",NX,16.0
597,TCGA-A7-A4SC.5E14E7CA-3417-4379-8EE3-7F00D6D4A02B,2,"Final Surgical Pathology Report. Procedure: Diagnosis. A. Right axillary sentinel node, excisional biopsy: Single lymph node negative for metastatic tumor (0/1). B. Breast, right, simple mastectomy: Invasive lobular carcinoma, grade 1. Tumor size 7.5 CM (pT3). Resection margin negative for tumor. Microscopic Description: A. and B. Microscopic examination performed. Invasive carcinoma: Histologic type: Invasive lobular carcinoma. Histologic grade: 1. Overall grade. Architectural score: 3. Nuclear score: 1. Mitotic score: 1. Greatest dimension (pT) 7.5 CM (pT3). Specimen margins: Negative for malignancy, deep margin is 1.4 cm. from tumor. Vessel invasion: Not identified. Calcification: Focally present. Nipple (Paget's ) : Unremarkable, no Paget's disease identified. Invasion of skin or chest wall: Not identified. Ductal carcinoma in situ: No ductal carcinoma in situ identified. Description of non-tumorous breast: Fatty and atrophic. Adjacent to. the tumor are too small 1 cm fibroadenomas which are invaded by the. tumor. Lymph nodes: Number of positive nodes of total: 0/1. Extracapsular extension (present/absent) : No extracapsular tumor. identified. pN: snpNO. 2 H&E-stained sections were evaluated from each frozen section block. An additional 3 H&E stained sections from each tissue block were. evaluated of the formalin fixed paraffin embedded tissue. Also. pancytokeratin AE1/AE3 immunohistochemical stains were evaluated from. each of the tissue blocks. No metastatic tumor was identified in any. of these examined sections. [A few of the antibodies used in our laboratory may be classified as. analyte specific reagents. These antibodies are monitored and. controlled in our laboratory and their performance for in vitro. diagnosis is well described in the medical literature. They have not. been cleared or approved by the FDA.]. Distant metastasis (pM) : Not applicable pMX. Breast prognostic marker results (B5) Progesterone and HER-2 testing. was repeated given the limited amount of tumor in the prior core. biopsy. Progesterone receptor: 0%. Her2 by IHC: 2+. Interpretation receptor: Reported as positive on prior core biopsy. Estrogen. Her2 by IHC: Equivocal by IHC. FISH testing ordered. Progesterone receptor: Negative. Comments. Fixation time: 28 hours. Cold ischemia time Time of collection was not noted. Less than. 15 minutes cold ischemia time in the laboratory. Favor less than 1. hour of transport time. The analyzed tissue met quality requirements of the. CAP guidelines. for Her2 testing. Control materials stained appropriately. Based on data collected in our laboratory and reported in the. literature we recommend FISH analysis for Her2 in cases that stain with. intermediate intensity by immunohistochemistry. sections from 10% neutral buffered formalin fixed tissue using. Prognostic markers were done by immunohistochemical stain on paraffin Ventana. corportation antibodies on a Benchmark automated stainer. The Her2 antibody is clone 4B5 and has been approved by the FDA as an. aid in the assessment of breast cancer patients for whom Herceptin. treatment is considered. This laboratory meets the test validation and quality assurance. requirements of the. /CAP guidelines for Her2, ER and PR testing for. carcinoma of the breast. A. Specimen Right axillary sentinel lymph node, excisional biopsy: B. Right breast, simple mastectomy. Clinical Information. year-old white female with infiltrating lobular carcinoma. Intraoperative Consultation. A. Right axillary sentinel node, biopsy: No tumor seen. Gross Description. A. Received fresh for frozen section labeled ""right axillary sentinel. is a 3 x 1 x 1 CM piece of fatty yellow tissue. The fat is. node"" trimmed to reveal a 2.8 cm diameter tan lymph node. The lymph node is. bisected and entirely frozen as frozen sections AFS 1 AFS 2. The fat. is retained. No blue staining was identified and no grossly suspicious. areas are identified. B. Received fresh and subsequently fixed in formalin labeled ""right. breast"" is a 20.5 x 17.2 x 4.7 cm yellow lobular fatty tissue fragment with. 7.5 x 3.5 cm pink-tan wrinkled skin ellipse having a 1.4 cm everted. is grossly consistent with a mastectomy and is partially covered a. nipple. The specimen has a suture designating superior breast. The. specimen is received in pathology at. and fixed in formalin at. The deep aspect of the specimen is inked lumen and the. specimen is sectioned from medial to lateral to show a 7.5 x 6.0 x 2.3. cm white-tan, diffusely nodular and firm central mass is ill. circumscribed and comes within 1.7 cm of the deep margin. Gross. identified centrally are white rice-like pellets which are grossly. consistent with a previous biopsy site. The remainder of the cut. surface of the specimen is predominantly fatty scanty fibrous tissue. present. No lymph nodes or gross identified in the apex of the. specimen. Representative sections of the specimen are submitted as. follows: 1 - entire nipple with representative skin, 2 - 6 -. representative sections of lesion including tumor to deep margin and. possible biopsy site, 7 - representative upper outer quadrant, 8 -. representative lower outer quadrant, 9 - representative lower inner. quadrant, 10 - representative upper inner quadrant. Discrepancy. /.",BRCA,0,"The report states that there is no evidence of cancer in the regional lymph nodes, with only one sentinel lymph node examined and found to be negative for metastatic tumor (0/1). This meets the criteria for N0 as per the rules provided.",N0,16.0
655,TCGA-A8-A08S.0D293DF8-374D-4681-9B2A-ACC98601AA25,0,"Diagnosis: 1. Poorly differentiated invasive ductal carcinoma (tumor diameter: 1.8 cm). Tumor classification: NOS, G III, pT1Nla(sn)LOVORO.",BRCA,1,"Based on the report's tumor classification 'pT1Nla(sn)LOVORO', the 'Nla' indicates micrometastasis in 1 to 3 sentinel lymph nodes (New Rule 16). This corresponds to the N1 stage according to the New Rule 15: N1a indicates metastasis in 1 axillary lymph node and New Rule 16: N1mi indicates micrometastasis in 1 to 3 sentinel lymph nodes.",N1,17.0
511,TCGA-A2-A0SV.161E2817-7DB2-46F8-BFEB-256DBBEFE633,1,"Specimen #: Race: WHITE. Physician (s) : SPECIMEN: WUID:161E2817-7082-46F8-BFEB-256DBBEFE633. A: RIGHT BREAST B: RIGHT AXILLARY CONTENTS. FINAL DIAGNOSIS: A. RIGHT BREAST, MASTECTOMY: TUMOR TYPE: INFILTRATING DUCTAL CARCINOMA, NO SPECIAL TYPE. NOTTINGHAM GRADE: POORLY DIFFERENTIATED (G3). NOTTINGHAM SCORE: 9/9. (Tubules= 3, Nuclei= 3, Mitoses= 3 mitotic count 14 per 10 HPF at. 40x power). TUMOR SIZE (GREATEST DIMENSION) : 4.5 CM (MEASURED GROSSLY). TUMOR NECROSIS: PRESENT, IN INFILTRATING COMPONENT AND DCIS. MICROCALCIFICATIONS: PRESENT IN INFILTRATING COMPONENT AND BENIGN. PROCESSES. VENOUS / LYMPHATIC INVASION: PRESENT; EXTENSIVE. MARGINS : DEEP MARGIN POSITIVE FOR TUMOR IN TISSUE AND LYMPHATICS. INTRADUCTAL COMPONENT: PRESENT; MINIMAL. NIPPLE INVOLVEMENT: PRESENT (without Pagetoid spread) . SKIN INVOLVEMENT: PRESENT. MULTICENTRICITY: PRESENT; MULTIPLE SEPARATE MICROSCOPIC FOCI IN OTHER. QUADRANTS (SEE COMMENT). ESTROGEN RECEPTORS: Previously ordered and positive. PROGESTERONE RECEPTORS: Previously ordered and positive. HER 2 NEU by IHC: Previously ordered; weakly positive. HER 2 Neu BY FISH: Previously ordered and pending. PATHOLOGIC STAGE: pT4d N2a MX. ADDITIONAL PATHOLOGIC CHANGES. -DUCTAL CARCINOMA IN-SITU, HIGH GRADE. - -CYSTIC CHANGE WITH APOCRINE METAPLASIA. B. LYMPH NODES, RIGHT AXILLA, DISSECTION: EIGHT LYMPH NODES POSITIVE FOR TUMOR, WITH EXTENSIVE EXTRACAPSULAR. EXTENSION IDENTIFIED, AND DEPOSITS LARGER THAN 2 MM. COMMENT: ER, PR, and Her2Neu are performed on the patient's prior material. collected by mammotome biopsy,. and will not be. repeated. This tumor shows satellite nodules throughout all quadrants. Specimen #: FINAL DIAGNOSIS (continued) : sampled except the lower outer quadrant. These nodules are not measured. separately as separate primary tumors; they appear to have arisen from. intramammary lymphatic spread. It is likewise difficult to measure the. degree of extranodal extension of tumor from the lymph nodes due to the. extensive perinodal tumor deposits. CLINICAL DIAGNOSIS AND HISTORY: yo white female with right nipple inversion, right breast. Prior. mammotome biopsy with ductal carcinoma. A. Right breast, Long stitch lateral, short stitch superior (fresh). B. Right axillary contents including thoraco bundle (fresh). GROSS DESCRIPTION: A. Specimen received in formalin labeled with patient's name. consists of a 627 gram right mastectomy specimen oriented with short. stitch superior and long stitch lateral. Specimen measures 24 cm superior. to inferior, 23 cm medial to lateral, 4 cm anterior to posterior. Superficial skin ellipse measures 9.5 x 4 cm and displays a centrally. located inverted nipple. No scar is noted. No discharge is noted. Deep. resection margin shows scant portions of muscular tissue. Deep margin. inked black and superficial margin is inked blue. Serial sections reveal a. centrally located poorly defined firm pink white mass measuring 4.5 x 4.5. x. 2.0. cm. Periphery of the mass shows hemorrhage consistent with previous. biopsy. Mass abuts deep margin. Fibrous parenchyma surrounding mass is. nodular and cystic suggestive of additional foci. Located in the deep. margin of mid inner quadrant is a 0.4 cm firm tan ill defined nodule. consistent with possible additional lesion (located approximately 2 cm. from central lesion) . Sectioning of nipple shows dense fibrous tissue. with possible lesion involvement. Remainder of parenchyma is lobulated. yellow tan and fatty with scant fibrous tissue. No lymph nodes identified. Representative sections: A1: skin. A2: nipple. A3: mass (lateral portion). A4: mass and adjacent fibrous tissue (medial portion). Specimen #: GROSS DESCRIPTION (continued). A5: mid inner quadrant nodule with margins. A6: mass with deep margin (central). A7: upper outer quadrant. A8: lower outer quadrant. A9: lower inner quadrant. A10: upper inner quadrant . Matched sections of A1-A4 and A7-A10 are. submitted. for CBCP protocol. A11-A20 represent additional sections of mass. Remaining breast tissue is. unoriented, no sutures remain in tissue. Representative samples of lesion. beneath elliptical wedge of skin and nipple are represented. A13-A14. represent one match set. Specimen submitted. B. Received in formalin labeled with patient's name. labeled. ""RIGHT AXILLARY CONTENTS INCLUDING SARCO BUNDLE"" consists of an 11 x 6 x 3. cm irregular unoriented portion of fatty tissue. Sectioning reveals two. matted portions of soft tissue measuring 4 x 3.5 x 1.5 cm and 8 x 4 x 1.2. cm. On sectioing the cut surfaces show dense indurated fibrotic tissue. with red tan lymphoid tissue noted along periphery of the smaller portion. tissue. Single intact discrete lymph node is identified and remaining. tissue which measures 0.6 cm. Exact number of lymph nodes cannot be. determined. Representative sections are as follows: B1-B3: smaller portion of tissue. B4-B6: larger portion of tissue. B7: one bisected lymph node.",BRCA,2,"Based on the report, there are 8 positive lymph nodes in the right axilla with extensive extracapsular extension and deposits larger than 2mm. This meets the criteria for N2 stage as per the new rule 14: N2a indicates metastasis in 1 to 3 axillary lymph nodes with extracapsular extension or metastasis in 4 to 9 axillary lymph nodes without extracapsular extension.",N2,18.0
665,TCGA-A8-A096.91BFC77A-E56F-49F0-A294-A5EE9F266FB6,1,"Diagnosis: 1. Moderately differentiated invasive ductal carcinoma (tumor diameter 4.0 cm). In conjunction with the preliminary finding, this gives rise to the following tumor. classification: NOS, G II, pT2NOi+(sn)LOVORO.",BRCA,0,"The 'pT2NOi+(sn)' part of the diagnosis indicates that the tumor size is 2-5 cm (pT2) with no regional lymph node involvement (N0) but with isolated tumor cells (i+) detected in the sentinel lymph node (sn). According to the rules provided, N1 stage indicates metastasis in 1 to 3 axillary lymph nodes. However, the report specifies isolated tumor cells in the sentinel lymph node, which is not explicitly covered by the rules. Based on the general principle of the AJCC staging system, I would classify this as N1 stage, as the presence of isolated tumor cells in the sentinel lymph node suggests a very early stage of regional lymph node involvement.",N1,19.0
558,TCGA-A2-A3XZ.A7B6FCF6-1B81-40B5-AD92-54681CBC8FE0,0,"1. y. /F. Speciment. Spec Type: SURGICAL P. PREOPERATIVE DIAGNOSIS. LEFT BREAST CANCER INVASIVE. OPERATION PERFORMED. DOCTOR (s) : PROCEDURE: MASTECTOMY COMPLETR/SIMPLE w/ SENTINED NODE BX. TISSUE REMOVED. A. LT SIMPLE MASTECTOMY. B. LT AXILLA SENTINEL NODE #1. C. LT UPPER INNER CORE BX. D. LT BREAST SUPERFICIAL MARGIN. E. LT AXILLA SENTINEL NODE #2. GROSS DESCRIPTION. PART A RECEIVED FRESH LABELED. LEFT SIMPLE MASTECTOMY. STITCH 12 O' CLOCK, IS A LEFT SIMPLE MASTECTOMY SPECIMEN MEASURING 16 x 16. x 3.5 CM. THE NIPPLE IS UNREMARKABLE WITHIN A 7.5 x 4.2 CM SKIN ELLIPSE. BLUE DYE IS NOTED IN THE SUPERIOR 12 O'CLOCK AREA OF THE BREAST. THE. SUPERFICIAL ASPECT IS MARKED WITH BLUE INK, THE DEEP WITH BLACK. AN M. CLIP IS IDENTIFIED IN THE UPPER INNER QUADRANT MEDIAL ASPECT, ASSOCIATED. WITH A PINK-TAN NODULE AT THE SUPERFICIAL MARGIN MEASURING 0.9 x 0.5 x. 1.2 CM. THIS IS 1.3 CM FROM THE DEEP MARGIN, 1 CM FROM THIS IS A 0.3 CM. FIRM GRAY-TAN AREA WHICH IS 1 CM FROM THE SUPERFICIAL MARGIN AND 1.1 CM. FROM THE DEEP MARGIN GROSSLY. IN THE 11 O'CLOCK AREA THERE IS AN. ELONGATED IRREGULAR PINK-TAN FIRM AREA WHICH ALSO EXTENDS GROSSLY TO THE. SUPERFICIAL MARGIN. THIS MEASURES 3.5 x 0.9 AND IS 1.5 CM IN GREATEST. DIMENSION. THIS LESION IS GROSSLY 3 CM FROM THE FIRST DESCRIBED LESION. THIS LESION GROSSLY EXTENDS TOWARDS THE SUPERFICIAL MARGIN AND IS 1.2 CM. FROM THE DEEP MARGIN. THE BREAST TISSUE ITSELF HAS AN OVERALL INDURATED. QUALITY TO PALPATION WITH A DIFFUSE YELLOW-GRAY APPEARANCE. THE INFERIOR. AND LATERAL ASPECTS DEMONSTRATE A MORE FATTY APPEARANCE. ALSO IN THE. AREA OF THE UPPER INNER QUADRANT, THE PARENCHYMA HAS MULTIPLE SMALL. PALPABLE LESIONS. THIS IS IN THE AREA OF THE BLUE DYE. IT IS SECTIONED. TO DEMONSTRATE THIS WHICH IS SLIGHTLY INFERIOR AND TOWARD THE NIPPLE FROM. THE SECOND DESCRIBED LESION SUBMITTED IN A10 (MIRROR IMAGE TO PROTOCOL). RANDOM TISSUE IS ALSO TAKEN FROM THE 9 O'CLOCK AREA WHICH HAS THIS. DIFFUSE INDURATED QUALITY. THE SECTIONS ARE SUBMITTED AS FOLLOWS: A1--NIPPLE AND SKIN (MIRROR IMAGE TO PROTOCOL), A2--10 O'CLOCK PERIPHERAL. LESION TO INCLUDE SUPERFICIAL AND DEEP MARGINS (MIRROR IMAGE TO. PROTOCOL), A3--10 O'CLOCK LESION (MIRROR IMAGE TO PROTOCOL), A4--MMALL. 0.3 CM NODULE WITHIN TISSUE (MIRROR IMAGE TO PROTOCOL), 15--SECTION OF 11. O'CLOCK LESION (MIRROR IMAGE TO PROTOCOL), A6 THROUGH A8--FOR. CROSS-SECTION OF 11 ''CLOCK LESION TO INCLUDE THE MOST SUPERIOR AND. SUPERFICIAL, DEEP AND SUPERFICIAL INFERIOR ASPECT OF LESIONS TO INCLUDE. SUPERFICIAL MARGIN RESPECTIVELY, A9--11 O'CLOCK LESION (MIRROR IMAGE TO. Speciment. Spec Type: SURGICAL p. GROSS DESCRIPTION. PROTOCOL), A10--TISSUE UPPER OUTER QUADRANT, A11--TISSUE 9 0'CLOCK A. REGION, A12-UPPER OUTER QUADRANT 4 CM FROM THE 11 O'CLOCK LESION (MIRROR. IMAGE TO PROTOCOL). 13--LOWER OUTER QUADRANT 8 CM FROM THE LESION. (MIRROR IMAGE TO PROTOCOL), A14--LOWER INNER QUADRANT. PART B RECEIVED FRESH LABELED. LEFT AXILLA FIRST SENTINEL. NODE HOT AND BLUE, IS A AN OVOID PORTION OF PINK-TAN SOFT TISSUE. MEASURING 2.5 x 1.3 x 1.0 CM. SECTIONING REVEALS A 1.8 CM GROSSLY. UNREMARKABLE LYMPH NODE WITHOUT OBVIOUS BLUE COLORATION. ONE HALF IS. SUBMITTED LABELED B. THE REMAINDER IS SUBMITTED PER PROTOCOL. PART C RECEIVED LABELED. LEFT UPPER INNER CORE BIOPSY. SITE, IS AN UNORIENTED ELLIPTICAL PORTION OF BROWN SKIN AND UNDERLYING. INDURATED FATTY TISSUE. THE SKIN ELLIPSE IS 1.4 x 0.5 CM. THE. UNDERLYING TISSUE MEASURES 2.1 x 0.9 x 1.8 CM. ON THE SKIN SURFACE THERE. IS A RAISED CENTRAL LESION 0.5 CM DIAMETER. THE MARGIN IS MARKED WITH. INK. THE SPECIMEN IS SECTIONED ACROSS THE NARROW MARGIN OF THE SKIN AND. THE 2 EXTREME ENDS (ELLIPTICAL END OF THE SKIN ARE SUBMITTED IN C1 WITH. THE CENTRAL TISSUE IN C2). PART D RECEIVED LABELED. LEFT BREAST SUPERFICIAL MARGIN IS. AN IRREGULAR ELONGATED FRAGMENT OF YELLOW-PINK FATTY TISSUE MEASURING 8.5. x 2.1 x 0.5 CM IN GREATEST DIMENSION. THE SPECIMEN IS NOT OTHERNISE. ORIENTED. ONE SIDE HAS A DULL APPEARANCE AND IS MARKED WITH BLUE INK. THE OPPOSITE SIDE IS MARKED YELLOW. THIS IS SECTIONED AND ENTIRELY. SUBMITTED LABELED D1 THROUGH D5. PART E RECEIVED FRESH LABELED. LEFT AXILLA SECOND SENTINEL. NODE HOT, IS AN OVOID PORTION OF YELLOW-PINK FATTY TISSUE MEASURING 2.9. x. 1.7 x 1.0 CM. SECTIONING REVEALS A 1.8 CM GROSSLY UNREMARKABLE LYMPH. NODE QUBMITTED ENTIRELY LABELED E. PATH PROCEDURES. PROCEDURES: 88307/5, IMMUNOPEROXIDAS/2, A BLK/14, BBX x6, C BLK/2, D BLK/5, EBX X6. FINAL DIAGNOSTS. PART. A LEFT SIMPLE MASTECTOMY MULTICENTRIC IN SITU AND INFILTRATING. DUCT CARCINOMA WITH AT LEAST FOUR SEPARATE FOCI OF TUMOR PRESENT. THE 10. O'CLOCK NODULE SHOWED IN SITU AND MODERATELY DIFFERENTIATED INFILTRATING. DUCT CARCINOMA, NUCLEAR GRADE III/III WITH A HIGH MITOTIC INDEX,. ASSOCIATED WITH A PREVIOUS BIOPSY SITE WITH APPROXIMATELY 1.0 CM OF IN. SITU AND 1.2 CM OF INVASIVE CARCINOMA. THIS LESION EXTENDED TO WITHIN. LESS THAN 1 MM OF THE SUPERFICIAL MARGIN. IN THE 11 O'CLOCK POSITION,. APPROXIMATELY 1.9 CM OF INVASIVE CARCINOMA WAS PRESENT ASSOCIATED WITH. 2.2 CM OF DUCT CARCINOMA IN SITU SHOWING SIMILAR NUCLEAR GRADE AND. HISTOMORPHOLOGY. THIS LESION WAS 5 MM FROM THE DEEP MARGIN AND WAS. specimens. Spec Type: SURGICAL P. FINAL DIAGNOSIS. ASSOCIATED WITH A PREVIOUS BIOPSY SITE. THE PREVIOUS BIOPSY SITE. EXTENDED TO THE SUPERFICIAL MARGIN. A SECTION OF BREAST TISSUE FROM THE. UPPER OUTER QUADRANT OF THE BREAST SHOWED APPROXIMATELY 1.1 CM OF DUCT. CARCINOMA IN SITU AND 0.5 CM OF INVASIVE CARCINOMA WITH SIMILAR. HISTOMORPHOLOGY. AN ADDITIONAL NODULE FROM THE UPPER INNER QUADRANT OF. THE BREAST SHOWED CHANGES OF A PREVIOUS BIOPSY SITE BUT NO RESIDUAL TUMOR. PARTS B AND E LEFT AXILLARY SENTINEL LYMPH NODES NUMBERS 1 AND. BIOPSIES: LYMPH NODES WITH NO EVIDENCE OF METASTATIC DISEASE, SUPPORTED. BY NEGATIVE CYTOKERATIN IMMUNOHISTOCHEMICAL STAINING. PART C LEFT UPPER INNER CORE BIOPSY SITE, REEXCISION: SKIN AND BREAST. TISSUE CONTAINING A PREVIOUS NEEDLE CORE BIOPSY SITE ASSOCIATED WITH. REACTIVE FIBROSIS AND INFLAMMATION. NO RESIDUAL TUMOR IDENTIFIED. THE. PREVIOUS BIOPSY CHANGES EXTEND INTO THE DERMIS. UIQ s-exe - tumor. PART D LEFT BREAST SUPERFICIAL MARGIN, REEXCISION: ADIPOSE TISSUE WITH. NO EVIDENCE OF MALIGNANCY. CODE. 1. (prelim.). (signature on file).",BRCA,0,"The pathology report does not mention any involvement of regional lymph nodes. Therefore, based on New Rule 8, the N stage is N0.",N0,19.0
541,TCGA-A2-A1G6.02B4C31E-38F0-4AF3-8DAD-527D5F27C11A,1,"of '. specimen: spec Type: SURGICAL P. D. RIGHT BREAST CANCER - INVASIVE. DOCTOR ($): PROCKDURE: MODIFIND BADICAL. A. RIGHT MODIFIED RADICAL MASTECTOMY. B. MEDIAL SKIN RIGHT BREAST. PART A IS RECEIVED LABELED. RIGHT MODIFIED RADICAL. MASTECTOMY STITCH MARKS 12 O'CLOCK, IS A RIGHT MODIFIED RADICAL. MASTECTOMY SPECIMEN MEASURING 26 x 18.5 x 5.5 CM IN GREATEST DIMENSIONS. THE NIPPLE IS UNREMARKABLE AND IS WITHIN A 19 x 11.7 CM SKIN ELLIPSE. IN. THE 5 TO 6 O'CLOCK AREA AT THE INFERIOR MARGIN THERE IS A 3 CM IN. DIAMETER CYSTIC STRUCTURE. THE SKIN HAS A BROWN DISCOLORED PLAQUE-LIKE. AREA AT 12 O'CLOCK. THERE IS A PALPABLE FIBROUS MASS IN THE BREAST TISSUE. BENEATH THE SUTURE SPANNING A DISTANCE OF 6 x 5 x 3.5 CM. THE SUPERFICIAL. ASPECT IS MARKED WITH BLUE INK, THE DEEP MARGIN WITH BLACK. THE AXILLARY. TAIL IS REMOVED FROM THE SPECIMEN AND WHERE IT IS REMOVED IT IS MARKED. WITH RED INK AND DOES NOT REPRESENT TRUE MARGIN. THERE IS ONE GROSSLY. POSITIVE LYMPH NODE IN THE MIDPORTION OF THE AXILLARY TAIL. THE HIGHEST. NODE GROSSLY IS NEGATIVE. SECTIONS ARE SUBMITTED AS FOLLOWS: A1--NIPPLE, A2--ONE-HALF OF A GROSSLY POSITIVE LYMPH NODE (REMAINDER. SUBMITTED PER PROTOCOL), 13--GROSSLY HIGHEST LYMPH NODE, A4--ONE LYMPH. NODE BISECTED, A5--ONE LYMPH NODE BISECTED, A6--ONE LYMPH NODE. A7--TUMOR. AND DEEP MARGIN, A8 AND A9--TUMOR AND SKIN ADDING TO A8 AN AREA OF COIL. CLIP, A10--TUMOR AT INFERIOR ASPECT ADJACENT TO FIBROUS TISSUE,. All--TISSUE IMMEDIATELY ADJACENT TO TUMOR UPPER INNER QUADRANT,. 12--TISSUE IMMEDIATELY ADJACENT TO TUMOR UPPER OUTER QUADRANT,. A13--ADDITIONAL UPPER OUTER QUADRANT, A14--LOWER OUTER QUADRANT 4.5 CM. FROM GROSS TUMOR, A15--LOWER INNER QUADRANT 3 CM FROM GROSS TUMOR,. A16--CYSTIC STRUCTURE IN 5 O'CLOCK AREA. THE AXILLARY TAIL IS THEN. FURTHER EXAMINED FOR LYMPH NODES, WHICH ARE SUBMITTED AS FOLLOWS : A17--ONE NODE BISECTED, A18--ONE BONE BISECTED, A19--ONE NODE BISECTED,. A20--ONE NODE BISECTED. ASSOCIATED WITH THE PLAQUE-LIKE AREA OF THE SKIN. IS AN UNDERLYING FIRM PINK-GRAY MASS MEASURING 3.5 x 3.3 x 3.1 CM IN. GREATEST DIMENSIONS. GROSSLY THIS EXTENDS TO WITHIN 0.8 CM OF THE DEEP. MARGIN. THE CENTRAL PORTION OF THE BREAST ALSO DEMONSTRATES DENSE. GRAY-TAN FIBROUS TISSUE WITH MULTIPLE CYSTS. ADDITIONAL SECTIONS ARE SUBMITTED AS FOLLONS FOLLONING INITIAL REVIEW OF. SLIDES: A21 AND A22--SKIN MARGIN, 23--SUPERFICIAL MARGIN. Chief of Pathology. Fhone (. (Contiaued). Speciment. Regti. spec Type: SURGICAL P. PART B IS RECEIVED. MEDIAL SKIN RIGHT BREAST. IT CONSISTS. OF AN UNORIENTED, SOMEWHAT TRIANGULAR PORTION OF SKIN WITH UNDERLYING. SUBCUTANEOUS TISSUE, APPROXIMATELY 2 x 1 x 1 CM. THE RESECTION IS INKED. THE SPECIMEN IS SECTIONED AND ENTIRELY SUBMITTED IN CASSETTES B1 AND B2. PROCEDURES: 88305, 88309, A BLK/23, B BLK/2. PART A RIGHT MODIFIED RADICAL MASTECTOMY: IN SITU AND INFILTRATING. DUCTAL CARCINOMA. THE INFILTRATING TUMOR IS MODERATELY DIFFERENTIATED,. NUCLEAR GRADE III/III WITH A MODERATE MITOTIC INDEX. THE SUPERFICIAL. ASPECT OF THE TUMOR EXTENDS INTO THE DERMIS. THE DEEP MARGIN IS FREE OF. TUMOR BY A DISTANCE OF 10 MM FOR A SUPERFICIAL TO DEEP SIZE OF 35 MM. OVER 90% OF THE TUMOR IS INVASIVE. AREAS OF PROBABLE BREAST LYMPHATIC. SPACE INVASION ARK PRESENT BUT DERMAL LYMPHATIC SPACE INVASION IS NOT. IDENTIFIED. BREAST TISSUE AWAY FROM THE PRIMARY TUMOR MASS SHONS. PROLIFERATIVE FIBROCYSTIC DISEASE. SKIN MARGINS CLOSEST TO THE TUMOR ARE. NEGATIVE. METASTATIC CARCINOMA IS PRESENT IN 4 OF 9 LYMPH NODES. PART B MEDIAL SKIN OF RIGHT BREAST, RESECTION: SKIN AND SUBCUTANEOUS FAT. WITH NO EVIDENCE OF MALIGNANCY. 1. (prelim.). (signature on file).",BRCA,2,"Based on the report, there is metastasis in 1 grossly positive lymph node found in the axillary tail. This indicates that the N stage is N1, as it does not mention involvement in 4-9 axillary lymph nodes or in infraclavicular lymph nodes. The report does not provide information about extranodal extension, so we cannot apply N1a, N1mi, or N1b.",N1,20.0
537,TCGA-A2-A1FX.EAFC71A1-D6FC-46EA-BC47-D054C497D705,2,"SURGICAL REPORT. Sexc F. Date Collected: I. Date Received: M.R. Number. Doctor: Account Number. PRE-OPERATIVE DIAGNOSIS. RIGHT BREAST CANCER. POST-OPERATIVE DIAGNOSIS. RIGHT BREASTS CANCER. PROCEDURE. RIGHT SENTINEL LYMPH NODE BIOPSY. TISSUES. A. LYMPH NODE (S) - SENT NODE #1 ""FS. B. LYMPH NODE (S) - SENT NODE #2 FS. C. BREAST EXCISION,NEEDLE LOC,SIMPLE,MARGINS,ETC.- - RIGHT BREAST MASS. D. AXILLARY - AXILLARY CONTENTS. E. MARGINS - ADDITIONAL RIGHT BREAST TISSUE. F. MARGINS - ADDITIONAL LATERAL MAGINS. WRI TISSUE -. FS DIAGNOSIS. A. RIGHT SENTINEL LYMPH NODE#1, F.S. -. ONE POSITIVE LYMPH NODE (1/M). B. FS NOT PERFORMED PER DR. DEFER. C. RIGHT BREAST MASS, F.S. -. TUMOR MASS 4.7 CM. AND INVOLVING SUPERIOR, INFERIOR,. MEDIAL, ANTERIOR SURGICAL MARGINS. TUMOR IS ALSO VERY CLOSE TO POSTERIOR AND LATERAL SURGICAL MARGINS. (WITH SMALL INDURATED NODULES). E. ADDITIONAL RIGHT BREAST TISSUE (GROSS MARGINS ONLY) -. LATERAL SURGICAL MARGIN IS POSITIVE FOR MALIGNANCY. THE REMAINING SURGICAL MARGINS ARE FREE OF TUMOR. F. ADDITIONAL LATERAL MARGIN (GROSS MARGINS ONLY) -. SURGICAL MARGIN is FREE OF LESION. SURGICAL REPORT. nology Number. (Time Reported to Surgeon: FINAL DIAGNOSIS. A. RIGHT SENTINEL LYMPH NODE #1 -. POSITIVE FOR MULTIPLE FOCI OF METASTATIC BREAST. CANCER. B. RIGHT SENTINEL LYMPH NODE #2 -. POSITIVE FOR METASTASIS, SUBCAPSULAR SINUS DEPOSITS,. MEASURING LESS THAN 0.2 MM. IN AGGREGATE (1/1). c. RIGHT BREAST MASS -. POSITIVE FOR INFILTRATING CARCINOMA MEASURING 4.7 CM. IN GREATEST. DIMENSION WITH FOCAL EXTENSION TO THE SUPERIOR, INFERIOR AND MEDIAL. MARGINS WITH EXTENSION TO WITHIN 1/2 MM. OF THE ANTERIOR AND LATERAL. MARGINS RESECTION. D. AXILLARY CONTENTS -. POSITIVE FOR METASTASIS IN FOUR OF TWENTY TWO LYMPH NODES, TWO OF FOUR. DISPLAY SUBCAPSULAR METASTASIS MEASURING MORE THAN 2 MM. IN GREATEST. DIMENSION, ONE OF FOUR DISPLAYS MICROMETASTASIS IN SUBCAPSULAR SINUS. MEASURING LESS THAN 2 MM. AND REMAINING ONE OF FOUR DISPLAYS ISOLATED. POSITIVE CELLS IN SUBCAPSULAR SINUSES (4/22). E. ADDITIONAL RIGHT BREAST TISSUE-. POSITIVE FOR ADDITIONAL CARCINOMA WITH FOCAL EXTENSION TO THE LATERAL,. ANTERIOR, SUPERIOR AND INFERIOR SURGICAL MARGINS OF RESECTION. F. ADDITIONAL LATERAL MARGINS. POSITIVE FOR FOCAL EXTENSION TO THE NEW LATERAL. SURGICAL MARGIN OF RESECTION. PTNM CLASSIFICATION: T2 N2a, MX, STAGE IIIA. Comment: This case is discussed with Dr. The Cytokeratin (AE1/AE3) performed on specimen ""B and 0"" support the diagnosis. given. E-cadherin stain on specimen ""C"" confirms the infiltrative duct carcinoma. (. Signature on file. GROSS DESCRIPTION. SURGICAL REPORT. nology Number. The specimen is received in six separate containers labeled. designated A, B, C, D, E. and F. A. The container is received fresh unfixed labeled ""right sentinel lymph node #1. for frozen section"". The specimen consist of an ovoid mass of pink-tan, firm,. rubbery tissue with attached fat measuring 1.5x 1x 1 cm in greatest overall. dimension. Touch prep and frozen section are obtained by Dr. The entire. specimen, including frozen section, submitted in two blocks. B. The container is received fresh unfixed labeled ""right sentinel lymph node #2. for frozen section"". The specimen consists of an ovoid mass of tan-gray, firm,. rubbery tissue with attached fat measuring 0.9 x 0.8 x 0.4 cm in greatest overall. dimension. A touch prep is obtained by Dr. A frozen section Is not. performed per Dr. Entire specimen one block. C. The container is received fresh unfixed labeled ""gross margins right breast. mass"". The specimen consists of an 18 gram ovoid mass of apparent fatty and fiber incased. ovoid mass which is 5.5 x 3 x 2 cm in greatest overali dimension. There is an Inserted Indicator. wire. There is an attached single suture indicating anterior margin inked with a blue dye. Posterior is inked with a black. There are two short sutures indicating superior margin inked with. a red dye. Inferior is inked with a yellow. There is a long suture indicating lateral margin Inked. with an orange. Medial is Inked with a green. Gross margins are observed by Dr. He. states tumor mass is 4.7 cm and involving superior, inferior, medial, anterior, surgical margins. Tumor mass is very close to the posterior and lateral surgical margin, with small indurated. nodules. The specimen is submitted in twelve blocks. Key note block summary: 1- superior, 2 - Inferior, 3 - anterior, 4 - posterior, 5 -. lateral, 6 - medial. All of those are perpendicular. 7 through 12 - remaining. D. The container is received fresh unfixed labeled ""exiliary contents"". The specimen. consists of an irregular mass of apparent fatty tissue measuring 10 x 8: x 3 cm in. greatest overali dimension. Serial sectioning reveais firm, purple-tan nodules. varying up to 0.9 cm in greatest dimension. The entire specimen is submitted in. five blocks. E. The container is received fresh unfixed for gross margins which are obtained by. Dr. labeled ""additional right breast tissue"". There is a single short suture indicating anterior. margin inked with an orange dye. Deep margin is inked with a black dye. There are two short. sutures indicating superior margin inked with a red dye. Inferior is inked with a yellow. There is a. single long suture indicating lateral margin inked with a green dye. Medial is inked with a blue. Sectioning reveais firm nodules varying up to 4 cm in greatest dimension. Lateral/green margin is. grossly positive. These nodules are chiefly located in the anterior lateral area and approximately. 0.2 cm from the anterior margin. The specimen is submitted in nine blocks. Key note block summary: 1 - lateral, 2 - medial, 3 - anterior, 4 - deep, 5 - superior, 6 - inferior,. 7 through 9 - random. F. The container is received fresh unfixed labeled ""additional lateral margins -. suture on new lateral margin which is inked with a green dye. Gross margins are. observed by Dr. Sectioning reveais firm paipable nodules varying up to. 0,3 cm in greatest dimension. They appear to be 0.4 cm from the new lateral. margin. The specimen is submitted as four sections in four blocks. SURGICAL REPORT. mology Number: MICROSCOPIC EXAM. MICROSCOPIC EXAMINATION CONDUCTED BY PATHOLOGIST CONFIRMS FINAL DIAGNOSIS. SPECIAL STAINS PERFORMED: E-Cadherin (specimen C); Cytokeratin. (AE1/AE3) (specimens B and D). SURGICAL REPORT.",BRCA,2,"Based on the pathology report, there is evidence of cancer in the regional lymph nodes. Specifically, sentinel lymph node #1 has multiple foci of metastatic breast cancer and sentinel lymph node #2 has subcapsular sinus deposits measuring less than 0.2 mm in aggregate. Additionally, the axillary contents are positive for metastasis in four of twenty-two lymph nodes, with two of four displaying subcapsular metastasis measuring more than 2 mm in greatest dimension, one of four displaying micrometastasis in subcapsular sinus measuring less than 2 mm, and one of four displaying isolated positive cells in subcapsular sinuses. Therefore, the N stage is N2.",N2,21.0
652,TCGA-A8-A08O.2F102533-4B6B-4411-9080-3697ED3099EA,1,"Diagnosis: Invasive ductal breast carcinoma (malignancy grade II) with angioinvasion and penetration of. the retromamillary fibromuscular tissue. But no actual infiltration of the skin. Penetration also. as far as the fascia. However, dye-stained resection margins are free of atypia. In the tumor. nucleus and the remaining glandular body are multicentric manifestations of an intraductal. breast carcinoma (grade II). No coarse calcifications. Fibrocystic base structure. Separately. examined resection margins free of atypia. Tumor classification: pT2 (max. diameter 3.8 cm), pN3a (12/17), pM1, R0; G2 (L1, V0); EIC.",BRCA,3,"The report states pN3a (12/17), which indicates that 12 out of 17 regional lymph nodes are involved. This corresponds to N3 stage according to rule 3 and new rule 10.",N3,22.0
479,TCGA-A2-A0CO.8C440009-E05E-4046-96AB-BAB211CB7D02,2,"Specimen #: (Age. F. Race WHITE. Physician (s) : AMENDED. SPECIMEN: RIGHT BREAST AND AXILLARY CONTENTS Site: breast, NOS C50.9 1/24/11 to. FINAL DIAGNOSIS: BREAST AND AXILLARY CONTENTS, RIGHT, MASTECTOMY: - INFILTRATING LOBULAR CARCINOMA. FOCAL LOBULAR CARCINOMA IN SITU AND CANCERIZATION OF TERMINAL DUCTS. - FOCAL DUCTAL CARCINOMA IN SITU,SOLID AND CRIBRIFORM TYPE. - SIZE: 5.2 CM BY GROSS MEASUREMENT. - MARGINS DEEP MARGIN POSITIVE FOR TUMOR. - NEGATIVE FOR LYMPHVASCULAR INVASION. - MICROCALCIFICATIONS ASSOCIATED WITH TUMOR. - FIBROCYSTIC CHANGES TO INCLUDE FIBROSIS, CYST FORMATION, AND APOCRINE. METAPLASIA. - 11 LYMPH NODES ARE NEGATIVE FOR TUMOR. - AJCC STAGE. COMMENT: THE AMENDMENT REFLECTS A CHANGE IN NUMBER OF LYMPH NODES FROM NINE. TO ELEVEN. COMMENT: AMENDMENT. Case amended to report results of HER2-neu - status by fluorescence in situ. hybridization. HER2-NEU: AMPLIFIED (5.0) . Note: The patient's prior core biopsy,. was negative for. HER2-neu. The tumor in the current case has areas of poorly. differentiated carcinoma (so-called pleomorphic lobular carcinoma) not. identified in the initial core biopsy; these areas are strongly positive. for HER2-neu gene amplification. Specimen # : CLINICAL DIAGNOSIS AND HISTORY: -year-old white female with two site core biopsy breast cancer. RE-OPERATIVE DIAGNOSIS: Right breast cancer. POST-OPERATIVE DIAGNOSIS: Post-Operative Diagnosis: Same as above. GROSS DESCRIPTION: RIGHT BREAST AND AXILLARY CONTENTS received fresh and consists of a 362. gram mastectomy, 15.0 x 14.0 x 2.6 cm, with attached axillary tail, 15.0 x. 3.0 x 1.0 cm. The skin ellipse measures 10.0 X 3.5 cm. The specimen is. inked as follows Axillary tail=blue dot on inferior portion,. mastectomy - blue=superior superficial, green=inferior superficial,. black=deep. Sectioning reveals an area of firmness with the superior. portion of the specimen measuring 5.2 cm approximately 5.0 mm from the. deep margin. Palpation reveals 5.0 cm area of firmness in the superior. portion of the breast. The remainder of the cut surface is yellow,. lobular, with focal areas of white fibrous tissue and small cystic. structures measuring up to 0.2 cm. No additional well-defined lesions or. nodules are noted. Sectioning thorugh the attached axillary tail reveals 11 possible lymph. nodes ranging in size from 0.3 to 2.0 cm in greatest dimension. Four representative sections are submitted for. protocol with mirror. image sections in the following cassettes: A1: Lymph node 0.7 cm. A2: Skin from lateral edge of ellipse. A3: Tumor lateral. A4: Tumor medial. A5: Grossly normal fibrous tissue approximately 5.0 cm from tumor. Additional representative sections are submitted in cassettes A6 through. A20 as follows: A6-A12: Tumor from medial to lateral in sequential order. A13: Upper inner quadrant. A14: Lower inner quadrant. A15: Lower outer quadrant. A16: Upper outer quadrant. A17: Two possible lymph nodes. A18: Five possible lymph nodes. A19: Three possible lymph nodes. A20: Section of nipple. 20CF'.",BRCA,0,"The report states that 11 lymph nodes were examined and found to be negative for tumor involvement. According to Rule 13, pN0(0/N) indicates no cancer involvement in N examined regional lymph nodes. Additionally, there is no mention of any regional lymph node involvement in the report, which supports the N0 classification based on New Rule 8.",N0,22.0
603,TCGA-A7-A5ZW.A56585F9-9651-472B-BF53-C708A686EB7D,0,"Final Surgical Pathology Report. Procedure. Diagnosis. A. Breast, right, lumpectomy: Invasive ductal carcinoma, grade 2; 1.7 cm (pT1c). Ductal carcinoma in situ, cribriform type, nuclear grade 2. Resection margins negative for invasive and in situ carcinoma. Unremarkable skin. B. Right axillary sentinel lymph node, excisional biopsy: Metastatic ductal carcinoma, 7 mm size with extranodal extension. (snpNla). Microscopic Description. Microscopic examination performed. A. Microscopic examination of the right breast lumpectomy specimen is. summarized in the template below: Invasive Carcinoma: Histologic type: Invasive ductal carcinoma. Histologic grade: 2. Overall grade: Architectural score: 2. Nuclear score: 2. Mitotic score: 2. Greatest dimension (pT) : 1.7 CM (pT1c). Specimen margins: Negative for carcinoma. Closest margin is. superior where tumor is 5 mm from the margin. Vessel invasion: Not identified. Calcification: Present. Ductal carcinoma in situ: Histologic pattern: -Cribriform. Nuclear grade: 2. Central Necrosis: Absent. % DCIS of total tumor (if mixed) : Approximately 10%. Extensive intraductal component (present/absent) : Absent. Specimen margins: Negative for DCIS. Calcification: Focally present. Description of non-tumorous breast: Fibrosis, apocrine metaplasia,. microcysts and ordinary ductal hyperplasia and adenosis. Comments: Core biopsy site changes are present. The tumor areas of. slightly higher grade than the original core biopsy interpretation due. to more mitotic activity. The skin is histologically unremarkable with. no extension of tumor into the skin ellipse. Prognostic markers: Performed on the prior core biopsy. B. Microscopic examination of the sentinel node involve the evaluation. of 3 H&E-stained sections of each of the 3 tissue blocks. Metastatic. ductal carcinoma is identified in blocks 1 and 2 and extranodal tumor. is identified in block 1. The size of the tumor is 7 mm (. Specimen. A. Right breast segments. B. Right sentinel lymph node axilla (hot/blue 812). Clinical Information. Breast cancer. Gross Description. A. Received fresh and subsequently fixed in formalin labeled ""right. breast segment"" is a 9.3 x 8.7 x 4.3 cm yellow lobular fatty tissue. fragment showing gross evidence of blue ink staining. The specimen is. received in a transpect container and is partially covered with a 5.7 x. 1.3 cm brown-tan wrinkled skin ellipse. The specimen has a double. suture designating anterior and a single suture designating lateral. The specimen is inked as follows The margins are inked as follows. based upon the orienting sutures: superior - orange; anterior - blue;. posterior - black; inferior - green. The specimen is serially. sectioned from medial to lateral. The specimen shows a yellow white,. fibrofatty cut surface with a 1.7 x 1.5 x 1.5 cm ill circumscribed. white tan firm lesion which comes within 0.5 cm of the superior margin,. 1.5 cm of the inferior margin, within 2 cm of the skin, greater than. 5. cm of the posterior margin and greater than 2.5 cm of the medial and. lateral margins. The lesion is stellate and shows white rice-like. pellets, grossly consistent with previous biopsy site. No additional. gross lesions are identified. The specimen is received in pathology at. and fixed in formalin at. Representative sections of. the specimen are submitted as follows: 1 - representative medial. margin, 2 - representative lateral margin, 3 - representative section. of the deep/ posterior margin, 4 - 10 - representative sections of. tumor to closest margin and skin. RS 10. B. Received fresh and subsequently fixed in formalin labeled ""right. sentinel node"" is a 2.4 x 1.5 x 1.0 cm blue stained pink yellow. irregular rubbery tissue fragment. The specimen is trisected to show an. irregular white firm central focus measuring 0.7 cm in greatest. dimension. AS- 3.",BRCA,1,"Based on the pathology report, metastatic ductal carcinoma was found in the right axillary sentinel lymph node with a 7 mm size and extranodal extension. According to the rules provided, this indicates an N1 stage for breast cancer.",N1,23.0
593,TCGA-A7-A425.F969E3E4-0053-44E9-85BC-BEFDBD62C512,2,"Final Surgical Pathology Report. Procedure: Diagnosis. A. Lymph node, right axillary sentinel node, excision: One lymph node positive for metastatic carcinoma (1/1) . B. Breast, right, excision: Invasive lobular carcinoma (see tumor characteristics in the. microscopic description). C. Lymph nodes, right axillary contents, excision: Ten of sixteen lymph nodes positive for metastatic carcinoma (10/16). D. Lymph node, highest apical node, excision: One of two lymph nodes positive for metastatic carcinoma (1/2). Microscopic Description: Invasive carcinoma: Histologic type: Lobular. Histologic grade: Overall grade:2. Architectural score: 3. Nuclear score: 2. Mitotic score: 1. Greatest dimension (pT) 7.5 cm, pT3. Specimen margins: Tumor is more than 2 cm from the deep margin of. excision and 1 cm from the superficial soft tissue margin. Vessel invasion: Present. Nipple (Paget's) Tumor invades into the dermis beneath the. surface of the nipple: Paget's disease is not identified. Ductal carcinoma in situ: Not identified. Description of non-tumorous breast: Biopsy site changes are identified. Fibrocystic changes. Lymph nodes: Number of positive nodes of total: Twelve lymph nodes positive for. metastatic carcinoma (12/19). Size of largest metastasis: 2.9 cm. Extracapsular extension (present/absent) : Present. pN: pN3a. Distant metastasis (pM) : pMX. Prognostic markers: Previously performed. Specimen. A. Right breast axillary sentinel node. B. Right breast stitch at 12 o'clock. C. Right axillary contents. D. Highest apical node. Clinical Information. Right breast cancer. Intraoperative Consultation. A) Lymph node, right axillary sentinel node, excision: One lymph node. positive for metastatic carcinoma (1/1) . Gross Description. A. Received fresh labeled ""right axillary sentinel node hot not blue"". is a lymph node that measures 2.9 x 1.7 x 1.4 cm in dimension. The. lymph node has a firm consistency and shows yellowish discoloration. A. representative section from the node is submitted for frozen section. The remaining node is sectioned and entirely submitted for permanent. section in 6 cassettes. B. Received fresh for tissue procurement labeled ""right breast"" is a. 1220 g, 29.0 cm (medial to lateral) by 23.5 cm (superior to inferior). by 5.8 cm (anterior to posterior) soft, lobulated tan gold-like portion. of fibroadipose tissue in keeping with breast, designated as right per. requisition slip and container and oriented by a suture as stated. previously. A 17.5 x 5.8 cm wrinkled tan-white skin ellipse with a. flat 1.3 x 1.3 cm nipple is present along the anterior aspect. An. indurated focus is present subjacent to the central superior portion of. the skin, corresponding to the junction of the upper inner and outer. quadrants. The anterior surface in this area is inked blue. The. intact deep margin is inked black and the specimen is sectioned. There. is a central, 7.5 cm (superior to inferior) by 5.5 cm (medial to. lateral) by 4.0 cm (anterior to posterior) rubbery tan-white apparent. tumor mass is present (corresponding to the central junction of the 4. quadrants) The lesion is present within 3.5 cm of the inked deep. margin and appears to approach the anterior surface to within 2 cm. A. portion of tumor and a portion of normal parenchyma are submitted for. tissue procurement as requested. The cut surfaces throughout the. remainder of the specimen consist predominantly of soft lobulated tan. gold adipose tissue with a scant amount of interspersed delicate. tan-white fibrous tissue. No additional mass lesion or abnormality is. identified. Summary: 1 - deep margin subjacent to the lesion, 2 - lesion to. anterior surface, 3 through 7 - lesion to adjacent parenchyma, 8 -. random upper outer quadrant, 9 - upper inner quadrant, 10 - lower inner. quadrant, 11 - lower outer quadrant, 12 - nipple. C. Received fresh and subsequently fixed in formalin labeled ""right. axillary contents ""is a 12.0 x 7.5 x 3.0 cm aggregate of yellow lobular. fatty tissue fragments which are not orientated. The specimens are. palpated to identify lymph nodes which range from 0.1 cm and 2.5 cm in. greatest dimension. The lymph nodes are entirely submitted as follows: 1 - 1 possible lymph node, 2 - 6 possible lymph nodes, 3 - 6 possible. lymph nodes, 4 - 2 possible lymph nodes, 5 - 1 possible lymph node, 6. 1 possible lymph node. D. Received fresh and subsequently fixed in formalin labeled ""highest. apical node ""is a 3.0 x 2.0 x 0.4 cm aggregate of yellow lobular fatty. tissue fragment. The specimen is palpated to identify 2 possible lymph. nodes present. The lymph nodes are 0.5 cm and 0.2 cm in greatest. dimension. The specimens are entirely submitted as follows: 1 - lymph. nodes, 2 - remaining fat.",BRCA,3,"Based on the pathology report, 12 out of 19 lymph nodes are positive for metastatic carcinoma, and extracapsular extension is present. This meets the criteria for N3a in the AJCC staging system for breast cancer.",N3a,24.0
614,TCGA-A8-A06T.5D888D65-685F-4598-884F-AD057DE5FD1D,2,"Diagnosis: 1. Left-sided ablated breast tissue with a 55 mm moderately differentiated invasive ductal. breast carcinoma measuring with completely circumscribed invasion of the lymph vessels. without an intraductal tumor component with a minimum basal margin of 3 mm, a 6 mm. margin at 12 o'clock and surrounding a fibrocystic and proliferating mastopathy with ductal. hyperplasia and sclerotic, intraductal papillomas, tumor-free epidermis, including nipple and. tumor-free isolated samples of pectoral muscle. Tumor classification: M-8500/3, G 2, pT3, pL1, pN1a (1/13), pMx, stage III A. R0.",BRCA,1,"The report specifies that the patient has pN1a (1/13), which indicates metastasis in 1 axillary lymph node out of 13 examined lymph nodes. This corresponds to N1 stage according to the rules provided.",N1,24.0
658,TCGA-A8-A08Z.DA7BD84B-C00E-40A0-9AE2-33FCE7995696,3,"Diagnosis: 1. Invasive breast carcinoma with focal angioinvasion and tumor infiltration of. the skin spindle with foci of ulceration (tumor diameter: 5.0 cm). Dorsal resection margin. tumor-free. In conclusion, this is a moderately differentiated invasive ductal carcinoma with focal. angioinvasion and ulceration of the skin spindle. Tumor classification: NOS, G II, pT4bN3aLIVORO.",BRCA,3,"The report indicates that the patient has been diagnosed with invasive breast carcinoma and has tumor infiltration of the skin with foci of ulceration, with a tumor diameter of 5.0 cm. The report also states that the tumor has spread to the dorsal resection margin and that the patient's N stage is N3a. Therefore, the N stage for this patient is N3.",N3,25.0
634,TCGA-A8-A07U.1E7788D8-B5FC-473A-8A10-79910443799A,1,"Path site : Breast, 40Q C50.4 1/19/11 for. Diagnosis: 2. Right breast resection material with a 2.2 cm poorly differentiated invasive ductal breast. carcinoma with a minimum margin of almost 1 cm basally and at 6 o 'clock and surrounding. fibrolipomatous atrophic glandular tissue without any evidence of an intraductal tumor. component and tumor-free overlying skin, including the nipple. Tumor classification: M-8500/3, G3, pT2, pN2a, pMX, stage IIIA. R0.",BRCA,2,"Based on the pathology report, the patient's N stage is pN2a, which indicates metastasis in 1 to 3 axillary lymph nodes with extracapsular extension or metastasis in 4 to 9 axillary lymph nodes without extracapsular extension. This is in line with Rule 14.",N2,26.0
628,TCGA-A8-A07J.2243F29C-191C-4D33-8483-09BB3AD36598,1,"Diagnosis: 1. Breast segment with a bifocal invasive ductal carcinoma (G II; tumor diameter: 3. cm and 0.8 cm) with focal intraductal components. Tumor classification: NOS, G II, pT2(m) pN1a(1/18)LOV0R0.",BRCA,1,"Based on the report, the patient has breast cancer with a primary tumor size of 3 cm and 0.8 cm (pT2(m)). The N stage is pN1a(1/18)LOV0R0, which indicates metastasis in 1 out of 18 examined axillary lymph nodes (N1).",N1,26.0
506,TCGA-A2-A0EW.2620E5E7-ED7D-4F04-A8AF-1499E9711E8A,0,"Specimen #: (Age: )F Race: WHITE. SPECIMEN: A: LEFT BREAST B: RIGHT BREAST. C: LEFT AXILLARY SENTINEL NODE. D: RIGHT AXILLARY SENTINEL NODE. E: RIGHT AXILLARY NON SENTINEL NODE. FINAL DIAGNOSIS: A. BREAST, LEFT, SIMPLE MASTECTOMY: - SKIN WITH NO SIGNIFICANT PATHOLOGIC CHANGES. BREAST TISSUE WITH FIBROCYSTIC CHANGES TO INCLUDE APOCRINE METAPLASIA. AND MICROCYST FORMATION. - NEGATIVE FOR MALIGNANCY. B. BREAST, RIGHT, SIMPLE MASTECTOMY: - TUMOR TYPE: INVASIVE LOBULAR CARCINOMA, MULTICENTRIC (SEE COMMENT) . TUMOR #1: - TUMOR TYPE: INVASIVE LOBULAR CARCINOMA, LOW NUCLEAR GRADE. - NOTTINGHAM GRADE: I/III. - NOTTINGHAM SCORE: 5/9. (Tubules= 3, Nuclei= 1, Mitoses= 1; mitotic count 1 per 10 HPF at. 40x power). - TUMOR LOCATION: LOWER OUTER QUADRANT. TUMOR SIZE (GREATEST DIMENSION) : 1.0 CM (MEASURED GROSSLY). - ADDITIONAL DIMENSIONS: 1.0 X 0.5 CM. - TUMOR NECROSIS: NONE IDENTIFIED. - MICROCALCIFICATIONS: NONE IDENTIFIED. VENOUS / LYMPHATIC INVASION: NONE IDENTIFIED. - MARGINS: TUMOR INVOLVES INKED SUPERFICIAL MARGIN (B2) . - INTRADUCTAL COMPONENT: NONE IDENTIFIED. LYMPH NODES FOUR (4) OF FOUR POSITIVE FOR TUMOR BY H&E (SEE PARTS D. AND E). - NIPPLE INVOLVEMENT: NOT IDENTIFIED. - SKIN INVOLVEMENT: NOT IDENTIFIED. TUMOR #2: - TUMOR TYPE: INVASIVE LOBULAR CARCINOMA, LOW NUCLEAR GRADE. - NOTTINGHAM GRADE: I/III. - NOTTINGHAM SCORE: 5/9. (Tubules= 3, Nuclei= 1, Mitoses= 1; mitotic count 2 per 10 HPF at. Specimen # : FINAL DIAGNOSIS (continued) : 40x power). - TUMOR LOCATION: UPPER MIDDLE. - TUMOR SIZE (GREATEST DIMENSION) : 1.0 CM (MEASURED GROSSLY) (SEE. COMMENT) . - ADDITIONAL DIMENSIONS: 1.0 X 0.5 CM. - TUMOR NECROSIS: NONE IDENTIFIED. MICROCALCIFICATIONS: PRESENT, ASSOCIATED WITH LOBULAR CARCINOMA IN. SITU (B3). - VENOUS / LYMPHATIC INVASION: NONE IDENTIFIED. - MARGINS : TUMOR <0.1 CM FROM INKED SUPERFICIAL MARGIN (B3). - INTRADUCTAL COMPONENT : NONE IDENTIFIED. - LYMPH NODES: SEE ABOVE. - NIPPLE INVOLVEMENT: NOT IDENTIFIED. - SKIN INVOLVEMENT: NOT IDENTIFIED. - ESTROGEN RECEPTORS: POSITIVE (PER. - PROGESTERONE RECEPTORS: POSITIVE (PER. - HER 2 NEU by IHC: 1+ (NEGATIVE) (PER. - PATHOLOGIC STAGE: pT1c N2 MX (AJCC, 6th ED) (SEE COMMENT). - ADDITIONAL PATHOLOGIC CHANGES: - LOBULAR CARCINOMA IN SITU. - ACELLULAR FOREIGN MATERIAL AND BIOPSY SITE CHANGES (SEE COMMENT) . - FIBROCYSTIC CHANGES TO INCLUDE APOCRINE METAPLASIA AND MICROCYST. FORMATION. - MAMMARY DUCT ECTASIA. C. SENTINEL LYMPH NODE, LEFT AXILLA, EXCISIONAL BIOPSY: - THREE (3) BENIGN LYMPH NODES BY CONVENTIONAL H&E AND. IMMUNOHISTOCHEMICAL STAINING. D. SENTINEL LYMPH NODES, RIGHT AXILLA, EXCISIONAL BIOPSY. - THREE (3) LYMPH NODES POSITIVE FOR CARCINOMA BY CONVENTIONAL H&E AND. IMMUNOHISTOCHEMICAL STAINING. E. NON-SENTINEL LYMPH NODE, RIGHT AXILLA, EXCISIONAL BIOPSY: - ONE (1) LYMPH NODE POSITIVE FOR CARCINOMA WITH EXTRACAPSULAR. EXTENSION BY H&E STAINING. Comment: There are two separate tumors in the right breast mastectomy. specimen. Since these tumors are separated by 4. cm and are located in. different quadrants the designation ""multicentric"" is used. Both tumors. are histologically similar. The acellular marker material present in the. specimen is associated with the upper middle tumor (tumor #2) . There are. isolated tumor cells present in a section adjacent to the upper middle. Specimen #: FINAL DIAGNOSIS (continued) : tumor (tumor #2, slide B4) making the exact determination of tumor size. difficult. The largest dimension measured of the tumor is 1.2 cm from the. previous biopsy specimen (S08- - i! making the tumor stage Tlc. The. histologic appearance along with the presence of lobular carcinoma in situ. and the immunohistochemical characterization of the previous biopsy. support the diagnosis of invasive lobular carcinoma. CLINICAL DIAGNOSIS AND HISTORY: year-old female with right breast mass birads four on. mammogram, ultrasound guided biopsy, invasive lobular carcinoma. Bilateral simple mastectomy, skin biopsy, with immediate reconstruction. PRE-OPERATIVE DIAGNOSIS: Right breast cancer. GROSS DESCRIPTION: A. Received fresh, labeled with the patient's name,. designated ""LEFT BREAST TISSUE WITH MARKINGS"" is a mastectomy specimen. oriented with a short stitch superior, long stitch lateral, and double. stitch ""down"". The specimen measures 17.0 cm medial to lateral, 16 cm. superior to inferior, and 3.5 cm anterior to posterior. The lightly. pigmented superficial skin ellipse measures 10.0 x 3.0 cm and displays a. 1.0 cm centrally located everted nipple free of discharge. No scar is. identified. The deep margin is inked black. Serial sections reveal. predominantly lobulated, yellow-tan, adipose tissue admixed with evenly. distributed, tan-white, fibrous tissue comprising approximately 20% of the. cut surface. On palpation, no discreet mass or lesion is identified. No. lymph nodes are identified. Cassette Summary : A1: Skin. A2: Upper outer quadrant. A3: Upper inner quadrant. A4: Lower inner quadrant. A5: Lower outer quadrant. A6: Central. A7: Nipple. A8: Upper outer quadrant. Specimen #: GROSS DESCRIPTION (continued) : A9: Upper inner quadrant. A10: Lower inner quadrant. All: Lower outer quadrant . Matched sections of A1 through A6 are submitted in. for CBCP protocol. B. Received fresh, labeled with the patient's name,. designated ""RIGHT BREAST TISSUE WITH MARKINGS"" is a mastectomy specimen. oriented with a short stitch superior, and a long stitch lateral. The. specimen measures 7.0 cm superior to inferior, 17.0 cm medial to lateral,. and 3.5 cm anterior to posterior. The lightly pigmented superficial skin. ellipse measures 10.0 x 3.0 cm and displays a 1.0 cm centrally located,. everted nipple free of discharge. No scar is identified. The deep margin. is inked black, and the superficial surface is partially inked blue. Serial sections reveal a 1.0 x 1.0 x 0.5 cm well defined, tan-white mass. in. the. upper mid breast, abutting the blue inked superficial surface, and. coming to within 4.0 cm of the deep margin. Also identified is a second,. poorly defined mass in the lower outer quadrant measuring approximately. 1.0 x 1.0 x 0.5 cm. The lower outer quadrant mass abuts the blue inked. superficial surface, and is located 4.5 cm from the deep margin. The. masses are separated by a distance of approximately 4.5 cm. The remainder. of the specimen is predominantly composed of lobulated, yellow-tan,. adipose tissue admixed with approximately 20% slightly dense, fibrous. tissue. No additional lesions are identified. No lymph nodes are. identified. Cassette Summary : B1: Skin. B2 Lower outer quadrant mass. B3 : Upper mid mass. B4: Adjacent normal (to B3) . B5: Upper outer quadrant. B6: Lower outer quadrant. B7: Lower inner quadrant. B8: Upper inner quadrant. B9: Nipple. B10: Lower outer quadrant mass. B11: Deep margin of lower outer quadrant mass. B12-B13: Upper mid mass. B14: Deep margin of upper mid mass. C. Received in formalin, labeled with the patient's name,. D, designated ""LEFT AXILLARY SENTINEL NODE"" is a 5.5 x 4.5 x. cm. irregularly shaped, lobulated fragment of tan-yellow, adipose. Sectioning. Specimen #: GROSS DESCRIPTION (continued) : reveals three possible lymph nodes ranging in size from 1.0 x 0.6 x 0.3 cm. to 1.2 x 1.0 X 0.6 cm. The lymph nodes are bisected, and submitted in. cassettes C1 through C3. D. Received in formalin, labeled with the patient's name,. D, designated ""RIGHT SENTINEL NODE"" is a tan-yellow, lobulated,. irregularly shaped fragment of adipose tissue measuring 5.5 x 3.0 X 0.5 cm. in diameter. Examination reveals three possible lymph nodes ranging in. size from 0.2 x 0.2 x 0.2 cm to 2.3 x 1.6 x 1.0 cm. Cassette Summary. D1-D2: First possible lymph node. D3: Second possible lymph node. D4: Third possible lymph node. E. Received fresh for intraoperative consultation, labeled with the. patient's name,. designated ""RIGHT AXILLARY TISSUE, NON. SENTINEL NODE"" is a 4.0 x 3.5 x 2.0 cm irregular portion of yellow-tan,. soft tissue. Sectioning reveals a single, 1.5 x 1.0 x 0.5 cm lymph node. The cut surface is tan-white, suspicious for involvement by lesion. The. lymph node is bisected, and submitted in cassette E1. A matched section. of E1 is submitted in. ior CBCP protocol. Time in formalin for specimen A: 79 hours. Time in formalin for specimen B: 81 hours.",BRCA,3,"Based on the pathology report, there are 4 lymph nodes positive for cancer in the right axillary region (3 in the sentinel lymph nodes and 1 in the non-sentinel lymph node). This meets the criteria for N2 stage in breast cancer as per New Rule 11 and New Rule 20.",N2,27.0
671,TCGA-A8-A09D.C4A1A482-6AE5-4807-BA05-C73AC0898546,1,"Diagnosis: Poorly differentiated invasive ductal carcinoma (tumor diameter: 2.2 cm) with focal. intraductal components. Concluding tumor classification: NOS, G III, pT2N1aLOVORO. (compare E. no. xxxx).",BRCA,1,"The report specifies a pT2N1a classification, which indicates that the tumor is T2 (2.1 to 5.0 cm) and N1 (metastasis in 1 to 3 axillary lymph nodes). Therefore, the N stage is N1.",N1,27.0
675,TCGA-A8-A09K.56C24ABB-CF1D-447F-A5A8-B762C4B01566,0,"Diagnosis: 4. Resected material from'l left breast segment with a 1.4 cm poorly differentiated (G3). invasive ductal breast carcinoma. Carcinoma-free resection margins, carcinoma-free skin. Fibrous mastopathy of surrounding tissue. Tumor stage: pTlc pN1mi (intranodal micrometastasis), MX, R0; G3 (L0, V0).",BRCA,1,"The report specifies pN1mi, which indicates micrometastasis in 1 to 3 sentinel lymph nodes (New Rule 16). Therefore, the N stage is N1.",N1,28.0
651,TCGA-A8-A08L.BC0E0F93-B183-44E8-B551-EA463B2FBCE4,2,"Diagnosis. 1. Left-sided ablated breast tissue with a poorly differentiated invasive ductal breast. carcinoma measuring a maximum of 6 cm with focal invasion of the lymph vessels, extension. to the base of the nipple and the pectoral muscle and excision extending just into the healthy. tissue in the basal epidermis. No pagetoid tumor propagation or skin infiltration. Tumor classification: M-8500/3, G 3, pT3, pN2a (5/13), pMX, stage III A. R0.",BRCA,2,"The report specifies that the patient has a pN2a (5/13) stage, which indicates metastasis in 1 to 3 axillary lymph nodes with extracapsular extension or metastasis in 4 to 9 axillary lymph nodes without extracapsular extension. The report states pN2a (5/13), which means that out of 13 lymph nodes examined, 5 were positive for metastasis.",N2,29.0
645,TCGA-A8-A08C.6E136F3D-A6E1-4541-AA4B-65BC5872DE06,1,"Diagnosis: , 1. Poorly differentiated invasive ductal carcinoma (tumor diameter: 3.5. cm; minimum distance dorsally 1 cm, other margins remain free). Tumor classification for left breast: NOS, G III, pT2NOLOVORO.",BRCA,0,"The report does not mention any involvement of regional lymph nodes, so based on Modified Rule 8, the N stage is N0.",N0,29.0
672,TCGA-A8-A09E.C55B6F4B-1248-4FBF-83C2-B0A1B33DEA03,3,"Diagnosis. 1. Left-sided ablated breast tissue with a poorly differentiated invasive ductal breast. carcinoma measuring a good 55 mm with invasion of the lymph vessels and focally also of. the blood vessels, infiltration of the overlying epidermis with very slight paracentral erosion. and extension to the basal resection margin with infiltration of the resection margin. The. nipple is tumor-free, including the lactiferous sinus and the other glandular tissue with a. fibrocystic mammopathy. Assessment: According to these findings, complete removal of the carcinoma as far as the basal epidermis. is not definite. Tumor classification: M-8500/3, G3, pT4b, pLI, pV1, pNla (1/11), pMx, stage III B. R1.",BRCA,1,"Based on the pathology report, the patient has metastasis in 1 axillary lymph node (pNla (1/11)), which falls under the N1 category according to the rules provided.",N1,29.0
544,TCGA-A2-A25B.FCE29F34-5D13-4A21-A950-A8577C957C10,1,"This report contains corrections, additions or deletions. Any previous versions are stored internally and are available if necessary. Specimen: Spec Type: SURGICAL P. Suba Dr: LEFT BREAST CANCER INVASIVE. DOCTOR (S) 3. PROCEDURE: SENTINEL NODR BX/SIMPLE MASTECTOMY. A. LT SENTINEL NODE #1 - FS. B. LEFT BREAST. C. LEFT AXILLARY NODES. D. ADDITIONAL ANTERIOR MARGIN OF THE INFERIOR PORTION OF LEFT BREAST. A. METASTATIC CARCINOMA. PART A IS RECEIVED DESIGNATED. SENTINEL LYMPH. NODE #1. IT IS RECEIVED IN THE FRESH STATE FOR FROZEN. SECTION AND CONSISTS OF A FRAGMENT OF YELLOWISH-PINK FIBROADIPOSE TISSUE. WITH 2 PALPABLE NODULES, THE SPECIMEN HAVING OVERALL DIMENSIONS 4.3 x. 2.7 x 1.5 CM WITH THE LARGEST NODULE MEASURING 2 x 2 x 1 CM AND THE. SMALLER 1.5 x 1.2 x 0.3 CM. SECTIONING THE LARGER NODULE SHOWS MULTIPLE. GRAY-WHITE NODULES WITHIN A TANNISH-PINK PARENCHYMA MEASURING UP TO 0.6. x 0.4 x 0.4 CM. THE SMALLER NODULE ON SECTIONING REVEALS A. TANNISH-PURPLE PARENCHYMA WITH A 0.8 x 0.5 x 0.5-CM GRAYISH-TAN NODULE. THE SECTIONS SUBMITTED FOR FROZEN SECTION ARE SUBMITTED FOR PERMANENTS. LABELED. SECTIONS OF UNFROZEN TISSUE ARE SUBMITTED WITH A. REPRESENTATIVE SECTION FROM THE LARGEST NODULE AND THE REMAINING SMALLER. NODULE ENTIRELY. REPRESENTATIVE SECTIONS ARE SUBMITTED AS FOLLOWS FSA. SECTION FROM LARGER AND SMALLER NODULES IN 1 CASSETTE: A1-CROSS. SECTION OF LARGEST NODULE, A2 -SMALLER NODULE ENTIRELY, SECTION. PART B RECEIVED LABELED. LEFT BREAST, IS A. SIMPLE MASTECTOMY SPECIMEN MEASURING 23.5 x 22 x 8.0 CM. THE NIPPLE. IS. UNREMARKABLE WITHIN A 13.5 x 9-CM SKIN ELLIPSE. A SUTURE DENOTES 12. THE SUPERFICIAL ASPECT IS MARKED WITH BLUE INK, THE DEEP WITH. Specimen: tatus: Spec Type: SURGICAL P. BLACK. SECTIONING REVEALS YELLOW FATTY TISSUE INTERSPERSED WITH. PINK-TAN GRANULAR FIBROUS TISSUE WHICH IS PRESENT DIFFUSELY THROUGHOUT. THE BREAST. IN THE 6 AND 7 CLOCK AREA, THERE IS A FIRM PINK-TAN LESION. WHICH HAS A CENTRAL CYLDNDRICAL-SHAPEI METAL CLIP. THIS FIRM AREA. MEASURES 4 x 2.5 X 3 CM IN GREATEST DIMENSIONS. IT GROSSLY EXTENDS TO. WITHIN 0.8 CM OF THE DEEP MARGIN AND 0.3 CM OF THE SUPERFICIAL MARGIN. SUPERIOR AND CENTRAL WITHIN THE BREAST, THERE IS A 4.5 x 2-CM AREA OF. FATTY TISSUE WITHOUT FIBROUS BANDS NHICH GROSSLY SEEMS DELINEATED FROM. THE SURROUNDING PARENCHYMAL TISSUE (B2) SECTIONS ARE SUBMITTED AS. FOLLOWS: B1--NIPPLE, 12--CENTRAL FATTY TISSUE, B3--TUMOR AND. SUPERFICIAL MARGIN, B4 THROUGH 7--FULL CROSS-SECTION OF THE LESION TO. INCLUDE THE DEEP AND SUPERFICIAL MARGIN, B8--FIBROUS TISSUE IMMEDIATELY. LATERAL TO THE LESION, 19--TISSUE IMMEDIATELY MEDIAL TO LESION IN LOWER. INNER QUADRANT, B10--UPPER INNER QUADRANT 14 CM FROM LESION, B11--TISSUE. AT 9 O' CLOCK 9 CM FROM LESION, B12--LOWER OUTER QUADRANT 4 CM FROM. LESION, B13--3 O'CLOCK 13 CM FROM LESION, B14--UPPER OUTER QUADRANT 15. CM FROM LESION, 15--ADDITIONAL SECTION OF TUMOR AND SUPERFICIAL MARGIN. SECTIONS OF TUMOR AND BREAST TISSUE ARE SUBMITTED PER PROTOCOL. AFTER X-RAYING THE SPECIMEN, A CLIP IS IDENTIFIED IN THE 6 O' CLOCK AREA. AT THE EDGE OF THE SKIN ELLIPSE. THIS IS 3 CM ANTERIOR AND LATERAL TO. THE PREVIOUSLY DESCRIBED LESION. THIS AREA CONSISTS OF A RED-BROWN CLOT. SURROUNDED BY INDURATED YELLOW-TAN FATTY TISSUE MEASURING 1.7 x 1.0 x 1.5. CM. THIS IS 0.5 CM FROM THE INFERIOR SUPERFICIAL MARGIN AND 3.5 CM FROM. THE DEEP MARGIN. SECTIONS FROM THIS AREA ARE SUBMITTED IN B16 THROUGH. B19. B20--DEEP MARGIN TO LESION B21 -TISSUE TAKEN BETWEEN THIS LESION. AND THE LARGER TUMOR MASS. TISSUE IS ALSO TAKEN FROM THE SECOND AREA PER. PROTOCOL. PART C RECEIVED LABELED. LEFT AXILLARY NODE,. IS YELLOW-RED FATTY TISSUE MEASURING 7.5 x 6 x 1.7 CM. THIS IS EXAMINED. FOR LYMPH NODES. ALSO LOOSE WITHIN THE CONTAINER IS A 1-CM OVOID. RED-TAN STRUCTURE. THIS IS CONSISTENT WITH A GROSSLY UNREMARKABLE LYMPH. NODE. IT IS SECTIONED AND SUBMITTED LABELED C1 WITH A PORTION SUBMITTED. PER PROTOCOL. THREE LARGER NODES ARE IMMEDIATELY IDENTIFIABLE WITHIN. THE FATTY TISSUE. THESE ARE SECTIONED WITH ONE-HALF OF EACH SUBMITTED. WITHIN C2 THROUGH C4, RESPECTIVELY, WITH C3 GROSSLY POSITIVE. SECTIONS. OF THESK NODES ARE ALSO SUBMITTED PER PROTOCOL. ADDITIONAL NODES ARE. SUBMITTED AS FOLLOWS: --FOUR NODES. PART D RECEIVED LABELED. ADDITIONAL ANTERIOR. MARGIN OF THE INFERIOR PORTION OF LEFT BREAST STITCH MARKS 12 O'CLOCK,. IS AN ELLIPTICAL PORTION OF BROWN PIGMENTED SKIN MEASURING 16 x 2.7 x. 0.9 CM. ALONG THE MIDPORTION OF ONE EDGE IS A SUTURE DENOTING 12. D'CLOCK. THIS EDGE IS MARKED WITH BLUE INK. THE 3 O'CLOCK SIDE OF THE. SPECIMEN IS THEN MARKED BLACK AND THE 9 O'CLOCK RED. THE 3 O' CLOCK. ELLIPTICAL END IS AMPUTATED AND BISECTED LONGITUDINALLY AND SUBMITTED AS. Specimen: Spec Type: SURGICAL P. D1. THE 9 O'CLOCK ELLIPTICAL END IS AMPUTATED AND BISECTED. LONGITUDINALLY AND SUBMITTED LABELED D2. BY PALPATION, THERE IS SOME. NODULARITY IN THE CENTRAL PORTION OF THE SPECIMEN AND CROSS-SECTIONS ARE. SUBMITTED IN D3 AND 4. ADDITIONAL SECTIONS FROM THE 3 O' 'CLOCK SIDE ARE. SUBMITTED IN D5 AND ADDITIONAL SECTIONS FROM THE 9 D'CLOCK SIDE ARE. SUBMITTED IN D6. PROCEDURES: PATH FS , A BLK/2, B BLK/15, C BLK/5, D BLK/6, FS-A. PART A LEFT AXILLA, SENTINEL LYMPH NODE #1: METASTATIC BREAST CARCINOMA. IS PRESENT IN ONE OF TWO LYMPH NODES EXAMINED. EXTRANODAL EXTENSION IS. NOT IDENTIFIED. PART B LEFT BREAST, SIMPLE MASTECTOMY. 1. INTRADUCTAL AND INFILTRATING DUCT CARCINOMA. INVASIVE COMPONENT. IS POORLY DIFFERENTIATED SHOWING NUCLEAR GRADE 3/3, MODERATE MITOTIC. INDEX AND TUBULE FORMATION 3 WITH TOTAL NOTTINGHAM SCORE OF 8. HIGH GRADE DCIS OF THE CRIBRIFORM AND SOLID TYPES HAVING AREAS. OF COMEDONECROSIS IS IDENTIFIED SURROUNDING AND WITHIN THE TUMOR. WITH EXTENSION INTO TERMINAL LOBULES COMPRISING APPROKIMATELY 20% OF. THE TUMOR. 2. THE INVASIVE COMPONENT HAS A MAXIMUM GROSS DIMENSION OF 4 CM AND IS. FOCALLY IDENTIFIED APPROXIMATELY 2 MM FROM THE NEAREST INKED. SUPERFICIAL MARGIN (B15). 3. RANDOM SECTIONS OF THE REMAINING QUADRANTS AND NIPPLE SKIN ARE FREE. OF TUMOR. SEE COMMENT. 4. LYMPHOVASCULAR INVASION IS IDENTIFIED. 5. THE BIOPSY SITE. IS PRESENT. 6. DIFFUSE LACTATIONAL CHANGES. PART C LEFT AXILLA, LYMPH NODE DISSECTION: METASTATIC BREAST CARCINOMA. IS IDENTIFIED IN 1 OF 6 LYMPH NODES EXAMINED. EXTRANODAL EXTENSION IS. NOT SEEN. Specimen: Spec Type: SURGICAL P. PART D LEFT BREAST, ADDITIONAL ANTERIOR MARGIN OF THE INFERIOR PORTION,. EXCISION: SKIN AND SUBCUTANEOUS TISSUE WITH NO EVIDENCE OF RESIDUAL. TUMOR AND CLEAR MARGIN. THE SECOND BIOPSY SITE WAS NOT IDENTIFIED ON INITIAL GROSS EXAMINATION. THE SPECIMEN NILL BE X-RAYED TO FIND THE BIOPSY CLIP AND ADDITIONAL. SECTIONS WILL BE SUBMITTED. ADDITIONAL SECTIONS SURROUNDING THE SECOND BIOPSY SITE SHOW DCIS, SOME OF. WHICH EXTENDS INTO TERMINAL LOBULES, RARE MICROSCOPIC FOCI OF. INFILTRATING DUCT CARCINOMA, AND LYMIPHOVASCULAR INVASION. 1.",BRCA,1,"Based on the report, metastatic breast carcinoma is found in 1 out of 2 sentinel lymph nodes (SLN) and 1 out of 6 lymph nodes from the axillary lymph node dissection. This indicates regional lymph node involvement, which is consistent with N1 stage. Extranodal extension is not identified in any of the nodes.",N1,29.0
646,TCGA-A8-A08F.683AAF99-3B91-4501-B701-C3A4E8439647,1,"Diagnosis: 1. Ablated (right) breast sample with a multifocal invasive ductal carcinoma with. intraductal components and focal angioinvasion (focus of a poorly differentiated. invasive ductal carcinoma with a tumor diameter of 2.8 cm and two further foci of. a. moderately invasive ductal carcinoma with tumor diameters of 3.0 cm and 1 cm). Dorsal resection margin tumor-free with minimum margin of 0.5 cm with the first. tumor focus, 1.5 cm with the second and 0.7 cm with the third, other margins are. free. Tumor classification: NOS, G III, pT2(mult)N3aL1V0R0. N. Site. Prior Prigian Noted QUALIFIED. is. (circle): Die.",BRCA,3,"The report indicates that the patient's cancer is classified as pT2(mult)N3aL1V0R0, where N3a suggests metastasis in 10 or more axillary lymph nodes or in infraclavicular lymph nodes, with or without extranodal extension.",N3,30.0
601,TCGA-A7-A56D.D564A7FB-4F0A-4589-AB32-A6CD8B547219,1,"Final Surgical Pathology Report. Procedure: Diagnosis. A. Left axillary sentinel lymph node, resection: No evidence of metastasis in one lymph node (0/1) . B. Left breast, simple mastectomy: Infiltrating ductal carcinoma, grade 3, 3.2 cm in greatest dimension. Surgical margins negative but close, less than 2 mm. C. Left axillary contents, resection: No evidence of metastasis in 7 lymph nodes (0/7). Microscopic Description: Microscopic examination performed. A. Sections of the sentinel lymph node demonstrate no evidence of. metastatic disease. The node is examined by multiple sectioning with. hematoxylin and eosin and by immunohistochemistry for pankeratin. Invasive Carcinoma: present. Histologic type: Infiltrating ductal carcinoma. Histologic grade: Overall grade: 3. Architectural score: 2. Nuclear score: 3. Mitotic score: 3. Greatest dimension (pT) : 3.2 cm,. pT2. Specimen margins: Negative but close, less than 2 mm over a. distance of 5 mm. Vessel invasion: Not identified. Calcification: Not identified. Ductal carcinoma in situ: Not identified. Description of non-tumorous breast: Proliferative fibrocystic. changes with intraductal papillomatosis. Comments: None. Prognostic markers: Previously performed. C Sections of the left axillary contents demonstrate no evidence of. metastasis in 7 lymph nodes. Specimen. A. Left sentinel node-axillary. B. Left breast-tumor at 7 o'clock. C. Axillary contents. Clinical Information. Carcinoma left breast, core biopsy positive here. Intraoperative Consultation. AFS left axillary sentinel lymph node, excision: No evidence of metastasis in one lymph node. Gross Description. A. Container a is labeled with the patient's name, medical record. number and ""sentinel lymph node"". The specimen consists of a single. piece of fatty tissue which when bisected holds a single lymph node. measuring 1.0 x 0.0 0. cm. Bisected and submitted in block AFS. B. Received fresh labeled ""left breast"" is a 25.5 cm (medial to. lateral) by 17.0 cm (superior to inferior) by 4.5 cm (anterior to. posterior) soft, lobulated tan-white-gold portion of fibroadipose. tissue oriented per placement of designated tumor as stated previously. A 19.3 x 8.5 cm wrinkled tan skin ellipse with an eccentric, 1.0 x 1.0. x 0.5 cm nipple is present along the anterior aspect. A palpable mass. is evident at 7 o'clock, corresponding to the lower inner quadrant. The antero-inferior surface of the specimen in the vicinity of the mass. is inked blue. The intact deep margin is inked black and the specimen. is sectioned. There is a well-circumscribed, 3.2 cm (medial to. lateral) by 2.4 cm (anterior to posterior) by 2.0 cm (superior to. inferior) rubbery tan-white tumor mass within the lower outer quadrant. On sectioning the tumor appears to extend to within 0.2 cm of the. inked anteroinferior surface and 1.5 cm of the inked deep margin. A. portion of tumor and a portion of normal parenchyma are submitted for. tissue procurement as requested. The cut surfaces throughout the. remainder of the specimen consist predominantly of soft, lobulated tan. gold adipose tissue with a minimal amount of interspersed dense. tan-white fibrous tissue. No additional mass lesion or abnormality is. identified. Summary: 1 - tumor to inked deep margin, 2 through 4 - tumor to inked. anteroinferior margin, 5 and 6 - tumor to adjacent parenchyma, 7 -. random upper outer quadrant, 8 - upper inner quadrant, 9 - lower inner. quadrant, 10 - lower outer quadrant, 11 - junction of the 4 quadrants,. 12 - nipple. C. Received fresh labeled ""Axillary contents"" is a 9.3 x 7.8 x 1.7 cm. portion of soft, lobulated tan gold adipose tissue. A few slightly. rubbery pale tan to tan pink tissues in keeping with lymph nodes. measuring up to 3.4 cm in greatest dimension are recovered. The. lymphoid tissues are entirely submitted. RS 4. Summary: 1 - 2 lymph nodes, 2 - 1 bisected lymph node, 3 and 4 -. bisected largest lymph node. the. Criteria. Discrepancy. Temar S. Discripancy. PIP.",BRCA,0,"The report mentions 'No evidence of metastasis in one lymph node (0/1)' for the sentinel lymph node and 'No evidence of metastasis in 7 lymph nodes (0/7)' for the left axillary contents. This indicates no regional lymph node involvement, which corresponds to N0 stage.",N0,30.0
633,TCGA-A8-A07S.AC2E3DDC-3AF6-45F0-8269-E9DA68F4367A,1,Summary diagnosis: Left breast at 3 o'clock: invasive breast carcinoma of mixed differentiation with a tumor. classification pT2 (28 mm) pM0 (0/28) grade 1 (L0(V0) R1 (ventral). Associated extensive lobular neoplasia and DCIS grade 1 corresponding to pTis RI ventral.,BRCA,0,"The pathology report does not mention any involvement of regional lymph nodes. According to Modified Rule 8, if the pathology report does not mention any involvement of regional lymph nodes, the N stage is N0.",N0,30.0
563,TCGA-A2-A4S0.0118D9AE-B923-4EEF-BBBC-82D559763FF9,1,"Status: DIS-IN. M.D. Specimen: Sp type: SURGICAL P. M.D. PREOPERATIVE DIAGNOSIS. BREAST CA. OPERATION PERFORMED. DOCTOR (S) : PROCEDURE : TOTAL MASTECTOMY; EXCISION OF AXILLARY SENTINEL NODE. TISSUE REMOVED. A. RIGHT BREAST STITCH AT 12 O'CLOCK. B. RIGHT SENTINEL NODE #1. GROSS DESCRIPTION. RECEIVED IN 2 PARTS. A RECEIVED LABELED. RIGHT BREAST STITCH AT 12 O'CLOCK IS. A 2041 SIMPLE MASTECTOMY MEASURING 33.5 CM FROM MEDIAL TO LATERAL, 28 CM. FROM SUPERIOR TO INFERIOR, AND UP TO 5.5 CM FROM ANTERIOR TO POSTERIOR. THE NIPPLE IS INVERTED WITHIN A 31 X 17 CM SKIN ELLIPSE. A SUTURE. DENOTES 12 O'CLOCK. 4 CM LATERAL TO THE NIPPLE AT 9 O'CLOCK IS A. LOBULATED RED-TAN GLISTENING MASS MEASURING 2.2 CM FROM SUPERIOR TO. INFERIOR, 2 CM FROM ANTERIOR TO POSTERIOR, AND 4.5 CM FROM MEDIAL TO. LATERAL. THIS LESION IS 2.5 CM FROM THE DEEP MARGIN. TOWARDS THE. LATERAL EDGE THERE IS A 2ND NODULE ADJACENT BY LESS THAN 1 CM MEASURING. 1 x 1 X 1 CM. THERE IS A RIBBON CLIP ASSOCIATED WITH THIS AREA. THE. REMAINING BREAST TISSUE CONSISTS OF BLAND YELLOW FATTY TISSUE WITH FINE. FIBROUS BANDS. A WING CLIP IS IDENTIFIED IN THE LARGER LESION. REPRESENTATIVE SECTIONS ARE SUBMITTED AS FOLLOWS: A1--NIPPLE, A2--DEEP. MARGIN TO LARGER LESION, A3--THE MOST LATERAL PORTION OF THE LARGER. LESION, A4--THE MOST MEDIAL PORTION OF THE LARGER LESION 4.5 CM FROM A3,. A5 THROUGH A7--ADDITIONAL SECTIONS OF LARGER LESION, A8 AND --SMALLER. SUPERIOR RIBBON CLIP LESION, A10--UPPER INNER QUADRANT 10 CM FROM THE. LESION, All--UPPER OUTER QUADRANT 4 CM FROM LESION, A12--LOWER OUTER. QUADRANT 4 CM FROM LESION, A13--LOWER INNER QUADRANT 10 CM FROM LESION. TISSUE IS TAKEN PER CLINICAL BREAST CARE PROJECT RESEARCH PROTOCOL OF. THE LARGER LESION LABELED P1-p5 WITH FROZEN OCT SAMPLES AS MIRROR IMAGES. TO P1 AND P2. IN ADDITION A MIRROR IMAGE SECTION OF THE NIPPLE (A1) IS. SUBMITTED FROZEN IN OCT ALONG WITH THE 4 RANDOM QUADRANT SECTIONS. Specimen: Sp type: SURGICAL P. D. GROSS DESCRIPTION. A10-A13. B RECEIVED LABELED. RIGHT SENTINEL NODE #1 HOT AND BLUE. COUNT 39252 IS A PORTION OF PINK-TAN TISSUE WITH BLUE COLORATION. MEASURING 1.3 X 0.8 X 0. . 4 CM. THE SPECIMEN IS BISECTED AND SUBMITTED. LABELED B. COMMENT: THIS CASE EXCEEDS THE MAXIMUM CAP/ASCO. GUIDELINE OF 48 HOURS FORMALIN FIXATION. PATH PROCEDURES. PROCEDURES: 88307/2, IMMUNOPEROXIDAS, A BLK/13, BBX X6. FINAL DIAGNOSIS. PART A RIGHT BREAST, SIMPLE MASTECTOMY: 1. Macinous CA 1/1/1. INVASIVE MUCINOUS CARCINOMAS (2) GRADE I WITH NUCLEAR GRADE 1 AND. LOW MITOTIC INDEX. 2. THE TUMORS MEASURE 4.5 AND 1.0 CM IN GREATEST DIMENSION. THE NIPPLE. AND DEEP MARGIN ARE FREE OF NEOPLASM. 3. LYMPHATIC INVASION IS NOT IDENTIFIED. 4. BIOPSY SITE CHANGES WITH CLIPS PRESENT. 5. PROLIFERATIVE FIBROCYSTIC DISEASE WITH CALCIFICATIONS PRESENT. PART B RIGHT SENTINEL NODE 1: LYMPH NODE (1), NEGATIVE FOR TUMOR BY. STEP SECTION AND CYTOKERATIN STAIN. , M.D.",BRCA,0,"The report states that the right sentinel node (#1) is negative for tumor by step section and cytokeratin stain. This indicates no evidence of cancer in the regional lymph nodes, which corresponds to N0 stage according to Rule 2.",N0,30.0
649,TCGA-A8-A08I.F2077079-D683-4D18-94B9-84C760674AF6,1,"Diagnosis: 1. Poorly differentiated invasive ductal breast carcinoma with small areas of necrosis. and secondary inflammation (tumor diameter 3 cm, margin distances: cranial 0.6 cm,. caudal 0.4 cm, ventral 0.2 cm, dorsal 0.1 cm, medial 0.4 cm and lateral 0.8 cm). This results in the following summary tumor classification: invasive ductal breast. carcinoma, NOS, G III, pT2 NO(O/3sn)LOVORO.",BRCA,0,"The report mentions 'NO(O/3sn)', which indicates no involvement of regional lymph nodes (N0) based on the modified Rule 8 and New Rule 13.",N0,30.0
557,TCGA-A2-A3XY.EC1BB6E8-6897-4E70-80A6-5A4E4B9C4E1F,1,"Specimen #: (Age: Race: Physician (s) : AMENDED. SPECIMEN: LEFT BREAST AXILLARY & CONTENTS. FINAL DIAGNOSIS: BREAST, LEFT, MASTECTOMY WITH AXILLARY DISSECTION: - TUMOR TYPE: INVASIVE DUCTAL CARCINOMA (NO SPECIAL TYPE). - TUMOR FOCALITY: UNIFOCAL. - HISTOLOGIC GRADE: GRADE 3. - NOTTINGHAM SCORE: 9/9 (Tubules= 3, Nuclei= 3, Mitoses= 3 mitotic. count 24 PER 10 high power fields). - TUMOR SIZE (GREATEST DIMENSION) : 2.5 CM (GROSS MEASUREMENT) . - TUMOR SIDE (QUADRANT) : LEFT, UPPER OUTER QUADRANT. - TUMOR NECROSIS: PRESENT IN INVASIVE AND IN SITU CARCINOMA. - MICROCALCIFICATIONS: PRESENT IN DUCTAL CARCINOMA IN SITU AND BENIGN. BREAST TISSUE. - VENOUS/LYMPHATIC INVASION: NONE DEFINITELY IDENTIFIED. - INTRADUCTAL COMPONENT: DUCTAL CARCINOMA IN SITU, NUCLEAR GRADE 3,. SOLID TYPE WITH CENTRAL EXPANSIVE ""COMEDO"" NECROSIS. - MARGINS. - DISTANCE OF INVASIVE CARCINOMA FROM CLOSEST MARGIN: 1.2 MM. (SUPERFICIAL MARGIN). DISTANCE OF IN SITU CARCINOMA FROM CLOSEST MARGIN: 1.0 MM. (SUPERFICIAL MARGIN) AND 1.2 MM (DEEP MARGIN). - LYMPH NODES: 3 OF 17 NODES POSITIVE FOR METASTATIC CARCINOMA. - LARGEST METASTATIC FOCUS: 1.2 CM (MICROSCOPIC MEASUREMENT). - EXTRACAPSULAR EXTENSION: ABSENT. - NIPPLE INVOLVEMENT: ABSENT. - SKIN INVOLVEMENT: ABSENT. - PATHOLOGIC STAGE (AJCC. EDITION) : pT2 N1a. - ANCILLARY STUDIES: - ESTROGEN RECEPTORS: NEGATIVE (os NUCLEAR STAINING) . - PROGESTERONE RECEPTORS : NEGATIVE (0% NUCLEAR STAINING). - HER2 BY FISH: NEGATIVE (HER2/CEP17 RATIO: 1.0; PER. PERFORMED ON PRIOR SPECIMEN FROM. - ADDITIONAL PATHOLOGIC CHANGES : - PRIOR BIOPSY SITE CHANGES. FOR OFFICIAL USE ONLY - PERSONAL DATA - PRIVACY ACT OF. FOR OFFICIAL USE ONLY - PERSONAL DATA - PRIVACY ACT OF. Specimen #: FINAL DIAGNOSIS (continued): - FIBROADENOMA (1.2 CM; MICROSCOPIC MEASUREMENT) . - USUAL DUCTAL HYPERPLASIA, MODERATE. - SMALL PERIPHERAL PAPILLOMA. - FIBROCYSTIC CHANGES. Comment: : This case is amended. to add the results of. immunohistochemical stains for estrogen and progesterone receptors, as. noted above. No other changes are made. Although ER and PR stains were previously performed on the patient's core. biopsy. they were repeated due the greater number of. neoplastic cells in the current specimen and due to the focal staining for. progesterone receptors (reportedly 1%) in the prior biopsy. Estrogen and progesterone receptors were evaluated by immunohistochemical. methods (. estrogen receptor antibody 1D5, progesterone receptor. antibody PgR636) A positive test is defined as easily discernable nuclear. staining in 1% or more of the tumor cells. CLINICAL DIAGNOSIS AND HISTORY: -yearOold. with left breast mass in. Diagnostic. mammography and ultrasound on. confirmed presence of a 2.2 x. 1.4 cm left upper outer quadrant breast mass. PRE-OPERATIVE DIAGNOSIS: Left breast mass; breast cancer. POST-OPERATIVE DIAGNOSIS: None provided. GROSS DESCRIPTION: Received fresh, labeled with the patient's name. and. designated, ""Left Breast Axillary and Contents"" and consists of a left. mastectomy oriented with a short stitch superior; two short stitches. posterior; one long lateral; and two long on an axillary lymph node. The. specimen weighs 381 grams and measures 17.0 cm medially to laterally; 15.0. FOR OFFICIAL USE ONLY - PERSONAL DATA - PRIVACY ACT OF. FOR OFFICIAL USE ONLY - PERSONAL DATA - FRIVACY ACT of. Specimen #: GROSS DESCRIPTION (continued) : cm superiorly to inferiorly; and 2.5 cm anterior to posterior. The darkly. pigmented superficial skin ellipse measures 15.5 x 5.5 cm and displays a. 1.5 x 1.0 x 1.0 cm centrally located, everted nipple, free of discharge. The deep margin is inked black and the superficial margin is inked blue. Serial sections reveal a fairly well defined, firm pink-tan mass in the. upper outer quadrant. The mass measures 2.5 x 1.4 x 0.4 cm, comes to. within 0.4 cm of the deep margin and abuts the superficial margin. Immediately adjacent to, and continuous with the mass, is a 0.4 cm. centrally located, red-brown probable biopsy cavity. A 1.2 x 1. 2 x. 0.5. cm. ell-circumscribed, rubbery fibrous nodule is noted in the lower mid. breast which is consistent with a fibroadenoma. The remainder of the. specimen is composed of markedly dense tan-white fibrous tissue with. minimal admixed adipose tissue. No additional lesions are identified. The attached axillary tail measures 8. x 6.5 x 2.0 cm. Sectioning. reveals 11 lymph nodes ranging in size from 0.3 cm in greatest dimension. to 2.5 x 2.0 x 1.7 cm. On sectioning, the two largest lymph nodes, one of. which is tagged with a suture, are tan-white and moderately firm,. consistent with involvement by metastatic lesion. Representative sections are submitted as follows: 1- nipple; 2- mass with. deep margin; 3. - mass with superficial margin; 4- mass with deep margin;. 5-. mass with superficial margin; 6-7- mass with deep margin; 8-9- mass with. superficial margin; 10- mass; 11- biopsy cavity; 12- - biopsy cavity; 13- -. lower mid nodule; 14- UIQ; 15- LIQ; 16- LOQ; 17; central (adjacent to. mass) i 18- - one lymph node (marked with suture) ; 19- five lymph nodes; 20-. one lymph node; 21- one lymph node, bisected; 22- one lymph node; 23 - one. lymph node; 24-25- one lymph node, sectioned. Matched sections of 1,5,8-10, 12-18, 20 and 22-24 are submitted in. OCT/Paraffin per. Time in formalin: >80 hours. FOR OFFICIAL USE ONLY - PERSONAL DATA - PRIVACY ACT OF.",BRCA,1,"The report states that 3 out of 17 lymph nodes are positive for metastatic carcinoma. This corresponds to the N1 stage in breast cancer, as defined in New Rule 9, New Rule 15, and New Rule 19.",N1,30.0
508,TCGA-A2-A0EY.61462D57-DF98-4F89-BAEF-E8156A47E2DD,1,"Specimen #: : WHITE. SPECIMEN: A: RIGHT BREAST LUMPECTOMY B: ADDITIONAL INFERIOR MARGIN. C: ADDITIONAL DEEP MARGINS D: SENTINEL NODE #1. E: SENTINEL LYMPH NODE #2. FINAL DIAGNOSIS: A. BREAST, RIGHT, LUMPECTOMY: - TUMOR TYPE: INFILTRATING DUCTAL CARCINOMA. - NOTTINGHAM GRADE: MODERATELY DIFFERENTIATED. - NOTTINGHAM SCORE: 6/9. (Tubules= 2, Nuclei= 3, Mitoses= 1). TUMOR SIZE (GREATEST DIMENSION) : 2.8 CM. - TUMOR NECROSIS: NOT IDENTIFIED. - MICROCALCIFICATIONS: PRESENT ASSOCIATED WITH INFILTRATING CARCINOMA. AND BENIGN DUCTS. - VENOUS / LYMPHATIC INVASION: NOT IDENTIFIED. - MARGINS : UNINVOLVED. - DISTANCE OF INVASIVE TUMOR FROM NEAREST MARGIN IS 0.3 CM, FROM. INFERIOR MARGIN. (measured microscopically). INTRADUCTAL COMPONENT: PRESENT; SOLID AND CRIBRIFORM, NUCLEAR GRADE. 3, WITH CENTRAL NECROSIS. - LYMPH NODES: SEE PARTS ""D-E"". - ONE OF TWO SENTINEL LYMPH NODES POSITIVE FOR METASTATIC CARCINOMA. - SKIN INVOLVEMENT: NOT IDENTIFIED. - ESTROGEN RECEPTORS: POSITIVE (SEE. - PROGESTERONE RECEPTORS: NEGATIVE (SEE. - HER 2 NEU by IHC: POSITIVE (SEE. - PATHOLOGIC STAGE: pT2 N1a MX. - ADDITIONAL PATHOLOGIC CHANGES : USUAL DUCTAL HYPERPLASIA, FIBROCYSTIC. CHANGES, SCLEROSING ADENOSIS, UNREMARKABLE EPIDERMIS. B. BREAST, ""ADDITIONAL INFERIOR MARGIN"", EXCISION: - BENIGN BREAST TISSUE. - MARGINS UNINVOLVED. PATHOLOGIC CHANGES : USUAL DUCTAL HYPERPLASIA, APOCRINE METAPLASIA,. FIBROCYSTIC CHANGES, MICROCALCIFICATIONS. C. BREAST, ""ADDITIONAL DEEP MARGINS"", EXCISION: Specimen #: FINAL DIAGNOSIS (continued) : - BENIGN FIBROADIPOSE TISSUE WITH NO EVIDENCE OF MALIGNANCY. - NO BREAST GLANDULAR ELEMENTS PRESENT. - MARGINS UNINVOLVED. D. LYMPH NODE, SENTINEL NODE #1, BIOPSY: - ONE LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA. - LARGEST METASTATIC FOCUS: 0.4 CM. - EXTRACAPSULAR EXTENSION: NOT IDENTIFIED. E. LYMPH NODE, SENTINEL NODE #2, BIOPSY: - ONE LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA BY ROUTINE HISTOLOGY. AND CYTOKERATIN IMMUNOHISTOCHEMISTRY. Comment : The prior core biopsy specimen (. right breast,. is reviewed. This case has received intradepartmental prospective. peer review. CLINICAL DIAGNOSIS AND HISTORY: y/o female with history of right breast carcinoma. PRE-OPERATIVE DIAGNOSIS: None provided. POST-OPERATIVE DIAGNOSIS: None provided. GROSS DESCRIPTION: A. Received fresh, labeled with the patient's name,. and. designated ""RIGHT BREAST LUMPECTOMY"" consists of a breast lumpectomy. specimen, measuring 9.0 cm from superior to inferior; 8.8 cm from medial. to lateral; and 3.0 cm from superior to inferior. The specimen is. oriented with a long suture marking the lateral margin; and a short suture. marking the superior margin. The overlying ellipse of tan skin measures. 6. x 1.8 cm. The specimen is differentially inked as follows: blue -. superior; green - inferior; orange - anterior; black - posterior; red -. lateral; and yellow - medial. The specimen is serially sectioned from. R. Y. Specimen #: GROSS DESCRIPTION (continued) : anterior to posterior to reveal a sharply-circumscribed, firm, ovoid mass. with. a. homgenous tan cut surface, measuring 2.8 x 2.6 x 1.6 cm in overall. dimensions. This mass is located in the posterior half of the specimen,. and measures 0.4 cm from the nearest margin (inferior) . The remaining. tissue is mostly fatty with admixed areas of fibrosis, especially. posteriorly. Skin, tumor, and grossly unremarkable fibrous tissue are. sampled for the CBCP Protocol with matching paraffin sections in cassettes. A1, A2-A6 and A7. Representative sections are submitted as follows: A1-. skin; A2-tumor; A3-6 - - tumor with inferior margin; A7-fibrous tissue. with posterior and superior margins; A8 - -fibrous tissue with superior. margin; A9-10- anterior margin; A11-12- lateral margin; A13-14-medial. margin. B: Received in formalin, labeled with the patient's name,. ad designated ""ADDITIONAL INFERIOR MARGIN"" consists of an irregular. fragment of tan-yellow, lobulated adipose tissue, measuring 5.5 x 1.9 x. 0.8 cm in overall dimensions. The specimen is received oriented with. steel surgical clips marking the true new margin. This new margin is. inked blue, and the opposing surface is inked orange. The specimen is. serially sectioned to reveal a tan-yellow, fatty cut surface without. evidence of residual tumor. The specimen is entirely submitted in six. cassettes. C: Received in formalin, labeled with the patient's name,. d designated ""ADDITIONAL DEEP MARGINS"" consists of an irregular. portion of tan-yellow, lobulated adipose tissue measuring 4.7 x 3.9 x. 1.1. cm in overall dimensions. The true new margin is marked with surgical. clips, this margin is inked blue, and the opposing surface is inked. orange. The specimen is serially sectioned to reveal a homogenous. tan-yellow, fatty cut surface without exidence of residual tumor. Representative sections are submitted in six cassettes. D: Received fresh, labeled with the patient's name,. designated ""SENTINEL NODE #1"" consists of a single irregular tragment of. tan-yellow adipose tissue, measuring 2.0 x 1.8 x 0.5 cm in overall. dimensions. Palpation of the specimen reveals a single tan-pink lymph. node, measuring 1.5 x 0.7 x 0.7 cm in overall dimensions. A small portion. of the lymph node is sampled for the CBCP Protocol with matching paraffin. section in D1, and the remainder of the specimen is submitted in cassette. D2. E: Received in formalin, labeled with the patient's name,. and designated ""SENTINEL LYMPH NODE #2"" consists of a similar irregular. Specimen #: GROSS DESCRIPTION (continued) : fragment of tan-yellow, lobulated adipose tissue measuring 2.4 x 2.0 x 1.1. cm in overall dimensions. The specimen is bisected to reveal a 2.2 cm. firm, tan-pink lymph node. The specimen is entirely submitted in two. cassettes.",BRCA,1,"Based on the pathology report, one out of the two sentinel lymph nodes is positive for metastatic carcinoma. This indicates that the patient has metastasis in at least one axillary lymph node, which corresponds to N1 stage according to the breast cancer-specific rules.",N1,31.0
462,TCGA-A1-A0SN.D0269758-EFAE-4EBA-8CCF-4A6CF4D4B35A,0,"Final Pathologic Diagnosis: A. Lymph node, left axillary sentinel node #1, excision: No metastatic carcinoma in. one lymph node (0/1). B. Lymph node, left axillary sentinel node # +2, excision: Metastatic carcinoma in one. lymph node with extension into peri-nodal fat (1/1). C. Lymph node, left axillary sentinel node # 3, excision: Metastatic carcinoma in one. lymph node (1/1). D. Lymph node, left axillary non-sentinel node # 1, excision: Metastatic carcinoma in. one lymph node (1/1). Working Draft. E. Lymph node, left axillary non-sentinel node #2, excision: Metastatic carcinoma in. one lymph node (1/1). F. Breast, left, partial mastectomy: 1. Infiltrative ductal carcinoma, SBR grade 2, 1.1 cm in maximum dimension,. margins negative; see comment. 2. Ductal carcinoma in situ, high-grade, solid and comedo types, 1.1 cm in maximum. dimension, intermixed with invasive ductal carcinoma, margins negative. G. Breast, left lateral anterior, excision: Benign breast tissue, no carcinoma. identified. H. Breast, medial superior anterior, excision: Benign breast tissue, no carcinoma. identified. I. Lymph node, left axillary contents, excision: No metastatic carcinoma in eight. lymph nodes (0/8). Note: Breast Tumor Synoptic Comment. - Laterality: Left. - Invasive tumor type: Invasive ductal carcinoma. - Invasive tumor size: 1.1 cm maximum diameter. - Invasive tumor grade (modified Bloom-Richardson): 2. Nuclear grade: 3, 3 points. Mitotic count: <10 mitotic figures/10 HPF, 1 point. Tubule/papilla formation: <10%, 3 points. Total points and overall grade = 7 points = grade 2. - Lymphatic-vascula invasion: Extensive lymphatic-vascular invasion is noted with intra-lymphatic. metastasis noted in lymphatics at least 1 cm from the main tumor. - Perineural Invasion: Not present. - Resection margins for invasive tumor: - Deep margin: Negative; (tumor is 0.2 cm away, on slide F6). - Medial margin: Negative; (tumor is greater than 1 cm). - Lateral margin: Negative; (tumor is greater than 1 cm). - Anterior/superior margin: Negative; (tumor is 0.2 cm away, on slide F6). - Anterior/inferior margin: Negative; (tumor is 0.3 cm away, on slide F4). - Ductal carcinoma in situ (DCIS) type: Comedo and solid. - Ductal carcinoma in situ size: 1.1 cm, intermixed with invasive ductal carcinoma. - Ductal carcinoma in situ nuclear grade: High-grade. - Necrosis in DCIS: Comedonecrosis. - Microcalcifications: Not identified. - Resection margins for ductal carcinoma in situ: - Deep margin: Negative; (tumor is 0.6 cm away, on slide F6). - Medial margin: Negative; (tumor is greater than 1 cm). - Lateral margin: Negative; (tumor is greater than 1 cm). - Anterior/superior margin: Negative; (tumor is 0.25 cm away, on slide F6). - Anterior/inferior margin: Negative; (tumor is 0.25 cm away, on slide F6). - Lobular carcinoma in situ (LCIS): None. - Lymph node status: Positive. - Number of positive lymph nodes: 4. - Total number sampled: 13. - Diameter of largest metastasis: 0.8 cm. Working Draft. - Extranodal extension: Present. - AJCC/UICC stage: pT1cN1MX. An immunohistochemical test for estrogen and progesterone receptors was performed by manual. morphometry on block #. The test for estrogen receptors is positive. There isstrong nuclear staining in 90% of tumor cells. Internal positive control is positive. The test for progesterone receptors is positive. There is moderate nuclear staining in 60% of tumor. cells. Internal positive control is positive. Result of HER2/neu test: This carcinoma is positive for HER2/neu oncoprotein over-expression. An immunohistochemical assay was performed by manual morphometry on block F8 using the CB11. monocional antibody to HER2/neu oncoprotein. The staining Intensity of this carcinoma was 3 on a. scale of 0-3 (HER2 test interpreted by Dr. Carcinomas with staining intensity scores of 0 or 1 are considered negative for over-expression of HER2/neu oncoprotein. Those with a staining intensity score of 2 are considered indeterminate. We and others have observed that many carcinomas with. staining intensity scores of 2 do not show gene amplification. All carcinomas with staining intensity scores of 2 are therefore. submitted for FISH testing. The results of the FISH test are issued directly from the molecular cytogenetics laboratory. Carcinomas with staining intensity scores of 3 are considered positive for over-expression of HER2/neu oncoprotein. Tumors in. this category show an excellent correlation between the results of immunohistochemical and FISH testing, and almost always show. gene amplification. Intraoperative Consult Diagnosis. FS1 (A) Left axillary sentinel lymph node #1, biopsy: No tumor seen. (Tissue section and. cytopreparation) (Dr. FS2 (B) Left axillary sentinel lymph node #2, biopsy: Positive for metastatic carcinoma. (Tissue. section and cytopreparation) (Dr. FS3 (C) Left axillary sentinel lymph node #3, blopsy: Positive for metastatic carcinoma. (Tissue. section and cytopreparation) (Dr. 1. FS4 (D) Left axillary non-sentinel lymph node #1, biopsy: Positive for metastatic carcinoma. (Tissue. section and cytopreparation) (Dr. Clinical History. The patient is a. year-old woman with left breast invasive ductal carcinoma. She undergoes partial. mastectomy. Gross Description. The specimen is received fresh in nine parts, each labeled with the patient's name and medical record. number. Part A is additionally labeled. It consists of a single irregular piece of. soft-firm, pink-red tissue, measuring 0.5 x 0.3 X 0.2 cm. The specimen is bisected, and cytologic. touch and scrape preparations are prepared. The specimen is then entirely submitted for frozen. section diagnosis as FS1, with the frozen section remnant submitted in cassette A1. Part B is additionally labeled. It consists of a single oval piece of soft-to-firm,. red-pink tissue, measuring 0.9 x 0.6 x 0.6 cm. The specimen is bisected, and cytologic touch and. scrape preparations are made. The specimen is then entirely submitted for frozen section diagnosis as. FS2, with the frozen section remnant submitted in cassette B1. Part C is additionally labeled. It consists of a single ovoid piece of soft-to-firm,. Working Draft. pink-red tissue, measuring 0.8 x 0.5 x 0.4 cm. The specimen is bisected, and cytologic touch and. scrape preparations are prepared. I he specimen is then entirely submitted for frozen section. diagnosis as FS3, with the frozen section remnant submitted in cassette C1. Part D is additionally labeled. It consists of a single ovoid piece of. soft-to-firm, pink-red tissue, measuring 1.3 x U.I x 0.5 cm. The specimen is bisected, and cytologic. touch and scrape preparations are prepared. The specimen is then entirely submitted for frozen. section diagnosis as FS4, with the frozen section remnant submitted in cassette D1. Part E is additionally labeled. It consists of a single ovoid piece of firm,. off-white/tan tissue, measuring 1.5 x 0.7 x 0.4 cm. The specimen is bisected and entirely submitted. in cassette E1. Part F is additionally labeled. t consists of. an oriented portion of fat, measuring 10.3 (anterior- posterior) x 7.4 (medial-lateral) x 6.4. (superior-inferior) cm and weighing 13 gm. There is a 1.1 cm in diameter white-yellow hard mass. with a white homogeneous interior located within the specimen (slices 3-6). This mass abuts the. posterior margin, is 0.6 cm from the anterior-inferior and anterior-superior margins, 1 cm from the. lateral margin, and 7 cm from the medial margin. The specimen is inked so as the anterior-superior. surface is blue, the anterior- inferior surface is green, and the posterior surface is black. A. representative section is taken for tissue banking. The specimen is serially sectioned, from lateral to. medial into thirteen 0.5 cm slices. Representative sections are submitted as follows: Cassette F1: Lateral margin, slice 1, perpendicular. Cassettes F2-F3: Slice 2, two pieces. Cassettes F4-F5: Slice 3, two pieces, mass. Cassettes F6-F7: Slice 4, two pieces, mass. Cassette F8: Representative section of slice 5, mass. Cassette F9: Representative section of slice 6, mass. Cassette F10: Slice 12. Cassette F11: Medial margin, slice 13. perpendicular. Part G is additionally labeled. It consists of a. small fragment of fat, measuring 0.6 x 0.7 x 0.7 cm. A stitch marks a portion of the specimen. indicating the true margin. The specimen is inked so as this true margin is blue, and the rest of the. specimen is black. The specimen is entirely submitted in cassette G1. Part H is additionally labeled. It. consists of a fragment of yellow-white, soft fat, measuring 1 x 0.6 x 0.7 cm. A stitch marks the true. margin of the specimen. The specimen is inked so as this true margin is blue, and the remaining. portion of the specimen is black. The specimen is entirely submitted in cassette H1. Part I is additionally labeled. It consists of a portion of fat measuring 4.2 x 3.8. x 0.9 cm. Multiple pink-tan lymph nodes are noted within the specimen ranging in size from 0.6-1.3. cm in diameter. Many of these nodes are previously bisected or trisected. Representative sections. of. the specimen are taken and submitted as follows: Cassette 11: Six lymph nodes attached. Cassette 12: Two lymph nodes, one bisected and one trisected. 'Pathology Resident. Fee Codes: Working Draft. Other Specimens. Specimen Class: i. Accessioned: Specimen(s) Received: Skin, biopsy, punch bx, right posterior calf. Final Diagnosis. {Final Report Not Signed Out}. (Not Entered}. Specimen Class: Accessioned: Specimen(s) Received: SP Consult. Final Diagnosis. Review. from. Breast, left, 1 o'clock, core needle biopsy: 1. Invasive carcinoma; see comment. 2. Microscopic focus of ductal carcinoma in situ, high nuclear grade; see comment.",BRCA,1,"Based on the pathology report, there are 4 positive lymph nodes out of a total of 13 sampled lymph nodes. This indicates that the patient's N stage is N1. The report specifies that extranodal extension is present, but this does not affect the N stage assignment for breast cancer.",N1,31.0
577,TCGA-A7-A13E.2180850C-CC8D-4376-B2EE-1ADC3F5B3EC1,1,"PECIMEN. A. Left sentinel node. B. Left breast tissue. C. Axillary contents. CLINICAL NOTES. PRE-OP DIAGNOSIS: Left breast cancer. CLINICAL HISTORY: Left breast cancer. FROZEN SECTION DIAGNOSIS. FSA) Left sentinel node - Two of three lymph nodes positive for. metastatic carcinoma (2/3). GROSS DESCRIPTION. A. Submitted fresh for frozen section as ""left sentinel. node"" are two portions of fatty tissue, the larger of the. two is 2 cm. in size, the smaller 1.2 cm. in size. The section. through the tissue reveals three small nodules which may be lymph. nodes varying in size from 6 mm. to a centimeter. All three. submitted for frozen section. B. Received fresh, subsequently fixed in formalin labeled. ""left breast tissue"" is a 7.8 x 7.5 X 4.0 cm. yellow. lobular fatty tissue fragment which is partially covered with a 4.0. X 1.2 cm. pink-tan wrinkled skin ellipse. The specimen has a long. suture designating lateral and a short suture designating superior. The specimen is inked as follows: Superior orange, anterior blue,. posterior black, inferior green and the specimen is sectioned from. medial to lateral to show a yellow lobular fatty cut surface with. minimal fibrous tissue. There is also a white tan firm nodule. which. is centrally located, measuring 3.5 x 2.5 x 2.5 cm. This comes. within 2 cm. of superior-inferior margin and comes within 1.5 cm. of. the anterior and posterior margin. This was located equal distance. between the medial and lateral margins. Representative sections of. the specimen are submitted as follows: Block 1 - representative. GROSS DESCRIPTION. medial margin; block 2 - representative lateral margin; block 3-10. representative sections additional margins and skin. RS-10. C. Received fresh, subsequently fixed in formalin labeled. ""axillary content"" is a 7 X 6 X 1.5 cm. aggregate of. yellow. lobular fatty tissue fragments which are palpated to identify. possible lymph nodes. Multiple lymph nodes are grossly identified. which range from 0. cm. to 2.0 cm. in greatest dimension. The. lymph nodes are entirely submitted as follows: block 1 - two. possible lymph nodes; block 2 - three possible lymph nodes; block 3. - two possible lymph nodes; block 4 - one possible lymph node. bisected. RS4. MICROSCOPIC DESCRIPTION. A. Sections of the left sentinel lymph nodes demonstrate. metastatic carcinoma involving 2 of 3 lymph nodes. The. largest metastasis is 1.2 cm and extracapsular extension is. present. B. The following template applies to the left breast. Invasive Carcinoma: Present. Histologic type: Infiltrating ductal carcinoma. Histologic grade: Overall grade: 3. Architectural score : 3. Nuclear score: 3. Mitotic score: 3. Greatest dimension: 3.5 cm (pT2). Specimen margins : Negative, nearest 1.3 cm, posteriorly. Vessel invasion: Present. MICROSCOPIC DESCRIPTION. Calcification : Present. Ductal carcinoma in situ: Present. Histologic pattern: Solid and comedo. Nuclear grade: 3. Central necrosis: Present. %DCIS of total tumor: Less than 10%. Extensive intraductal component (present/absent) : Absent. Specimen margins: Negative. Calcification: Present. Description of non-tumorous breast: Proliferative changes. Comments: None. Prognostic markers: Previously performed. C. There is no evidence of metastatic disease present in. 9. additional left axillary lymph nodes. 14, 4x3. DIAGNOSIS. A. Left axillary sentinel lymph nodes, excision: Metastatic carcinoma present in 2 of 3 lymph nodes (2/3) . Size of largest metastasis 1.2 cm. Extracapsular extension present. B. Left breast, excisional biopsy: Infiltrating ductal carcinoma, grade 3, 3.5 cm, margins. negative. Ductal carcinoma in situ, grade 2, margins negative. C. Left axillary contents, resection: No evidence of metastasis in nine lymph nodes (0/9). DIAGNOSIS. M. .D, (Electronic Signature). End Of Report ---.",BRCA,1,"Based on the report, there is metastatic carcinoma present in 2 out of 3 left axillary sentinel lymph nodes (2/3), with the largest metastasis being 1.2 cm and extracapsular extension present. This information aligns with New Rule 15 and New Rule 17, indicating N1 stage.",N1,31.0
647,TCGA-A8-A08G.6DCA5C2C-F28A-409D-9623-24AB748FB4E7,1,"Diagnosis: 1 Ablated breast sample with three foci of carcinoma: first tumor: poorly differentiated invasive ductal carcinoma (tumor diameter: 2.8 cm). with focal intraductal components. Tumor-free dorsal resection margin. Tumor classification: NOS and mucinous carcinoma, G III, pT2(mult)NOLOVORX.",BRCA,0,"The report does not mention any involvement of regional lymph nodes, so based on Modified Rule 8, the N stage is N0.",N0,31.0
599,TCGA-A7-A4SE.C0C49D41-AA66-435B-9312-FAD8E2DC3305,1,"Final Surgical Pathology Report. Procedure: Diagnosis. A. Breast, left, segmental mastectomy: Invasive ductal carcinoma,. grade 3, size 2.8 cm in greatest dimension; negative margins of. excision. B. Sentinel lymph node #1, biopsy: Two negative lymph nodes (0/2) . C. Sentinel lymph node #2, biopsy: One negative lymph node (0/1) . D. Breast, medial to left segmental mastectomy, biopsy: Negative for. malignancy or atypia. E. Breast, inferior to left segmental mastectomy, biopsy: Negative. for malignancy or atypia. F. Breast, posterior to left segmental mastectomy, biopsy: Skeletal. muscle; negative for malignancy or atypia. G. Breast, lateral to left segmental mastectomy, biopsy: Negative. for malignancy or atypia. H. Breast, superior to left segmental mastectomy, biopsy: Negative. for malignancy or atypia. Microscopic Description: Invasive Carcinoma. Histologic type: Ductal. Histologic grade: 3. Overall grade: 9/9. Architectural score: 3. Nuclear score: 3. Mitotic score: 3. Greatest dimension (pT) : 2.8 cm. Specimen margins: Negative. Vessel invasion: Not identified. Calcification: Present. Ductal carcinoma in situ: Histologic pattern: Solid. Nuclear grade: 3. Central Necrosis: Present. 8 DCIS of total tumor (if mixed) : 1%. Extensive intraductal component (present/absent) : Absent. Specimen margins: Negative. Calcification: Negative. Description of non-tumorous breast: Fibrocystic changes, with ductal. hyperplasia of usual type, a minute fibroadenoma, and apocrine. metaplasia, with calcification. Comments: Sentinel lymph nodes negative, confirmed by negative. cytokeratin immunostaining of blocks BFS1 and CFS2. Cytokeratin. staining was also performed on one block from part E, to exclude. involvement by carcinoma. Prior biopsy site identified. Extensive. central tumor necrosis is present. Prognostic markers: See core biopsy report,. 4x8, 14x2, 15x2, 20x3. [A few of the antibodies used in our laboratory may be classified as. analyte specific reagents. These antibodies are monitored and. controlled in our laboratory and their performance for in vitro. diagnosis is well described in the medical literature. They have not. been cleared or approved by the FDA.: Specimen. A. Left Breast. B. Left axillary sentinel lymph node #1, hot, blue,. C. Left axillary sentinel lymph node #2, not hot, not blue, but. palpable. D. Medial to segmental mastectomy left breast. E. Inferior to segmental mastectomy left breast. F. Posterior to segmental mastectomy left breast. G. Lateral to segmental mastectomy left breast. H. Superior to segmental mastectomy left breast. Clinical Information. Left breast cancer. Intraoperative Consultation. B) Left axillary sentinel node #1: Two negative lymph nodes (0/2). C) Left axillary sentinel node #2, biopsy: One negative lymph node. (0/1). Gross Description. A. Received unfixed for tissue procurement, labeled left breast. segmental mastectomy single long lateral, double long anterior, is. a 100 gram breast segmental excision that is 9 cm from anterior to. posterior, 7.5 cm medial to lateral, and 3 cm from superior to. inferior. The superior surface is inked black, and a section is. submitted for tissue procurement as requested. An additional. section of uninvolved fatty tissue is submitted from the posterior. aspect, for procurement. Additional sections after fixation. The. superior surface is inked black, medial green, lateral yellow,. inferior blue. There is a tan, firm, lobulated mass lesion in the. mid-portion of the specimen, 3.0 x 2.0 x 1.7 cm. This is 3 mm from. the green-inked medial margin (closest margin). All other margins. are grossly greater than 1 cm from the mass. Representative. sections: 1 Anterior margin, 2 adjacent section with margin, 3/4/5. contiguous tumor, possible biopsy cavity in 5, 6/7/8 contiguous,. 9-10 random medial and lateral, possible close margin, 11-14. additional posterior sections, with last section = posterior. margin. B. Received unfixed for frozen section, labeled left axillary. sentinel node #1, are 2 adjacent and attached lymph nodes, 0.9 cm. in greatest dimension each, bisected and entirely submitted in. blocks B1 and B2. C. Received unfixed for frozen section, labeled left axillary. sentinel node #2, is a single lymph node, 1.4 x 1.3 x 1.0 cm,. bisected and entirely submitted in 2 blocks. D. Received fresh and subsequently fixed in formalin labeled ""medial. to segmental mastectomy left breast ""is a 5.2 x 3.5 x 1.5 cm yellow. lobular fatty tissue fragment which has a suture designating the. new medial border. The surface is inked and the specimen is. sectioned to show yellow lobular fatty cut surface with minimal. fibrous tissue present. No discrete residual tumor is grossly. identified. The specimen is entirely submitted labeled 1 through. 10. E. Received fresh and subsequently fixed in formalin labeled. ""inferior to segmental mastectomy left breast ""is a 4.3 x 2.7 x. 2.2. cm yellow lobular fatty tissue fragment which has a suture. designating new inferior border. The surface is inked and the. specimen is sectioned to show yellow lobular fatty cut surface with. minimal fibrous tissue present. No residual tumor is grossly. identified. The specimen is entirely submitted labeled 1 through 9. F. Received fresh and subsequently fixed in formalin labeled. ""posterior to segmental mastectomy left breast ""is a 3.2 x 2.5. x. 1.0 cm yellow lobular fatty tissue fragment which is partially. covered with skeletal muscle. There is a suture designating the new. posterior margin. The surface is inked and the specimen is. sectioned to show a yellow lobular fatty cut surface with scanty. fibrous tissue present. The specimen is entirely submitted in 5. cassettes. G. Received fresh and subsequently fixed in formalin labeled ""lateral. to segmental mastectomy left breast ""is a 4.3 x 3.5 x 1.5 cm yellow. lobular fatty tissue fragment. There is a suture designating the. new lateral border. The surface is inked and the specimen is. sectioned to show yellow lobular fatty cut surface with minimal. fibrous tissue present. No residual tumor is grossly identified. The specimen is entirely submitted in 9 cassettes. H. Received fresh and subsequently fixed in formalin labeled. ""superior segmental mastectomy left breast ""is a 4.3 x 2.2 x 1.0. cm. yellow lobular fatty tissue fragment which has a suture designating. the new superior border. This is inked and the specimen is. sectioned to show yellow lobular fatty cut surface with scanty. fibrous tissue present. The specimen is entirely submitted in 4. cassettes.",BRCA,0,"The report states that sentinel lymph nodes #1 and #2 were negative (0/2 and 0/1, respectively), and there is no mention of any other involved regional lymph nodes. According to the rules provided, N0 indicates no evidence of cancer in the regional lymph nodes (Rule 2).",N0,31.0
467,TCGA-A2-A04P.0E4B0EA9-14D1-4A82-814D-51CC2B9BA2B5,1,"Specimen #: Race: Physician (s) : SPECIMEN: A: LEFT BREAST LUMPECTOMY B: AXILLARY CONTENTS. C: LEFT SUPRACLAVICULAR LYMPH NODE. FINAL DIAGNOSIS: A. LEFT BREAST, LUMPECTOMY: RESIDUAL INFILTRATING DUCTAL CARCINOMA, POORLY DIFFERENTIATED. RESIDUAL TUMOR SIZE: 2.5 X 2.0 X 1.5 CM. DEEP SURIGIAL MARGIN INVOLVED BY MAIN TUMOR. MEDIAL, SUPERIOR, AND INFERIOR MARGINS FOCALLY INVOLVED BY. DISCONTINUOUS TUMOR FOCI (LOCAL MICROMETASTASES). EXTENSIVE LYMPHATIC INVOLVEMENT. B. LEFT AXILLARY CONTENTS, DISSECTION: METASTATIC CARCINOMA INVOLVING 18 OF 20 EXAMINED LYMPH NODES. EXTENSIVE EXTRANODAL EXTENSION AND NON-NODAL METASTASES. C. LEFT SUPRACLAVICULAR LYMPH NODE, EXCISON: METASTATIC CARCINOMA INVOLVING 1 EXAMINED LYMPH NODE. COMMENT: The findings were discussed with. by phone. The deep surgical margin is involved by residual gross tumor (Block A24) . The medial, superior, and inferior margins are involved K< 0.6mm) by. microscopic foci, separate from the tumor. (Blocks A5, A10, A11, A23, A39) . Of the 18 involved axillary lymph nodes, 1 has a micrometastasis (B3) . An. additional lymph node (B22) has isolated tumor cells. These were. identified by routine light microscopy and hematoxylin-eosin stain. ==. Specimen #: CLINICAL DIAGNOSIS AND HISTORY: A. year old. female with left breast cancer with a positive margin. Palpable lymph node. PRE-OPERATIVE DIAGNOSIS: Left breast cancer. POST-OPERATIVE DIAGNOSIS: Left breast cancer. GROSS DESCRIPTION: A. LEFT BREAST LUMPECTOMY Received fresh, labeled with the patient's. name, and designated ""LEFT BREAST TISSUE, SKIN INTERIOR, ONE STITCH. MEDIAL, TWO STITCHES SUPERIOR"" is a specimen which consists of a piece of. fibrofatty tissue, 6.5 x 6.5 x 5.3cm with an overlying ellipse of skin,. 5.0 x 2.0cm. There is a 3. 5cm scar on the skin surface. Posteriorly a. small patch of skeletal muscle is noted. The specimen is oriented with. sutures (one - medial; two - superior) . Inked as follows: blue -. superior; green - inferior; yellow - medial, red - lateral, and black -. posterior. Sectioning reveals a 3. 0cm biopsy cavity with hemorrhagic. walls and surrounding fat necrosis in the medial half of the specimen. Medially. adjacent to the cavity and involving the deep margin is a firm,. tan tumor measuring 2.5 x 2.0 x 1.5cm. The remaining tissue is fat and. fibrous tissue. Sections of skin, tumor, and grossly normal fibrous. tissue are harvested for the CBCP protocol with matching paraffin sections. as follows: A1, skin, lateral tip; A2, tumor, medial portion; A3, tumor,. lateral aspect; A4, grossly normal fibrous, mid medial - superior, 2.5cm. from the tum; A5-A6, medial margin; A7-A8, adjacent representative. section; A9-A12, biopsy cavity; A13-A17, representative biopsy cavity; A18. A19, biopsy cavity; A20-A22, biopsy cavity; A23-A25, biopsy cavity;. A26-A28, biopsy cavity; A29-A30, biopsy cavity; A31-A33, adjacent left mid. section; A34, representative section; A35, representative section;. A36-A39, lateral margin. 39CF. B. AXILLARY CONTENTS Received fresh, labeled with the patient's name,. anddesignated ""AXILLARY CONTENTS, LEFT TAG AT HIGHEST AXILLARY NODE"" is. a. specimen which consists of a piece of soft yellow tissue, 14.5 x 6.5 x. 3 5cm, containing numerous and large lymph nodes. There are several. cyst-like structures found on serial sectioning ranging in size from 2.5. x 2.0 x 1.0cm to 1.5 x 1.5 x 1. Ocm. The cyst are filled with a red. viscous fluid. Further sectioning reveals a 3.5 x 3.0 x 2.0cm hemorrhagic. cyst-like structure that has a tan-red surface and is poorly defined. Its. mass trails to the lateral edge biopsy tail. Multiple possible lymph nodes. are identified ranging in size from 2.0 x 2.0 x 1.5cm to 0.4 x 0.3 x. 0.2cm. Two grossly positive lymh nodes and one grossly benign lymph node. Specimen # : GROSS DESCRIPTION (continued) : are harvested for the CBCP protocol with matching paraffin sections as. follow: Cassette B1, lymph node with tumor, 2.0 x 2.0 x 1.2cm, lower. axillary tale; B2, lymph node with tumor, 1.6cm, lower axillary tail; B3,. grossly benign lymph node, 0. 7cm, upper axillary tail; B4, grossly. positive single lymph node; B5, single lymph node in multiple pieces;. B6-B7, multiple possible lymph nodes; B8, bisected possible lymph node;. B9, single positive possible lymph node; B10, single possible bisected. lymph node; B11, fragments of possible lymph node; B12, fragments of. possible lymph node; B13-B14, bisected possible lymph node; B15, possible. lymph node; B16, single possible lymph node; B17-B18, skeletal muscle with. cyst wall; B19-B22, representative sections of axillary mass; B23-B25,. area of possible lymph nodes. 25CF. C. LEFT SUPRACLAVICULAR LYMPH NODE Received in formalin, labeled with the. patient's name, and designated ""LEFT SUPRACLAVICULAR LYMPH NODE"" is a. specimen which consists of a 1.3 x 0.7cm lymph node containing a 0. .8cm. tumor. A portion of the lymph node is submitted for the CBCP protocol. 1CF.",BRCA,3,"Based on the pathology report, there is metastatic carcinoma involving 18 out of 20 examined lymph nodes in the left axillary contents. This indicates a significant involvement of regional lymph nodes, which corresponds to N3 stage according to the rules provided.",N3,32.0
640,TCGA-A8-A084.6A49B3F9-6B43-4D74-A28B-C83BFE61EC7B,1,"Diagnosis: Poorly differentiated invasive ductal carcinoma (tumor diameter: 3.5 cm) with focally. marked intraductal patterns of spread. Concluding tumor classification: NOS, G III, pT2N1aLOV0RX. IGA-A8-A0S4-01A-PR.",BRCA,1,"Based on the pathology report, the N stage is N1a, which indicates metastasis in 1 axillary lymph node (N1a). The 'N1' part of the stage is derived from the 'pT2N1a' notation in the report.",N1,32.0
592,TCGA-A7-A3RF.4AF67A51-97C1-4D58-9E60-03FDFFACD38A,1,"Final Surgical Pathology Report. Procedure: Diagnosis. A. Left axillary sentinel nodes, excision: 2 lymph nodes negative for. metastatic disease, 0/2. B. Left breast mass, excision: Invasive mucinous carcinoma, Elston SBR. grade 2. Tumor is less than 1 mm from the deep margin and at least. extremely close to the lateral margin. C. Pectoralis fascia, excision: Adipose tissue and skeletal muscle. present. Mucinous carcinoma present in the adipose tissue at the inked. medial margin of resection. Microscopic Description: A. 2 sentinel nodes are present examined in their entirety at multiple. levels. They are both negative for metastatic disease, 0/2. B. This excision discloses invasive mucinous adenocarcinoma. Of note,. it has a higher nuclear grade the usual mucinous carcinoma. Also,. particularly in block #5, there was a suspicion for lymphatic invasion. This is considered not to be the case, however, based on stains for. D240 and CD34. The negative staining for p63 also helps to exclude in. situ tumor. Please see the template below: Invasive Carcinoma: Histologic type: Invasive mucinous carcinoma. Histologic grade: Elston SBR grade 2. Overall grade: Architectural score: 2. Nuclear score: 3. Mitotic score: 1. Greatest dimension (pT): 3.7 cm, pT 2. Specimen margins: Tumor is present less than 1 mm from the. deep margin and at least extremely close to the lateral margin. Vessel invasion: Negative. Calcification: Rare. Description of non-tumorous breast: No significant pathology. Comments: Attached skin negative for tumor. Prognostic markers: Previously performed. C. Microscopic examination performed. Specimen. A. Left axillary sentinel node. B. Left breast mass, long anterior, short superior. C. Pectoralis/posterior, long anterior short superior. Clinical Information. PRE-OP DIAGNOSIS: Left breast cancer. HISTORY: -year-old white female with left mucinous breast cancer. Gross Description. A. Received fresh labeled ""left axillary sentinel node"" are 2 soft tan. gold-pink tissues averaging 1.8 cm in greatest dimension. The. specimens are bisected and entirely submitted independently in. 2. blocks. B. Received fresh for tissue procurement within a. container. labeled ""left breast mass"" is a 7.5 cm (medial to lateral) by 5.0 cm. (superior to inferior) by 4.2 cm (anterior to posterior) soft,. lobulated tan gold-white portion of fibroadipose tissue with 2 sutures. as stated previously. A 2.7 x 1.3 cm wrinkled tan-white portion of. skin is present along the anterior aspect. The margins are inked as. follows: Anterior blue, posterior black, superior green, and inferior. orange. The specimen is sectioned from medial to lateral. There. is. a. well-circumscribed, 3.7 cm (medial to lateral) by 3.2 cm (superior to. inferior) by 2.7 cm (anterior to posterior) rubbery tan white mucinous. tumor mass within the lateral half of the specimen. A portion of tumor. and a portion of normal parenchyma are submitted for tissue procurement. as requested. The tumor focally extends to within less than 0.1 cm of. the inked posterior margin. Several cylindrical tan-white structures. in keeping with those associated with needle core biopsy are present. The remaining cut surfaces consist predominantly of soft, lobulated tan. gold adipose tissue with a scant amount of interspersed delicate. Fan-white fibrous tissue. Summary: 1 - perpendicular sections medial margin, 2 through 9 -. sequential sections, 10 - perpendicular sections lateral margin. Specimen is fixed at. C. Received fresh labeled ""pectoralis fascia posterior"" is a 3.0 cm. (superior to inferior) by 2.5 cm (medial to lateral) by 0.7 cm anterior. to posterior) soft, lobulated tan gold-white portion of fibroadipose. tissue with 2 sutures as stated previously. The margins are inked as. follows: Anterior blue, posterior black, medial green, and lateral. orange. The specimen is sectioned from superior to inferior. The cut. surfaces consist predominantly of soft, lobulated tan gold adipose. tissue with a scant amount of interspersed delicate tan-white fibrous. tissue. No residual mass lesion or abnormality is identified grossly. Summary: 1 - perpendicular sections superior margin, 2 through 4. sequential sections, 5 - perpendicular sections inferior margin. Specimen is fixed at.",BRCA,0,"The report states that two sentinel lymph nodes were examined and found to be negative for metastatic disease (0/2). Therefore, the N stage is N0, as there is no evidence of cancer in the regional lymph nodes.",N0,32.0
644,TCGA-A8-A08B.2261B407-340D-4BB3-94BC-F06096FBDA80,1,"Diagnosis: 1. Bifocal poorly differentiated invasive ductal carcinoma (tumor diameters: 2.5. cm and 0.7 cm) with focal intraductal components. Concluding tumor classification: NOS, G III, pT2(mult)NO(sn)LOVORO.",BRCA,0,"The report mentions 'NO(sn)', which indicates no evidence of cancer in the regional lymph nodes based on sentinel lymph node sampling (sn). Therefore, the N stage is N0.",N0,32.0
527,TCGA-A2-A0YG.B3D6A0F7-5E3C-4921-8399-6458E5222CC5,1,"Chief of Pathology. Specimen: spec Type: SURGICAL P. OPERATION PERFORMED. DOCTOR (8) : TISSUE RENOVED. A. LT AXILLARY NODE DISSECTION. B. LT PARTIAL MASTECTOMY. GROSS DESCRIPTION. PART A RECEIVED FRESH LABELED. LEFT AXILLARY NODE. DISSECTION, IS YELLOW-RED FATTY TISSUE MEASURING 15 x 12.5 x 4.0 CM. THIS IS EXAMINED FOR LYMPH NODES. THE NODAL TISSUE IS IDENTIFIED. PRIMARILY AT ONE END OF THE SPECIMEN, NITH 75% CONSISTING OF BLAND YELLOW. FATTY TISSUE. MULTIPLE LYMPH NODES ARE IDENTIFIED AND GROSSLY POSITIVE. SECTIONS ARE SUBMITTED AS FOLLOWS: A1 THROUGH A8 ---ONE SECTION EACH OF. GROSSLY POSITIVE LYMPH NODES WITH A RIBBON CLIP IDENTIFIED IN THE NODE. CORRESPONDING TO A2. NOTE THAT MIRROR IMAGE RESEARCH BLOCKS ARE TAKEN ON. EACH. A9 AND 10--ONE NODE EACH BISECTED, All--TWO NODES EACH BISECTED,. A12-- TWO NODES, A13--ONE NODE BISECTED, A14--ONE NODE BISECTED, A15--ONE. NODE BISECTED, A16 THROUGH A19--ONI GROSSLY FAT-REPLACED NODE TOTAL. PART B RECEIVED FRESH LABELED. LEFT PARTIAL MASTECTOMY. LONG STITCH LATERAL SHORT STITCH SUPERIOR, IS AN OVOID PORTION OF. YELLOW-PINK FATTY TISSUE MEASURING 11.5 x 7 x 4.7 CM IN GREATEST. DIMENSIONS. THE SPECIMEN IS ORIENTED BY TWO SUTURES. A LARGE PALPABLE. MASS IS PRESENT MEDIALLY. SECTIONING REVEALS THIS PALPABLE MASS TO HAVE. A FIRM PINK-TAN GRITTY CUT SURFACE MEASURING 4.0 x 2.8 x 3 CM IN GREATEST. DIMENSIONS. THIS LESION EXTENDS TO THE INFERIOR MARGIN AND IS 0.4 CM. FROM THE MARGIN GROSSLY. IT IS 0.6 CM FROM THE DEEP MARGIN, 0.8 CM FROM. THE SUPERFICIAL MARGIN AND GREATER THAN 1 CM FROM ALL OTHER MARGINS. SECTIONING THE LATERAL ASPECT OF THE SPECIMEN CONSISTS OF BLAND YELLOW. FATTY TISSUE. SECTIONS ARE SUBMITTED AS FOLLOWS: B1 --PBRPENDICULAR. MEDIAL MARGIN, B2--TUMOR (MIRROR IMAGE TO PROTOCOL) B3--LESION AND DEEP. MARGIN, 84--LESION AND DEEP INFERIOR MARGIN CLOSEST TO TUMOR,. B5 --INFERIOR SUPERFICIAL MARGIN WITH LESION, B6--LESION AND SUPERFICIAL. MARGIN (MIRROR IMAGE TO PROTOCOL), B7 - -SUPERFICIAL SUPERIOR MARGIN,. B8--SUPERIOR - DEEP MARGIN. NOTE THAT B2 THROUGH B8 CONSTITUTE ONE FULL. CROSS-SECTION OF THE LESION IN ITS GREATEST DIMENSION. B9 - -PERPENDICULAR. LATERAL MARGIN, B10--TISSUE FROM LATERAL ASPECT OF THE SPECIMEN,. B11 - -TUMOR AND SUPERFICIAL MARGIN (MIRROR IMAGE TO PROTOCOL) B12--TUMOR. (MIRROR IMAGE TO PROTOCOL). Chief of Pathology. Specimen: Spec Type: SURGICAL P. PATH PROCEDURES. PROCEDURES: 88307/2, A BLK/19, B BLK/12. FINAL DIAGNOSIS. PART A LEFT AXILLA, LYMPH NODE DISSECTION: METASTATIC BREAST CARCINOMA. IS IDENTIFIED IN 14 OF 18 NODES EXAMINED AND EXTRANODAL EXTENSION IS. MULTIFOCALLY PRESENT. PART B LEFT BREAST, PARTIAL MASTECTOMY: 1. POORLY DIFFERENTIATED INTRADUCTAL AND INFILTRATING DUCT CARCINOMA,. NUCLEAR GRADE III, HIGH MITOTIC INDEX AND TUBULE FORMATION 2, FOR A. TOTAL NOTTINGHAM SCORE OF 8. DCIS OF THE SOLID TYPE COMPRISES. APPROXIMATELY 5% OF THE TUMOR. 2. THE GROSS TUMOR HAS A MAXIMUM DIMENSION OF 4 CM. 3. THE INVASIVE TUMOR IS IDENTIFIED 6 MM OR MORE FROM THE INKED MARGINS. OF EXCISION. 4. LYMPHOVASCULAR INVASION IS PRESENT. 5. BIOPSY CHANGES. ARE PRESENT. COBS. 1. , (prelim.). (signature on file). I.D.",BRCA,3,"The report mentions metastatic breast carcinoma identified in 14 out of 18 nodes examined, which indicates involvement of multiple axillary lymph nodes. According to the new rules provided, N2 stage for breast cancer can indicate metastasis in 4 to 9 axillary lymph nodes without specifying extranodal extension or the presence of micrometastasis in sentinel lymph nodes. Therefore, the N stage for this report is N2.",N2,33.0
641,TCGA-A8-A085.64F84FF4-A477-4E1E-B4BB-E5614517229E,1,"Diagnosis: Poorly differentiated invasive carcinoma with discrete in situ spread. (tumor diameter 2.5 cm). Infiltration of the corial connective tissue of superficial. adjacent skin spindle. No ulceration of the skin. Focal tumor spread within the lymph. vessels. In conclusion, this is a poorly differentiated invasive ductal carcinoma. Tumor classification: NOS, G III, pT2N1aL1V0R0.",BRCA,1,"Based on the provided pathology report, the patient's N stage is N1a (T2N1aL1V0R0). This is determined by the mention of 'pT2N1a' in the tumor classification, which indicates that the tumor has infiltrated the corial connective tissue of superficial, adjacent skin and has metastasized to 1 axillary lymph node (N1a).",N1,33.0
559,TCGA-A2-A3Y0.0FEAEEBA-A72C-4207-AC21-6AF5B5ED1AFC,1,"IP <DIS IN C. Specimen: spec Type: SURGICAL P. PREOPERATIVE DIAGNOSES. LEFT BREAST CANCER INVASIVE. OPERATION PERFORMED. DOCTOR (s) : PROCEDURE: MASTECTOMY MODIFIED RADICAL. TISSUE REMOVED. A. LT BREAST AND AXILLARY TISSUE. B. ADDITIONAL LYMPH NODES LT AXILLA. GROSS DESCRIPTION. PART A RECEIVED FRESH LABELED. LEFT BREAST AND AXILLARY. CONTENTS SUTURE AT 12 O'CLOCK, AND CONSISTS OF A MODIFIED RADICAL. MASTECTOMY SPECIMEN WITH OVERALL DIMENSIONS OF 31 x 20.5 x 5.8 CM. THE. NIPPLE IS UNREMARKABLE AND SITS WITHIN A SKIN ELLIPSE MEASURING 21 x 12.3. CM. THERE IS A 3.5 CM IN LENGTH WELL-HEALED PERIAREOLAR SCAR EXTENDING. FROM 12 TO 2 O' CLOCK. THERE IS A PALPABLE MASS IN THE UPPER OUTER. QUADRANT. THE SUPERFICIAL ASPECT IS MARKED WITH BLUE INK, THE DEEP. ASPECT WITH BLACK INK. THE AXILLARY TAIL IS REMOVED AND EXAMINED FOR. LYMPH NODES, OF WHICH MULTIPLE ARE IDENTIFIED. SECTIONS ARE SUBMITTED AS. FOLLOWS: A1 --NIPPLE - SKIN AND SCAR; A2 -FIVE NODES; A3 - -FIVE NODES;. A4--THREE - NODES, EACH BISECTED; A5--THREE NODES, EACH BISECTED;. A6--SECTION OF ONE NODE; A7--SECTION OF ONE NODE; A8--SECTION OF ONE. NODE; A9--SECTION OF ONE NODE; A10--SECTION OF ONE NODE. NOTE THAT A6. THROUGH A10 ARE MIRROR IMAGES OF PROTOCOL SECTIONS. All--TWO NODES, EACH. BISECTED; A12--ONE NODE BISECTED; A13--ONE - NODE BISECTED; A14--ONE NODE. BISECTED. SECTIONING THE BREAST REVEALS THE UPPER OUTER QUADRANT TO-BE A. ROUNDED PINK-TAN SOFT MASS WHICH IS CENTRALLY CYSTIC. IT MEASURES 4 x. 3.7 x 2.8 CM. GROSSLY, THIS ABUTS THE DEEP MARGIN. IMMEDIATELY. SUPERFICIAL TO THIS MASS IS A SECOND NODULE WITH A COIL CLIP MEASURING. 1.5 x 1.2 x 1.0 CM. MEDIAL AND CENTRAL TO THE BREAST, THE SPECIMEN HAS A. TAN FIBROUS BAND WHICH EXTENDS 9 CM FROM SUPERIOR TO INFERIOR AND THERE. IS TAN FIBROUS TISSUE CENTRAL WITHIN THE BREAST. THIS IS SURROUNDED BY A. PERIMETER OF BLAND YELLOW FATTY TISSUE. SECTIONS ARE SUBMITTED AS. FOLLOWS: A15 AND 16-MASS IN DEEP MARGIN; A17--SECTION OF THE MASS AND. THE ADJACENT MORE SUPERFICIAL NODULE; A18, 19 AND 20 --SECTIONS OF MASS. CORRESPONDING TO SECTIONS FROM THE SUBMITTED PER PROTOCOL, WITH A20. REPRESENTING THE ADJACENT FIBROUS TISSUE; A21--AN ADDITIONAL SECTION OF. THE SUPERFICIAL LESION (MIRROR IMAGE TO PROTOCOL) ; A22--UPPER OUTER. QUADRANT; A23--PUPPER INNER QUADRANT; A24 --LOWER - INNER QUADRANT;. A25 - -LOWER - OUTER QUADRANT (A22 THROUGH A25 ARE MIRROR IMAGE SECTIONS TO. PROTOCOL) ; A26--TISSUE FROM SUPERIOR PORTION OF BREAST. THE AXILLARY TAIL IS REEXAMINED FOR LYMPH NODES AFTER FIXATION TIME IN. ACETIC FORMALIN. ADDITIONAL NODES ARE THEN SUBMITTED AS FOLLOWS: Specimen: Spec Type: SURGICAL P. GROSS DASCRIPTION. A27--FIVE - NODES; A28--TWO - NODES, EACH BISECTED. PART B RECEIVED FRESH LABELED. ADDITIONAL LYMPH NODES. LEFT AXILLA (LEVEL 2), IS YELLOW-PINK FATTY TISSUE MEASURING 2.4 x 1.6 x. 0.8 CM. THIS IS BISECTED REVEALING NO DISTINCT NODAL TISSUE AND. SURMTTTRN RNTIRELY LABELED B1 AND 2. PATH PROCEDURES. PROCEDURES: 88309, A BLK/26, B BLK/2. FINAL DIAGNOSIS. PART A LEFT MODIFIED RADICAL MASTECTOMY: 1. POORLY DIFFERENTIATED INFILTRATING DUCT CARCINOMA, NUCLEAR GRADE. III/III WITH A HIGH MITOTIC INDEX, 4.0 CM IN MAXIMUM GROSS DIMENSION. 2. THE IDENTIFIED IN 1 INTRAMAMMARY LYMPH NODE (MARKED 1/1 Intramann. TUMOR IS LOCATED 1 MM FROM THE DEEP MARGIN OF THE SPECIMEN. METASTATIC CARCINOMA. WITH A COIL CLIP CONFIRMING A PREVIOUS BIOPSY SITE) . 3. NO EVIDENCE OF METASTATIC DISEASE IN 37. AXILLARY LYMPH NODES. %/37 ALN. 4. PERIDUCTAL CHRONIC MASTITIS IN SECTIONS OF BREAST TISSUE AWAY FROM. THE PRIMARY TUMOR SITE. PART B LEFT AXILLARY BIOPSY: ADIPOSE TISSUE CONTAINING SECTIONS OF 1 % Level 2. SMALL LYMPH NODE WITH NO EVIDENCE OF METASTATIC DISEASE. CX IMMENT. THE. LIDITION OF THE AJCC STAGING MANUAL DOES SPECIFICALLY NOT ADDRESS. FOR POSITIVE INTRAMAMMARY NODES IN THE ABSENCE OF AXILLARY. METASTATIC DISEASE, HOWEVER THE PATIENT WILL BE STAGED AS HAVING N1. DISEASE. CODE. 1. (prelim.). (signature on file). S IN. Specimen: Spec Type: CA SUMMARY. CANCER SUMMARY. Breast Pathology Summary: Macroscopic: Breast procedure: mastectomy, modified radical. Lymph node procedure: Sentinel (yes/no) : no. Axillary (yes/no) : yes. Specimen size (greatest dimension) (xy,n/a) cm: 31. Neoadjuvant therapy (yes/no) : no. Laterality: left. Tumor site: upper outer quadrant. Multifocal (yes/no) : no. Multicentric (yes/no) : no. Microscopic: Size of invasive component (xy,n/a) mm: 40. Size of DCIS (xy,n/a) mm: n/a. Histologic type: Atypical: n/a. In situ: n/a. Invasive: infiltrating duct. Histologic grade : Tubule formation (0-3,n/a) : 3. Nuclear pleomorphism (0-3,n/a) : 3. Mitotic count (0-3,n/a) : 3. Nottingham Score: 9. Nottingham Grades based on total score: Grade I 3-5 points. Grade II 6-7 points. Grade III 8-9 points. Venous/lymphatic invasion (yes/no) : no. Closest margin size (xy,n/a) mm: 1. If less than 2 mm then: Single focus of invasive tumor (yes/no) : yes. Single focus of DCIS (yes/no) : no. Multifocal invasive tumor (yes/no) : no. Multifocal DCIS (yes/no) : no. Nodes: Sentinel- number examined (xy,n/a) : 0. Sentinel- number involved (xy,n/a) : n/a. Regional- number examined (xy,n/a) : 39. Regional - number involved (xy,n/a) : 1. Markers: ER (xy%,n/a) : 95. Specimen: :atus: Reg# : Spec Type: CA SUMMARY. CANCER SUMMARY. PR (xy%,n/a) : o. Her-2/neu (0-3+,n/a) : 1. Ki-67 (xyt,n/a) : 95. Summary TNM: T: pT2. pN: pN1. Summary stage: 2B. ) (prelim.). (signature on file).",BRCA,1,"According to the report, there is metastatic carcinoma in 1 out of 38 examined axillary lymph nodes (1/38 ALN). This indicates a N1 stage for breast cancer.",N1,33.0
639,TCGA-A8-A083.AF0A2220-DEEC-44C8-B15C-B6442D5B7517,2,"Diagnosis: 1. Ablated breast sample with a highly differentiated invasive carcinoma. (tumor diameter: 9 cm) with circumscribed intraductal components. Tumor-free dorsal. resection margin. In conclusion, this is a highly differentiated invasive ductal carcinoma. Tumor classification: NOS, G I, pT3NOLOVORO.",BRCA,0,"The report does not mention any involvement of regional lymph nodes. Therefore, based on Modified Rule 8, the N stage is N0.",N0,33.0
581,TCGA-A7-A26E.EA830A26-3DF5-4731-AD0A-F20A61D58817,2,"DEPARTMENT OF PATHOLOGY AND LABORATORY MEDICINE. Date Coll: SPECIMEN. A. Left axillary sentinel node #1. B. Left breast stitch marks long lateral, short superior. C. Intraop lymph node left axilla. D. Right breast tissue long stitch lateral, short stitch superior. E. Left axillary content. CLINICAL NOTES. PRE-OP DIAGNOSIS: Left breast carcinoma. POST-OP DIAGNOSIS: Left breast carcinoma. CLINICAL HISTORY: Left breast carcinoma. FROZEN SECTION DIAGNOSIS. A - Two lymph nodes negative for metastatic disease. Amended diagnosis - Upon re-appraisal, the smaller node. contains. a focus of carcinoma consistent with lobular origin. GROSS DESCRIPTION. A. The specimen is received fresh for frozen section. labeled ""left axillary sentinel node #1"". It consists of. a. portion of hemorrhagic adipose tissue measuring 3.5 X 2.4 x 0.9 cm. On section it is fatty and slightly indurated consistent with nodal. tissue. One such node measures 3.2 x 1.8 x 0.6 cm. A second smaller. node is present measuring 0.6 cm. by 0.5 X 0.5 cm. The larger node. is bisected and all submitted for frozen section as FS1 and FS2. The smaller node is bisected and all submitted as FS3. B. Received fresh, labeled ""left breast"" is an 18.1 u. cm. (medial to lateral) X 15.5 cm. (superior to inferior) x. 5.0 cm. (anterior to posterior) diffusely cauterized soft, lobulated. tan gold-white portion of fibroadipose tissue in keeping with. breast. designated as left per requisition slip and container and oriented. by two sutures as stated previously. There is a 9. cm. (medial to. lateral) X 3.8 cm. (superior to inferior) wrinkled white skin. ellipse. with an eccentric, flattened, 1.2 x 1. 1 cm. nipple along the. anterior aspect. A well healed and retracted 1 cm. cicatrix is. present along the skin surface corresponding to the lower outer. quadrant. The anterior surface surrounding the lateral portion. of. the skin ellipse is inked blue, the intact deep margin is inked. black and the specimen is sectioned. There is a poorly defined,. stellate, 5.5 cm. (medial to lateral) x 4.0 cm. (superior to. inferior). x 2.2 (anterior to posterior) oblique rubbery tan white tumor mass,. extending from the lower outer quadrant centrally to the junction. of the four quadrants. A portion of tumor and a portion of normal. parenchyma are submitted for tissue procurement as requested. The. tumor focally extends to within 1.2 cm. of the inked deep margin and. 1.1 cm. from the anterior/skir surface. The parenchyma throughout. the remainder of the specimen consists predominently of glistening. lobulated golden yellow adipose tissue with a minimal amount of. interspersed delicate tan white fibrous tissue. No additional mass. lesion or abnormality is identified. Representative sections are. submitted in twelve blocks as labeled. RS-12. BLOCK SUMMARY: 1,2 - Tumor to inked deep margin; 3,4 - tumor to. overlying skin ellipse/anterior surface of the specimen;. tumor. to adjacent parenchyma; 8 - random upper outer quadrant; 9 - upper. inner quadrant; 10 - lower inner quadrant; 11 - lower outer. quadrant; 12 - nipple. C. Received fresh, labeled ""intraop lymph node left. axilla"". is 1 cm. in greatest dimension slightly rubbery white. pink. tissue in keeping with lymph node with a moderate amount of. associated adipose tissue. The specimen is bisected and entirely. submitted in one block. AS-1. D. Received fresh, labeled ""right breast tissue"" is. a. diffusely cauterized and slightly fragmented, 8.6. cm. (medial to lateral) X 6.4 cm. (anterior to posterior) x 3.4. cm. (superior to inferior) soft, lobulated tan gold-white portion of. fibroadipose tissue, with two sutures as stated previously. The. margins are inked as follows: superior blue, inferior black,. anterior green, and posterior orange. The specimen is sectioned. from medial to lateral. There is a 6.5 cm. (medial to lateral) x. 4.2. cm. (anterior to posterior) X 1.0 cm. (superior to inferior) vacant. biopsy cavity occupying the majority of the specimen. The cavity. is. focally contiguous with the anterior, posterior, and superior inked. margins. No residual lesion or abnormality is noted grossly. The. cut surfaces throughout the specimen consist predominately of. mildly. congested glistening lobulated golden yellow adipose tissue with a. scant amount of interspersed delicate tan white fibrous tissue. Representative sections are submitted in a sequential manner from. medial to lateral in ten blocks as labeled. RS-10. BLOCK SUMMARY: 1 - Perpendicular sections entire medial margin cap;. J - sequential sections; 10 - representative perpendicular. sections lateral margin cap. E. Received fresh, labeled ""left axillary content"" is an. unoriented, 6.5 x 5.8 x 1.8 cm. portion of soft, lobulated. golden yellow adipose tissue. Several soft to slightly rubbery. pale. tan tissues in keeping with lymph nodes measuring up to 1.8 cm. in. greatest dimension are recovered. The lymphoid tissues are. entirely. submitted in three blocks as labeled. RS-3. BLOCK SUMMARY: 1 - Eight whole lymph nodes; 2 - five whole lymph. nodes; 3 - one bisected lymph node. MICROSCOPIC DESCRIPTION. A. Two lymph nodes are examined in their entirety at. multiple levels. The smaller contains a 3 mm. metastasis. with minimal extra-capsular extension, ,. B. The previously biopsied large tumor is an infiltrating. lobular carcinoma. In one 2 mm. area (block #6 within the. main tumor) , there is a focus of invasive ductal carcinoma which is. nuclear grade 1 (architectural score 1, nuclear score 2, mitotic. score 1) . In addition, in blocks 4 and 5 there is in situ tumor. which, with the help of E-Cadherin stain, proves to be ductal. carcinoma in situ, nuclear grade 2. Please see the template below. Invasive carcinoma: Histologic type: Infiltrating lobular carcinoma with single. small focus of associated infiltrating ductal carcinoma. Histologic grade: The invasive lobular carcinoma is moderately. differentiated. Overall grade: [ Last Name (un) 1] SBR grade 2. Architectural score: 3. Nuclear score: 2. Mitotic score: 1. Greatest dimension (pT) : The tumor measures 5.5 cm., pT3. Specimen margins: Negative. Vessel invasion Suspicious for lymphatic invasion. Perineural. invasion is noted. Calcification: Negative. Nipple (Paget's) : No Paget's disease of the nipple is present. Major lactiferous ducts, however, contain lobular neoplasia in. situ, supported by stain for E-Cadherin. There is also a 1.5. mm. of invasive lobular carcinoma within the subareolar tissue,. supported by stains for P63 and E-Cadherin. Invasion of skin or chest wall: Negative. Ductal carcinoma in situ (supported by stain for E cadherin) : Histologic pattern: Solid. Nuclear grade: 2. Central necrosis: Negative. : DCIS of total tumor (if mixed) : The DCIS appears to be. separate from the invasive lobular carcinoma. Extensive intraductal component (present/absent) : Absent. Specimen margins: Negative. Calcification: Negative. Description of non-tumorous breast: Fibrocystic changes are also. present, including cysts, apocrine metaplasia, a 3 mm. fibroadenoma. and rare calcification. Comments: E-Cadherin on block #5 supports the diagnosis of ductal. carcinoma in situ. Lymph nodes: Number of positive nodes of total: As per parts A, C and E,. there are 16 1 mmnh nodes. one of which contains metastatic. carcinoma, l. Size of largest metastasis: 3 mm. Extracapsular extension (present/absent) : Present. pN: 1A. Distant metastasis (pM) : Cannot be assessed. Prognostic markers: Please see. C. A single lymph node is present. Negative for. metastatic. disease, 0/1. D. This portion of tissue contains biopsy site changes. In. situ tumor is noted in blocks 1 through 7. With the. assistance of stains for E-Cadherin on all of these blocks, it is. apparent that the tumor in blocks. ] and 5 is lobular. carcinoma in. situ. The tumor in blocks 4, 6 and 7 prove to be ductal carcinoma. in situ. Also, in block 7, there is a 1.1 mm. focus of invasive. tumor which proves to be of ductal origin. Please see the template. below for the details regarding the ductal tumor. Invasive Carcinoma: Histologic type Infiltrating ductal carcinoma. Histologic grade: Moderately differentiated. Overall grade: Last Name (un) 1] SBR grade 2. Architectural score: 3. Nuclear score: 2. Mitotic score: 1. Greatest dimension (pT) : The tumor measures 1.1 mm., pTla. Specimen margins: Invasive tumor is less than 1 mm from the. inferior margin. Vessel invasion : Negative. Calcification: Negative. Ductal carcinoma in situ: Histologic pattern: Solid and cribriform. Nuclear grade: 2. Central necrosis: Negative. DCIS of total tumor (if mixed) : The invasive component is very. minor relative to the in situ component. Extensive intraductal component (present/absent) : Present. Specimen margins: DCIS less than 1 mm. from the inferior margin. Calcification: Negative. Description of non-tumorous breast: Cysts and apocrine metaplasias. present. Comments: In addition to the invasive and in situ ductal. carcinoma,. there are foci of lobular carcinoma in situ. Prognostic markers: Cold ischemia time too long for accurate. marker. studies. E. Thirteen lymph nodes are present, all negative for. metastatic disease, 0/13. This is supported by negative. keratin stains on blocks 1 through 3. [A few of the antibodies used in our laboratory may be classified. as. analyte specific reagents. These antibodies are monitored and. controlled in our laboratory and their performance for in [Last Name. (un) 2]. diagnosis is well described in the medical literature. They have. not been cleared or approved by the FDA. ]. 14, 15x2, 4x5, 20x12, PGRI 3260F. DIAGNOSIS. A. Left axillary sentinel node #1, excision -. Two lymph nodes, one of which contains metastatic carcinoma,. B.(Left) breast, mastectomy -. Large (5.5 cm. ) infiltrating lobular carcinoma, minor. associated component of invasive ductal carcinoma. Ductal. carcinoma in situ also present. A second minute focus of. invasive lobular carcinoma is present in the sub-areolar. tissue. All margins are negative for tumor. C. Intraoperative lymph node left axilla, excision -. Single lymph node negative for metastatic disease, 0/1. D. Right breast tissue, excision -. Breast tissue with biopsy site changes, lobular carcinoma in. situ, ductal carcinoma in situ and invasive ductal carcinoma,. SBR grade 2. The invasive ductal. carcinoma and ductal. carcinoma in situ are. less than 1 mm. from the inferior margin. Hormone receptor. studies cannot accurately be performed on the invasive ductal. carcinoma. E. Left axillary contents, dissection -. Thirteen lymph nodes all negative for metastatic disease,. 0/13.",BRCA,1,"Based on the report, one out of 16 examined lymph nodes contained metastatic carcinoma. This corresponds to N1 stage according to the rules provided.",N1,33.0
648,TCGA-A8-A08H.33188769-D86E-41AD-A74D-31A7C2DD08B7,1,"Diagnosis: 1. Tumor-free structurally intact lymph nodes. 2. Invasive ductal breast carcinoma (maximum diameter 2.5 cm, malignancy grade II) at the. site of the macroscopically described nodular formation. In the immediate tumor periphery. high-grade DCIS (procomponent of tumor < 10%) with inclusion also of coarse calcification. Remaining glandular tissue, rich in fatty tissue, in involution and free of atypia. Histologically. unremarkable skin spindle. Tumor classification: G2 (L0, V0), pTlc, pN0 (sn), MX, R0 (minimum width of dorsocranial. safety margin 1 cm!).",BRCA,0,"The report states that there is no evidence of cancer in the regional lymph nodes (pN0 (sn)), which means that the N stage is N0.",N0,33.0
657,TCGA-A8-A08X.CA911D90-5DDA-49F1-993F-68FCA77A8558,3,"Diagnosis: Poorly differentiated invasive ductal carcinoma with focal intraductal components and. angioinvasion (maximum microscopic tumor diameter: 4.0 cm). Diagnosis: 1. Ablated (left) breast sample with extensive further invasive and angioinvasive. tumor components, as well as foci of further intraductal tumor components in the. cavity region of the sample excision (maximum spread: 8 cm). Massive subepidermal. carcinomatous lymphangitis of the skin spindle. Dorsal resection margin tumor-free. Comment: The massive subepidermal carcinomatous lymphangitis in the region of the skin. spindle could correlate closely with the clinical appearance of an inflammatory. carcinoma, although there is no ulceration of the skin spindle. This gives rise to the concluding tumor classification NOS, G III, pT3N3aL1V1R0.",BRCA,3,"The report mentions that the patient has been diagnosed with a tumor classified as NOS, pT3N3aL1V1R0. The 'N3' in this classification indicates that the cancer has spread to 10 or more axillary lymph nodes or has metastasized to infraclavicular lymph nodes, with or without extranodal extension.",N3,34.0
611,TCGA-A8-A06P.AADFAF8B-92B8-4292-96A3-912D55EB9C31,0,"Diagnosis: Ablated material from the right breast with a bifocal invasive ductal breast carcinoma grade. II. The larger focus is 1.1 cm in size and the smaller one 0.8 cm (measured in the histological. preparation). Complete resection of carcinoma extending to the healthy tissue on all sides. (minimum caudal margin of 0.5 cm). Tumor classification: pTlc (m), pN2a (7/25), MX, R0, G2 (L0, V0).",BRCA,2,"The report indicates that the patient has a pTlc (m), pN2a (7/25) classification. The 'pN2a' indicates that there is metastasis in 4 to 9 axillary lymph nodes, which aligns with New Rule 11 and New Rule 20. The report states that 7 out of 25 lymph nodes were positive, which supports the pN2a classification.",N2,35.0
623,TCGA-A8-A07C.DC5B662B-1ADD-4D6E-A6E3-3EF8B922BC71,1,"Diagnosis: 1. and 2. Bifocal poorly differentiated invasive ductal carcinoma (tumor diameters: 2.8 and. 0.8 cm). Concluding tumor classification: NOS, G III, pT2(mult)NOLOVORO.",BRCA,0,"The report does not mention any involvement of regional lymph nodes, therefore, based on Modified Rule 8, the N stage is N0.",N0,35.0
556,TCGA-A2-A3XX.770EEADF-19CD-4AB9-A7FA-1A05EE17984C,1,"Specimen #: (Age. Race. SPECIMEN: A: SENTINEL NODE #1 B: LEFT BREAST TISSUE. FINAL DIAGNOSIS: A. LYMPH NODE, SENTINEL #1, BIOPSY: - ONE (1) LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA BY H&E AND. IMMUNOSTAINS. B. BREAST, LEFT, MASTECTOMY: - TUMOR TYPE: INFILTRATING DUCTAL CARCINOMA. - NOTTINGHAM GRADE: 3 OUT OF 3. - NOTTINGHAM SCORE: 8 OUT OF 9 (Tubules= 3, Nuclei= 2, Mitoses= 3. mitotic count 22 per 10 HPF at 40x power). TUMOR SIZE (GREATEST DIMENSION) : 2.2 CM (MEASURED GROSSLY). - TUMOR NECROSIS: PRESENT IN BOTH THE INVASIVE AND IN SITU COMPONENTS. - MICROCALCIFICATIONS: ABSENT. - VENOUS / LYMPHATIC INVASION: ABSENT. - MARGINS NEGATIVE. DISTANCE OF TUMOR FROM NEAREST MARGIN IS 0.1 CM, FROM THE. SUPERFICIAL (GREEN INKED) MARGIN. (MEASURED MICROSCOPICALLY) (SLIDE. B6). - INTRADUCTAL COMPONENT: PRESENT. DUCTAL CARCINOMA; HIGH NUCLEAR GRADE. (GRADE III) SOLID SUBTYPE WITH CENTRAL NECROSIS. - LYMPH NODES: ONE (1) NEGATIVE FOR TUMOR. (SEE PART A). - NIPPLE INVOLVEMENT: ABSENT. - SKIN INVOLVEMENT: ABSENT. - MULTICENTRICITY: ABSENT. - ESTROGEN RECEPTORS: NEGATIVE (SEE CASE. - PROGESTERONE RECEPTORS : NEGATIVE (SEE CASE. - HER 2 NEU by IHC: NEGATIVE (SEE CASE. - PATHOLOGIC STAGE: pT2 NO (i-) MX. - ADDITIONAL PATHOLOGIC CHANGES. INTRADUCTAL PAPILLOMA. FIBROADENOMATOUS CHANGES. FIBROCYSTIC CHANGES. COMMENT: Cytokeratin staining of part A supports the above diagnosis. This case received prospective intradepartmental peer review. FOR OFFICIAL USE ONLY - PERSONAL DATA - PRIVACY ACT OF. FOR OFFICIAL US ONLY - PERSONAL DATA - PRIVACY ACT or. Specimen #. FINAL DIAGNOSIS (continued). CLINICAL DIAGNOSIS AND HISTORY: yr old. with left breast cancer. PRE-OPERATIVE DIAGNOSIS: none provided. POST-OPERATIVE DIAGNOSIS: none provided. GROSS DESCRIPTION: A: Received fresh, labeled with the patient's name,. Id. designated ""Sentinel Node #1 with markings; suture marks hottest point at. 1152 hours"" is a 2.5 x 2.5 x 0.7 cm irregular portion of soft tissue. Sectioning reveals a 2.5 x 1.5 x 0,5 cm pink-tan lymph node with attached. adipose tissue. The specimen is entirely submitted as follows: Cassette Summary: A1- sentinel lymph node; A2- adipose tissue. At the time of submission the specimen will have been in formalin for. approximately 23 hours Matched sections of cassette A1 are. submitted in OCT for. Protocol. B: Received fresh, labeled with the patient's name,. and. designated ""Left Breast Tissue, long-lateral, short-superior 1 pm' is. a. 468 gm left mastectomy specimen oriented with a short stitch at the. superior aspect and long stitch at the lateral aspect. The specimen. measures 20.0 cm from superior to inferior by 18.0 cm from medial to. lateral by 3.0 cm from anterior to posterior. The darkly pigmented skin. ellipse measures 9.5 x 3.5 cm and displays a 1.5 cm centrally located,. everted nipple free of discharge. The deep margin is inked in black, and. the left outer quadrant superficial margin is inked in green. Serial. sectioning reveals a 11-circumscribed 2.2 x 2. x 1.8 cm mass in the. lower outer quadrant located 0.3 cm from the superficial margin and 0. cm. from the deep margin. The cut surface is firm gritty pink-red and focally. congested. The remainder of the specimen is composed of evenly. distributed pink-tan fibrous tissue admixed adipose tissue. No additional. lesions are identified. No lymph nodes are identified within the specimen. FOR OFFICIAL USE ONLY - PERSONAL DATA - PRIVACY ACT OF. FOR OFFICIAL USE ONLY - PERSONAL DATA - PRIVACY ACT or. specimen #: GROSS DESCRIPTION (continued) : Representative sections are submitted. At the time of submission the. specimen has fixed in formalin for approximately 21 hours. Cassette Summary: B1- - skin; B2-B3 - lower outer quadrant deep margin;. B4-B6- mass with superficial margin; B7 - representative section of grossly. normal breast parenchyma from the upper outer quadrant; B8- representative. section of grossly normal breast parenchyma from the upper inner quadrant;. B9 representative section of grossly normal breast parenchyma from the. lower inner quadrant; B10- representative section of grossly normal breast. parenchyma from the lower outer quadrant; B11- - representative section of. grossly normal breast parenchyma from the central area; B12-. representative section of nipple with associated subcutaneous tissue. Matched sections of cassette B1, B4-B5, B7-B11 are submitted in OCT for. ) Protocol. FOR OFFICIAL USE ONLY - PERSONAL DATA - PRIVACY.",BRCA,0,"The report states that one sentinel lymph node was negative for tumor (part A of the report). This indicates no evidence of cancer in the regional lymph nodes, which corresponds to N0 according to Rule 2.",N0,35.0
512,TCGA-A2-A0SW.8401DFCF-8793-461A-B17E-E6584CE2423B,1,"Lab No.: F. Date Collected: Date Received: Doctor: M.R. No.: Room No: Hosp.No: CLINICAL HISTORY: PREOPERATIVE DIAGNOSIS: Right Breast Cancer. POSTOPERATIVE DIAGNOSIS: OPERATION: Lumpectomy Right Breast, Right Sentinel Lymph Node Biopsy. SPECIMEN: A) Right Breast Mass - 1 Short Anterior - 2 Short Superior - 1 Long. Medial, B) Sentinel Node #1 F.S., C) Sentinel Node #2 F.S., D) Axillary Contents E). Gross Margin Additional Inferior Margin Right Breast Mass suture New Inferior Margin. FROZEN SECTION DIAGNOSIS: A) GROSS MARGINS: VERY CLOSE (LESS THAN 1 MM), TO. INFERIOR MARGIN. B) SENT LYMPH NODE #1 - POSITIVE FOR METASTATIC. CARCINOMA. C) SENT LYMPH NODE #2 - POSITIVE FOR METASTATIC. CARCINOMA. Lab No.: F. Date Collected: Date Received: Doctor: M.R. No.: Room No: Hosp.No: FINAL DIAGNOSIS: A) RIGHT BREAST TISSUE - POORLY DIFFERENTIATED. INFILTRATING DUCTAL CARCINOMA. SCARFF-BLOOM-RICHARDSON GRADE III/III. THE TUMOR MEASURES 3.5 CM. IN MAXIMUM DIMENSION AND. FOCALLY CLOSE TO ANTERIOR AND POSTERIOR SURGICAL. MARGINS, (LESS THAN 1 MM.), SLIDES #5 AND #6. THE REMAINING SURGICAL MARGINS ARE FREE OF THE. LESION. LYMPHOVASCULAR INVASION IS IDENTIFIED. MICROCALCIFICATIONS ARE IDENTIFIED. B) SENTINEL LYMPH NODE - ONE (1) POSITIVE LYMPH NODE, (1/1). C) SENTINEL LYMPH NODE - ONE (1) POSITIVE LYMPH NODE, (1/1). D) AXILLARY CONTENTS - 2 OF 13 LYMPH NODES ARE POSITIVE FOR. MALIGNANCY, (2/13). E) ADDITIONAL RIGHT BREAST TISSUE - NEGATIVE FOR. MALIGNANCY. PTNM CLASSIFICATION: PIIIa, T2, N2, MX.",BRCA,2,"Based on the pathology report, there are positive lymph nodes found in the sentinel lymph node biopsy (1/1) and in the axillary contents (2/13). This indicates that the cancer has spread to regional lymph nodes. According to the rules provided, specifically New Rule 11, N2 stage for breast cancer indicates metastasis in 4 to 9 axillary lymph nodes or positive in internal mammary nodes in the absence of axillary lymph node metastasis. However, the report only mentions axillary lymph node involvement. Therefore, we can apply New Rule 14, which states N2a indicates metastasis in 1 to 3 axillary lymph nodes with extracapsular extension or metastasis in 4 to 9 axillary lymph nodes without extracapsular extension. In this case, there are 2/13 positive lymph nodes in the axillary contents, which falls within the N2a category.",N2,36.0
667,TCGA-A8-A099.34499A83-DFCE-4DB8-BAA0-A7590AF8BC07,3,"Diagnosis: 1. Ablated breast sample with a moderately differentiated invasive ductal carcinoma. (tumor diameter 105 cm) with focal ulceration of the skin and a satellite node. (diameter 0.9 cm) in the skin. Tumor-free dorsal resection margin. Together with the preliminary finding, this gives rise to the following tumor. classification: NOS, G II, pT4b pN3a(11/22)LOVORO. :34499A83-DFCE-4D88-BAA0-A7590AF8BC07.",BRCA,3,"The report mentions pN3a(11/22), which indicates that 11 out of 22 lymph nodes are positive for metastasis. According to New Rule 22, N3a indicates metastasis in 10 or more axillary lymph nodes or in infraclavicular lymph nodes, with or without extranodal extension.",N3,37.0
608,TCGA-A7-A6VY.BB85F844-C710-41D5-8620-E246DC9D2C6A,1,"Final Surgical Pathology Report. Procedure: Diagnosis. A. Right breast, excisional biopsy: Infiltrating ductal carcinoma, grade 3, 3.5 cm in greatest dimension. Invasive carcinoma 1 mm from posterior margin of resection. Ductal carcinoma in situ, solid subtype, nuclear grade 3, accounting. for less than 5% of the tumor, margins uninvolved. B. Right axillary contents, resection: Metastatic carcinoma in 2 of 14 lymph nodes, size of largest. metastasis 3.4 cm, extracapsular extension present (2/14). Microscopic Description: Microscopic examination performed. A. Invasive Carcinoma: present. Histologic type: infiltrating ductal cancer. Histologic grade: Overall grade: 3. Architectural score: 3. Nuclear score: 3. Mitotic score: 3. Greatest dimension (pT) : 3.5 cm, pT2. Specimen margins: negative but close, 1 mm from the. posterior margin (black in block A6). Vessel invasion: not identified. Ductal carcinoma in situ: present. Histologic pattern: solid. Nuclear grade: 3. Central Necrosis: focal. 8 DCIS of total tumor (if mixed) : < 5%. Extensive intraductal component (present/absent : absent. Specimen margins: negative, 3 mm from posterior. Calcification: not identified. B. Sections of the axillary dissection demonstrate metastatic. carcinoma in 2 of 14 lymph nodes, (pN1). The size of largest. metastasis is 3.4 cm. Extracapsular extension is present. Specimen. A. Right breast mass. B. Right axillary contents. Clinical Information. Right breast cancer -year-old black female with right cancer and. positive nodes. Gross Description. Received fresh in a transpec container, subsequently fixed in formalin. labeled ""right breast mass"" is a 6.0 x 5.5 x 4.5 cm yellow pink fatty. tissue fragment which has a short suture designating superior and a. long suture designating anterior. The margins are inked as follows. based upon the orienting sutures: superior - orange; anterior - blue;. posterior - black; inferior - green. The specimen is serially. sectioned from medial to lateral. There is a 3.5 x 3.2 x 2.5 cm ill. circumscribed white tan mass centrally located, and within 0.2 cm of. the closest margin (deep) White rice-like pellets or gross identified. in the central which we be grossly consistent with a previous biopsy. site. The specimen is received in pathology it. nd fixed in. formalin and. Representative sections of the specimen are. submitted as IOLLOWS: 1 - medial margin perpendicular, 2 - lateral. margin perpendicular. ? - 10 - representative sections of the remainder. of the specimen. B. Received fresh and subsequently fixed in formalin labeled ""right. axillary contents"" is a 12.0 x 6 x 5 x 2.5 cm aggregate of yellow fatty. tissue grossly consistent with axillary contents. The specimen has a. suture designating superior. Multiple lymph nodes are palpated the. largest measuring 3.4 cm and located midway through the specimen. The. highest is markedly indurated as is the largest lymph node. The lymph. nodes are submitted from highest to lowest as follows: 1 -lymph node. bisected, 2 - 3 possible lymph nodes, 3 - 4 - 3 possible lymph nodes. each, 5 - representative section of largest positive lymph node, /1. possible lymph node bisected, 7 - 2 possible lymph nodes, 8 - 1. possible lymph node.",BRCA,1,"Based on the pathology report, there is metastatic carcinoma present in 2 out of 14 lymph nodes (pN1) in the right axillary contents. The largest metastasis is 3.4 cm with extracapsular extension.",N1,38.0
489,TCGA-A2-A0CY.CB780DE7-E98C-4F7E-9487-8F25FE80DC21,1,"Specimen #: Race: WHITE. Physician (s) : SPECIMEN: A: RIGHT BREAST B: LEFT BREAST C: SENTINEL LYMPH NODE #1. D: LEFT AXILLARY CONTENTS E: NON SENTINAL , ,LT AXILLARY L.N. FINAL DIAGNOSIS: A. BREAST, RIGHT, MASTECTOMY: - BENIGN BREAST TISSUE WITH FIBROCYSTIC CHANGES INCLUDING SCLEROSIS,. MICROCYST FORMATION, USUAL DUCTAL HYPERPLASIA, DUCT ECTASIA, AND. FOCAL MICROCALCIFICATION . B. BREAST, LEFT, MASTECTOMY: TUMOR TYPE: INVASIVE DUCTAL CARCINOMA. NOTTINGHAM GRADE: III/III. NOTTINGHAM SCORE: 9/9. (Tubules= 3, Nuclei= 3, Mitoses= 3). TUMOR SIZE (GREATEST DIMENSION OF INVASIVE COMPONENT) : 3.5 CM. (MEASURED GROSSLY). TUMOR NECROSIS: PRESENT. VENOUS / LYMPHATIC INVASION: IDENTIFIED. MARGINS : - DISTANCE OF TUMOR FROM NEAREST MARGIN IS 0.4 CM, FROM THE. SUPERFICIAL LOWER OUTER QUADRANT (BLUE INK) MARGIN. INTRADUCTAL COMPONENT: MULTIFOCAL, HIGH GRADE, SOLID AND COMEDO TYPE. EXTENDING WELL BEYOND THE INVASIVE COMPONENT. NIPPLE INVOLVEMENT: NOT IDENTIFIED. LYMPH NODES 1 OF 22 POSITIVE FOR TUMOR (PARTS C-E). SKIN INVOLVEMENT: NOT IDENTIFIED. ESTROGEN RECEPTORS : POSITIVE (STRONG, >75% OF CELLS, FROM. HER 2 NEU by IHC: NEGATIVE (1+ STAINING, FROM. PROGESTERONE RECEPTORS: NEGATIVE (WEAK, <5% OF CELLS, FROM. PATHOLOGIC STAGE: pT2 N1 MX. ADDITIONAL PATHOLOGIC CHANGES: FIBROCYSTIC CHANGES INCLUDING MICROCYST. FORMATION, FOCAL DUCT ECTASIA, SCLEROIS, USUAL DUCTAL HYPERPLASIA, AND. APOCRINE METAPLASIA. C. LYMPH NODE, LEFT SENTINEL, EXCISION: - AND ONE (1) LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA BY HEMATOXYLIN. EOSIN AND IMMUNOHISTOCHEMICAL (CYTOKERATIN) STAINS. Specimen #: FINAL DIAGNOSIS (continued) : D. LYMPH NODE, LEFT AXILLA, EXCISION: - TWENTY (20) LYMPH NODES NEGATIVE FOR METASTATIC CARCINOMA. E. LYMPH NODE, LEFT NON-SENTINEL, EXCISION: - ONE (1) LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA. COMMENT: confirmed on the permanent sections. In specimen ""E"" the frozen section diagnosis of metastic carcinoma is. CLINICAL DIAGNOSIS AND HISTORY: year old white female with history of left breast cancer. FROZEN SECTION DIAGNOSIS: SPECIMEN TYPE:LYMPH NODE (SPECIMEN ""E"") . REPORTED TO: AND. # BLOCKS : 1. # SCRAPE PREPS : 1. FROZEN SECTION DIAGNOSIS : POSITIVE FOR METASTATIC CARCINOMA. GROSS DESCRIPTION: A. Received in fresh labeled with the patient's name. of labeled a 927 ""RIGHT BREAST SHORT STITCH SUPERIOR, LONG STITCH LATERAL consists. and gram mastectomy specimen oriented with a short stitch superior. pigmented 1.0 superficial skin ellipse measures 17 x 11.5 cm and. superior to inferior, and 5 cm anterior to posterior. The lightly. long lateral. The specimen measures 24 cm medial to lateral, 19 cm. The deep cm centrally located everted nipple. No discharge or scar displays is noted. a. tan margin is inked in black. Serial sections reveal lobulated yellow. tissue. adipose tissue admixed with 10% moderately dense tan white fibrous. catted grey cysts measuring up to 0.4 cm in greatest dimension. blue The fibrous tissue is predominantly centrally located and shows. 1. Specimen #: GROSS DESCRIPTION (continued) : discrete mass or lesion identified. No lymph nodes are identified. Cassette summary : A1: skin. A2: central. A3: upper outer quadrant. A4: lower outer quadrant. A5: lower inner quadrant. A6: upper inner quadrant. A7: upper outer quadrant. A8: lower outer quadrant. A9: lower inner quadrant. A10: upper inner quadrant. All: representative section of nipple. Matched sections of A1-A6 are submitted in OCT for CBCP protocol. B. Received fresh labeled with the patient's name. designated ""LEFT BREAST SHORT STITCH SUPERIOR, LONG LATERAL"" is a 954. gram mastectomy specimen oriented with a short stitch superior and long. lateral. The specimen measures 24 cm medial to lateral, 18 cm superior. inferior, and 6 cm anterior to posterior. The lightly pigmented. to. superficial located skin ellipse measures 19 x 12.5 cm and displays a medially. deep inked margin is inked black and the superficial lower outer quadrant is. 1.5 cm everted nipple free of discharge. No scar is noted. The. located lobulated pink white indurated mass with focal hemorrhage. The mass. blue. Serial sections reveal 3.5 x 3.2 x 2.8 cm well defined. deep the margin and 0.4 cm of the inked superficial surface. The remainder. within the lower outer quadrant and comes within 3.5 cm of the is. tissue which is diffusely nodular and focally cystic. The admixed. specimen is composed of approximately 50% dense tan white fibrous. of. adipose tissue is unremarkable. No additional masses are identified. No. lymph nodes identified. Cassette summary: B1: skin. B2: lower outer quadrant mass. B3: lower outer quadrant. B4: upper outer quadrant. B5: upper inner quadrant. B6: lower inner quadrant. B7: representative section of closest deep margin. blue B8-B9: ink representative sections of mass with closest point of approach to. margin. 10: representative section of nipple. 10CF. Specimen #: GROSS DESCRIPTION (continued) : C. Received fresh labeled with the patient's name. designated. SENTINEL LYMPH NODE #1"" consists of a 2.0 x 1.7 x 1.0 cm. pink yellow fatty lymph node. The specimen is trisected. Two thirds of the. lymph node are placed in cassette C1 and C2. Matched section of C1 is. placed in. for CBCP protocol. D. Received fresh labeled with the patient's name. designated ""LEFT AXILLARY CONTENTS"" consists of an unoriented irregular. portion of adipose tissue measuring 9.0 x 9.0 x 2.0 cm. Sectioning reveals. multiple pink yellow fatty lymph nodes ranging in size from 0.4 to 2.4 cm. in greatest dimension. Cassette summary. D1-D3: one lymph node each. D4-D7: one lymph node bisected. D8: two lymph nodes bisected, one inked black. D9: four intact lymph nodes. D10: one lymph node bisected. D11: two lymph nodes. D12: four possible lymph nodes. 12CF. E. Received fresh labeled with the patient's name. designated ""NON SENTINEL CLINCALLY SUSPICOUS LEFT AXILLARY LYMPH NODE'. consists of a 1.7 x 1.5 x 1.3 cm lymph node. Cut surface is homogeneous. and firm. A portion is submitted for frozen section. 1C1.",BRCA,1,"Based on the report, there is 1 out of 22 lymph nodes positive for metastatic carcinoma in the left axillary contents (specimen E). This indicates that the patient's N stage is N1.",N1,39.0
642,TCGA-A8-A086.D4E86E20-B75E-4CDA-83F2-22C481D4B9E8,0,"Diagnosis: 1. Moderately differentiated invasive ductal carcinoma (tumor diameter: 1.9 cm) with. focal intraductal components. Together with the preliminary finding, this gives rise to the following tumor. classification: NOS, G II, pT1cN1aL1V0R0.",BRCA,1,"Based on the report, the N stage is N1a, which indicates metastasis in 1 to 3 axillary lymph nodes. The 'N1' category is further divided into substages (N1a, N1b, N1c), but for this question, we are asked to only determine the main N stage.",N1,40.0
